10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

FORM 10-Q

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2014

or

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 1-9819

DYNEX CAPITAL, INC.

(Exact name of registrant as specified in its charter)

Virginia	52-1549373
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
4991 Lake Brook Drive, Suite 100, Glen Allen, Virginia	23060-9245
(Address of principal executive offices)	(Zip Code)
(804) 217-5800 (Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes           x           No           o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes           x           No           o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o (Do not check if a smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes           o           No           x

On November 3, 2014, the registrant had 54,736,663 shares outstanding of common stock, $0.01 par value, which is the registrant’s only class of common stock.

DYNEX CAPITAL, INC.

FORM 10-Q

INDEX

			Page
PART I.	FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Consolidated Balance Sheets as of September 30, 2014 (unaudited) and December 31, 2013	1
		Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2014 (unaudited) and September 30, 2013 (unaudited)	2
		Consolidated Statements of Shareholders' Equity for the nine months ended September 30, 2014 (unaudited)	3
		Consolidated Statements of Cash Flows for the nine months ended September 30, 2014 (unaudited) and September 30, 2013 (unaudited)	4
		Notes to the Unaudited Consolidated Financial Statements	5
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	50
	Item 4.	Controls and Procedures	54
PART II.	OTHER INFORMATION
	Item 1.	Legal Proceedings	55
	Item 1A.	Risk Factors	55
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	55
	Item 3.	Defaults Upon Senior Securities	56
	Item 4.	Mine Safety Disclosures	56
	Item 5.	Other Information	56
	Item 6.	Exhibits	57
SIGNATURES			58

i

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

CONSOLIDATED BALANCE SHEETS

(amounts in thousands except share data)

	September 30, 2014			December 31, 2013
ASSETS	(unaudited)
Mortgage-backed securities (including pledged of $3,420,668 and $3,873,584, respectively)	$	3,615,393		$	4,018,161
Mortgage loans held for investment, net	41,454			55,423
Cash and cash equivalents	56,639			69,330
Restricted cash	32,755			13,385
Derivative assets	7,297			18,488
Receivable for securities sold	16,321			—
Principal receivable on investments	11,124			12,999
Accrued interest receivable	20,986			21,703
Other assets, net	11,542			7,648
Total assets	$	3,813,511		$	4,217,137
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities:
Repurchase agreements	$	3,150,254		$	3,580,754
Payable for unsettled mortgage-backed securities	—			10,358
Non-recourse collateralized financing	11,194			12,914
Derivative liabilities	18,058			6,681
Accrued interest payable	1,492			2,548
Accrued dividends payable	15,621			16,601
Other liabilities	2,845			1,405
Total liabilities	3,199,464			3,631,261
Shareholders’ equity:
Preferred stock, par value $.01 per share, 8.5% Series A Cumulative Redeemable; 8,000,000 shares authorized; 2,300,000 shares issued and outstanding ($57,500 aggregate liquidation preference)	55,407			55,407
Preferred stock, par value $.01 per share, 7.625% Series B Cumulative Redeemable; 7,000,000 shares authorized; 2,250,000 shares issued and outstanding ($56,250 aggregate liquidation preference)	54,251			54,251
Common stock, par value $.01 per share, 200,000,000 shares authorized; 54,734,817 and 54,310,484 shares issued and outstanding, respectively	547			543
Additional paid-in capital	763,228			761,550
Accumulated other comprehensive income (loss)	16,462			(33,816		)
Accumulated deficit	(275,848		)	(252,059		)
Total shareholders' equity	614,047			585,876
Total liabilities and shareholders’ equity	$	3,813,511		$	4,217,137

See notes to unaudited consolidated financial statements.

1

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

(amounts in thousands except per share data)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Interest income:
Mortgage-backed securities	$	25,207		$	30,820		$	79,104		$	95,827
Mortgage loans held for investment	793			846			2,255			2,711
	26,000			31,666			81,359			98,538
Interest expense:
Repurchase agreements	6,028			8,477			20,187			29,860
Non-recourse collateralized financing	30			241			76			760
	6,058			8,718			20,263			30,620
Net interest income	19,942			22,948			61,096			67,918
Provision for loan losses	—			—			—			(261		)
Gain (loss) on derivative instruments, net	4,842			(24,019		)	(31,654		)	(12,683		)
Gain (loss) on sale of investments, net	9,057			(825		)	5,273			2,597
Fair value adjustments, net	42			150			162			(590		)
Other income, net	897			748			1,108			761
General and administrative expenses:
Compensation and benefits	(2,351		)	(2,282		)	(7,232		)	(6,948		)
Other general and administrative	(1,563		)	(1,347		)	(4,620		)	(4,284		)
Net income (loss)	30,866			(4,627		)	24,133			46,510
Preferred stock dividends	(2,294		)	(2,294		)	(6,882		)	(5,608		)
Net income (loss) to common shareholders	$	28,572		$	(6,921	)	$	17,251		$	40,902
Other comprehensive income:
Change in fair value of available-for-sale investments	$	(6,867	)	$	(2,671	)	$	50,212		$	(112,037	)
Reclassification adjustment for (gain) loss on sale of investments, net	(9,057		)	825			(5,273		)	(2,597		)
Change in fair value of cash flow hedges	—			—			—			16,381
Reclassification adjustment for cash flow hedges (including de-designated hedges)	1,442			2,583			5,339			11,379
Total other comprehensive (loss) income	(14,482		)	737			50,278			(86,874		)
Comprehensive income (loss) to common shareholders	$	14,090		$	(6,184	)	$	67,529		$	(45,972	)
Weighted average common shares - basic and diluted	54,731			54,904			54,690			54,728
Net income (loss) per common share - basic and diluted	$	0.52		$	(0.13	)	$	0.32		$	0.75
Dividends declared per common share	$	0.25		$	0.27		$	0.75		$	0.85

See notes to unaudited consolidated financial statements.

2

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(UNAUDITED)

(amounts in thousands)

	Preferred Stock		Common Stock			Additional Paid-in Capital			Accumulated Other Comprehensive (Loss) Income			Accumulated Deficit			Total
Balance as of  December 31, 2013	$	109,658	$	543		$	761,550		$	(33,816	)	$	(252,059	)	$	585,876
Stock issuance	—		1			215			—			—			216
Granting and vesting of restricted stock	—		4			2,041			—			—			2,045
Amortization of stock issuance costs	—		—			(72		)	—			—			(72		)
Adjustments for tax withholding on share-based compensation	—		(1		)	(506		)	—			—			(507		)
Net income	—		—			—			—			24,133			24,133
Dividends on preferred stock	—		—			—			—			(6,882		)	(6,882		)
Dividends on common stock	—		—			—			—			(41,040		)	(41,040		)
Other comprehensive income	—		—			—			50,278			—			50,278
Balance as of September 30, 2014	$	109,658	$	547		$	763,228		$	16,462		$	(275,848	)	$	614,047

See notes to the unaudited consolidated financial statements.

3

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(amounts in thousands)

	Nine Months Ended
	September 30,
	2014			2013
Operating activities:
Net income	$	24,133		$	46,510
Adjustments to reconcile net income to cash provided by operating activities:
Decrease in accrued interest receivable	717			906
Decrease in accrued interest payable	(1,056		)	(462		)
Provision for loan losses	—			261
Loss on derivative instruments, net	31,654			12,683
Gain on sale of investments, net	(5,273		)	(2,597		)
Fair value adjustments, net	(162		)	590
Amortization of investment premiums, net	104,293			97,860
Other amortization and depreciation	7,007			4,398
Stock-based compensation expense	2,045			1,762
Other operating activities	(3,708		)	(3,907		)
Net cash and cash equivalents provided by operating activities	159,650			158,004
Investing activities:
Purchase of investments	(457,008		)	(1,325,082		)
Principal payments received on investments	404,464			742,551
Proceeds from sales of investments	376,278			327,962
Principal payments received on mortgage loans held for investment, net	14,150			10,775
Net payments on derivatives not designated as hedges	(9,086		)	(23,644		)
Other investing activities	(8		)	5,402
Net cash and cash equivalents provided by (used in) investing activities	328,790			(262,036		)
Financing activities:
(Repayments of) borrowings under repurchase agreements, net	(430,743		)	110,409
Principal payments on non-recourse collateralized financing	(1,753		)	(9,502		)
Increase in restricted cash	(19,370		)	(15,849		)
Proceeds from issuance of preferred stock	—			54,251
Proceeds from issuance of common stock, net of issuance costs	144			7,375
Cash paid for repurchases of common stock	—			(5,965		)
Payments related to tax withholding for share-based compensation	(507		)	(545		)
Dividends paid	(48,902		)	(52,343		)
Net cash and cash equivalents (used in) provided by financing activities	(501,131		)	87,831
Net decrease in cash and cash equivalents	(12,691		)	(16,201		)
Cash and cash equivalents at beginning of period	69,330			55,809
Cash and cash equivalents at end of period	$	56,639		$	39,608
Supplemental Disclosure of Cash Activity:
Cash paid for interest	$	15,703		$	22,065

See notes to unaudited consolidated financial statements.

4

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Dynex Capital, Inc., ("Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").

Basis of Presentation

The accompanying unaudited consolidated financial statements of Dynex Capital, Inc. and its subsidiaries (together, “Dynex” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all significant adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the consolidated financial statements have been included. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2014. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC.

Reclassifications

Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current year’s presentation. The Company's consolidated balance sheet as of December 31, 2013 now presents its "securitized mortgage loans, net" and "other investments, net" together as "mortgage loans held for investment, net". In addition, the Company has combined the presentation of its consolidated statements of income and its consolidated statements of other comprehensive income together as one financial statement which is now titled "consolidated statements of comprehensive income". The Company's "interest income - securitized mortgage loans" and "interest income-other investments" on its consolidated statements of income for the three and nine months ended September 30, 2013 is now presented together as "interest income-mortgage loans held for investment" on its consolidated statements of comprehensive income for the three and nine months ended September 30, 2013. These presentation changes have no effect on reported total assets, total liabilities, results of operations, or cash flow activities.

Consolidation

The consolidated financial statements include the accounts of the Company and the accounts of its majority owned subsidiaries and variable interest entities for which it is the primary beneficiary. All significant intercompany accounts and transactions have been eliminated in consolidation.

In accordance with Accounting Standards Codification ("ASC") Topic 810, the Company consolidates certain trusts through which it has securitized mortgage loans as a result of not meeting the sale criteria under GAAP at the time the financial assets were transferred to the trust. Additional information regarding the accounting policy for its securitized mortgage loans is provided below under "Mortgage Loans Held for Investment, Net".

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, fair value measurements of its investments, other-than-temporary impairments, contingencies, and amortization of premiums and discounts. These items are discussed further below within this note to the consolidated financial statements.

5

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT") under the Internal Revenue Code of 1986 and the corresponding provisions of state law. To qualify as a REIT, the Company must meet certain tests including investing in primarily real estate-related assets and the required distribution of at least 90% of its annual REIT taxable income to stockholders after consideration of its net operating loss carryforward and not including taxable income retained in its taxable subsidiaries. As a REIT, the Company generally will not be subject to federal income tax on the amount of its income or gain that is distributed as dividends to shareholders.

The Company assesses its tax positions for all open tax years and determines whether the Company has any material unrecognized liabilities in accordance with ASC Topic 740. The Company records these liabilities, if any, to the extent they are deemed more likely than not to have been incurred.

Mortgage-Backed Securities

In accordance with ASC Topic 320, the Company has designated its investments in MBS as available-for-sale ("AFS"). All of the Company’s MBS are recorded at fair value on the consolidated balance sheet. Changes in fair value for the Company's AFS securities are reported in other comprehensive income ("OCI") until each security is collected, disposed of, or determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income ("AOCI") into net income as a realized "gain (loss) on sale of investments, net" using the specific identification method.

The Company’s MBS pledged as collateral against repurchase agreements and derivative instruments are included in MBS on the consolidated balance sheets with the fair value of the MBS pledged disclosed parenthetically.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on MBS is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or "IO", securities) and their contractual terms.  Premiums and discounts on Agency MBS as well as any non-Agency MBS rated 'AA' and higher at the time of purchase are amortized into interest income over the expected life of such securities using the effective yield method and adjustments to premium amortization are made for actual cash payments as well as changes in projected future cash payments in accordance with ASC Topic 310-20. The Company's projections of future cash payments are based on input and analysis received from external sources and internal models, and includes assumptions about the amount and timing of credit losses, loan prepayment rates, fluctuations in interest rates, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets.

The Company holds non-Agency MBS that were rated less than 'AA' at the time of purchase by at least one national rating agency. These non-Agency MBS were purchased at discounts to their par value, which management does not believe to be substantial. The Company accretes the discount into income over the security's expected life, which reflects management's estimate of the security's projected cash flows in accordance with ASC Topic 325-40. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

Determination of MBS Fair Value.The Company estimates the fair value of the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company's MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security's coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. Refer to Note 7 for further discussion of MBS fair value measurements.

Other-than-Temporary Impairment.MBS is considered impaired when its fair value is less than its amortized cost. The Company evaluates all of its impaired MBS for other-than-temporary impairments ("OTTI") on at least a quarterly basis. An impairment is considered other-than-temporary if: (1) the Company intends to sell the MBS; (2) it is more likely than not that the Company will be required to sell the MBS before its fair value recovers; or (3) the Company does not expect to recover the full

6

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

amortized cost basis of the MBS. If either of the first two conditions is met, the entire amount of the impairment is recognized in earnings. If the impairment is solely due to the inability to fully recover the amortized cost basis, the security is further analyzed to quantify any credit loss, which is the difference between the present value of cash flows expected to be collected on the MBS and its amortized cost. The credit loss, if any, is then recognized in earnings, while the balance of impairment related to other factors is recognized in other comprehensive income.

Following the recognition of an OTTI through earnings, a new cost basis is established for the security. Any subsequent recoveries in fair value may be accreted back into the amortized cost basis of the MBS on a prospective basis through interest income. Please see Note 3 for additional information related to the Company's evaluation for OTTI.

Mortgage Loans Held for Investment, Net

Mortgage loans held for investment, net consist of mortgage loans originated or purchased by the Company from 1992-1998, and these mortgage loans are reported at amortized cost in accordance with ASC Topic 310-10. Substantially all of these loans have been pledged as collateral to support the repayment of securitization financing bonds issued by the Company. The associated securitization financing bonds are treated as debt of the Company and are presented as "non-recourse collateralized financing" on the consolidated balance sheet. Securitized mortgage loans can only be sold subject to the lien of the respective securitization financing indenture. An allowance has been established for currently existing and probable losses on the Company's mortgage loans held for investment.

Repurchase Agreements

Repurchase agreements are accounted for as secured borrowings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments

The Company's derivative instruments, which currently include interest rate swaps and Eurodollar futures, are accounted for in accordance with ASC Topic 815, which requires an entity to recognize all derivatives as either assets or liabilities in the balance sheet and to measure those instruments at fair value. All periodic interest costs and other changes in fair value, including gains and losses recognized upon termination, associated with derivative instruments are recorded in "gain (loss) on derivative instruments, net" on the Company's consolidated statement of comprehensive income.

Effective June 30, 2013, the Company discontinued cash flow hedge accounting for derivative instruments which had previously been accounted for as cash flow hedges under ASC Topic 815. Activity up to and including June 30, 2013 for those agreements previously designated as cash flow hedges was recorded in accordance with cash flow hedge accounting as prescribed by ASC Topic 815, which states that the effective portion of the hedge relationship on an instrument designated as a cash flow hedge is reported in the current period's other comprehensive income while the ineffective portion is immediately reported as a component of the current period’s net income. The balance remaining in AOCI related to the de-designated cash flow hedges is amortized into the Company's net income as a portion of "interest expense" over the remaining life of the interest rate swap agreements. Subsequent to June 30, 2013, changes in the fair value of the Company's derivative instruments, plus periodic settlements, are recorded in the Company's net income as a portion of "gain (loss) on derivative instruments, net".

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. The Company attempts to minimize

7

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

this risk by limiting its counterparties to major financial institutions with acceptable credit ratings, monitoring positions with individual counterparties and adjusting posted collateral as required.

Although MBS have characteristics that meet the definition of a derivative instrument, ASC 815 specifically excludes these instruments from its scope because they are accounted for as debt securities under ASC 320.

Share-Based Compensation

Pursuant to the Company’s 2009 Stock and Incentive Plan ("SIP"), the Company may grant share-based compensation to eligible employees, directors or consultants or advisers to the Company, including stock awards, stock options, stock appreciation rights, dividend equivalent rights, performance shares, and restricted stock units. The Company's restricted stock currently issued and outstanding under this plan may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date and recognized as compensation cost over the requisite service period with a corresponding credit to shareholders' equity as required by ASC Topic 718. The requisite service period is the period during which an employee is required to provide service in exchange for an award, which is equivalent to the vesting period specified in the terms of the share-based based award. None of the Company's restricted stock awards have performance based conditions. The Company does not currently have any share-based compensation issued or outstanding other than restricted stock.

Contingencies

In the normal course of business, there are various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, the Company evaluates whether to establish provisions for estimated losses from those matters in accordance with ASC Topic 450, which states that a liability is recognized for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed.

The Company and its subsidiaries are parties to various legal proceedings of which the ultimate outcome cannot be ascertained at this time. Although the results of those legal proceedings cannot be predicted with certainty, the Company believes, based on current knowledge, that the resolution of any of these proceedings will not have a material effect on the Company’s consolidated financial condition or liquidity. However, the resolution of any of those proceedings could have a material impact on consolidated results of operations or cash flows in a given future reporting period as the proceedings are resolved.

The Company has not been named as a party to any additional legal proceedings during the three or nine months ended September 30, 2014.

Recent Accounting Pronouncements

In June 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, which changes the accounting for repurchase-to-maturity transactions and repurchase financing arrangements. The guidance eliminates sale accounting for repurchase-to-maturity transactions and supersedes the guidance under which a transfer of a financial asset and a contemporaneous repurchase financing could be accounted for on a combined basis as a forward agreement, which has resulted in outcomes referred to as off-balance-sheet accounting. All of the Company's repurchase agreement transactions are accounted for as secured borrowings; therefore the accounting changes required by ASU No. 2014-11 do not impact the Company's consolidated financial statements. ASU No. 2014-11 also requires two additional disclosures about repurchase agreements and other similar transactions. The first disclosure requires an entity to disclose information on transfers accounted for as sales in transactions that are economically similar to repurchase agreements. The Company does not account for any of its repurchase agreement transactions as sales; therefore this new disclosure does not impact the Company's current disclosures. The second disclosure requires the following disclosures for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings: a disaggregation of the gross obligation by the class of collateral pledged;

8

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

the remaining contractual tenor of the agreements; and a discussion of the potential risks associated with the agreements and the related collateral pledged, including obligations arising from a decline in the fair value of the collateral pledged and how those risks are managed. The Company already provides these disclosures in its "Notes to the Unaudited Consolidated Financial Statements" and within "Liquidity and Capital Resources" in Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Quarterly Report on Form 10-Q. The amendments provided in ASU No. 2014-11 are effective for public business entities for the first interim or annual period beginning after December 15, 2014. ASU No. 2014-11 will not have a material impact on the Company's consolidated financial statements.

In addition, the FASB issued ASU No. 2014-12, Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company has not issued and does not anticipate issuing any share-based payments with terms that require a performance-based target; therefore this ASU will not have an impact on the Company's consolidated financial statements.

The FASB issued ASU No. 2014-13, Consolidation (Topic 810): Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity, which provides an alternative to Topic 820, Fair Value Measurement, for measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity to eliminate the difference in the fair value of the financial assets of a collateralized financing entity, as determined under GAAP, when they differ from the fair value of its financial liabilities even when the financial liabilities have recourse only to the financial assets. When the measurement alternative is elected, both the financial assets and the financial liabilities of the collateralized financing entity should be measured using the more observable of the fair value of the financial assets or the fair value of the financial liabilities. The amendments clarify that when the measurement alternative is elected, a reporting entity's consolidated net income (loss) should reflect the reporting entity's own economic interests in the collateralized financing entity, including; (1) changes in the fair value of the beneficial interests retained by the reporting entity, and (2) beneficial interests that represent compensation for services. The measurement alternative provided in ASU No. 2014-13 may be applied using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. The amendments may also be applied retrospectively to all relevant prior periods beginning with the annual period in which ASU No. 2009-17 was initially adopted. ASU No. 2014-13 is effective for public entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2015, and early adoption is permitted as of the beginning of an annual period. Management has evaluated ASU No. 2014-13 and has determined that if the Company elects to adopt this measurement alternative in the future for its currently existing consolidated collateralized financing entity, it will not have a material impact on the Company's consolidated financial statements.

The FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance about management's responsibility under GAAP to evaluate whether there is substantial doubt about an organization's ability to continue as a going concern and to provide related footnote disclosures. Specifically, the ASU (1) provides a definition of the term "substantial doubt", (2) requires an evaluation by management every reporting period including interim periods, (3) provides principles for considering the mitigating effect of management's plans, (4) requires certain disclosures when substantial doubt exists regardless of the success of any mitigating plans or actions, (5) requires an express statement and other disclosures when substantial doubt is not alleviated, and (6) requires an assessment for a period of one year after the date that the financial statements are issued. The amendments in this ASU are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management intends to comply with the requirements set forth in ASU No. 2014-15.

NOTE 2 – NET INCOME (LOSS) PER COMMON SHARE

Net income (loss) per common share is presented on both a basic and diluted basis. The Company does not currently have any potentially dilutive securities outstanding. Because the Company's Series A Cumulative Redeemable Preferred Stock and Series B Cumulative Redeemable Preferred Stock are redeemable at the Company's option for cash only, and may convert into shares of common stock only upon a change of control of the Company, the effect of those shares is excluded from the calculation of diluted net income (loss) per common share. Holders of unvested shares of the Company's issued and outstanding restricted common stock are eligible to receive non-forfeitable dividends. As such, these unvested shares are considered participating securities as per ASC 260-10 and therefore are included in the computation of basic net income (loss) per share using the two-class method.

9

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

Upon vesting, restrictions on transfer expire on each share of restricted stock, and each such share of restricted stock is converted to one equal share of common stock.

The following table presents the calculation of the numerator and denominator for both basic and diluted net income (loss) per common share for the periods indicated:

	For the Three Months Ended
	September 30, 2014					September 30, 2013
	Net  Income			Weighted-Average Common Shares		Net Loss			Weighted- Average Common Shares
Net income (loss)	$	30,866				$	(4,627	)
Preferred stock dividends	(2,294		)			(2,294		)
Net income (loss) to common shareholders	28,572			54,731,414		(6,921		)	54,903,637
Effect of dilutive instruments	—			—		—			—
Diluted net income (loss) to common shareholders	$	28,572		54,731,414		$	(6,921	)	54,903,637
Net income (loss) per common share:
Basic and diluted				$	0.52				$	(0.13	)

	For the Nine Months Ended
	September 30, 2014					September 30, 2013
	Net  Income			Weighted-Average Common Shares		Net  Income			Weighted- Average Common Shares
Net income (loss)	$	24,133				$	46,510
Preferred stock dividends	(6,882		)			(5,608		)
Net income (loss) to common shareholders	17,251			54,689,762		40,902			54,727,950
Effect of dilutive instruments	—			—		—			—
Diluted net income (loss) to common shareholders	$	17,251		54,689,762		$	40,902		54,727,950
Net income (loss) per common share:
Basic and diluted				$	0.32				$	0.75

10

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

NOTE 3 – MORTGAGE-BACKED SECURITIES

The following tables present the components and weighted average coupon ("WAC") for the portion of the Company’s MBS designated as AFS as of September 30, 2014 and December 31, 2013:

	September 30, 2014
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,200,149	$	120,667		$	2,320,816	$	7,593	$	(31,105	)	$	2,297,304	3.14	%
CMBS	305,566		19,186			$	324,752	13,803		(224		)	338,331		5.22	%
CMBS IO (1)	—		400,886			$	400,886	10,944		(113		)	411,717		0.83	%
Total Agency AFS:	$	2,505,715	$	540,739		$	3,046,454	$	32,340	$	(31,442	)	$	3,047,352
Non-Agency:
RMBS	$	9,522	$	(4	)	$	9,518	$	118	$	(81	)	$	9,555	4.20	%
CMBS	266,596		(12,374		)	254,222		16,397		(346		)	270,273		4.89	%
CMBS IO (1)	—		282,890			282,890		5,636		(313		)	288,213		0.69	%
Total non-Agency AFS:	$	276,118	$	270,512		$	546,630	$	22,151	$	(740	)	$	568,041
Total AFS securities	$	2,781,833	$	811,251		$	3,593,084	$	54,491	$	(32,182	)	$	3,615,393

(1) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $9,461,823 and $7,246,832, respectively, as of September 30, 2014.

	December 31, 2013
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,591,568	$	154,220		$	2,745,788	$	6,104	$	(59,742	)	$	2,692,150	3.22	%
CMBS (1)	273,830		19,061			292,891		10,793		(900		)	302,784		5.07	%
CMBS IO (2)	—		453,766			453,766		9,895		(3,334		)	460,327		0.83	%
Total Agency AFS:	2,865,398		627,047			3,492,445		26,792		(63,976		)	3,455,261
Non-Agency:
RMBS	13,845		(338		)	13,507		338		(80		)	13,765		4.61	%
CMBS	375,703		(18,277		)	357,426		15,366		(3,511		)	369,281		5.10	%
CMBS IO (2)	—		150,518			150,518		2,618		(1,999		)	151,137		0.66	%
Total non-Agency AFS:	389,548		131,903			521,451		18,322		(5,590		)	534,183
Total AFS securities	$	3,254,946	$	758,950		$	4,013,896	$	45,114	$	(69,566	)	$	3,989,444

(1) As of December 31, 2013, the Company had Agency CMBS with an amortized cost of $26,920 and fair value of $28,717 which were designated as trading securities and are not included in this table. The Company changed the designation of these Agency CMBS to AFS during the three months ended June 30, 2014. Changes in the fair value of these MBS while they were designated as trading were recognized in net income within "fair value adjustments, net". Changes in the fair value of these MBS, which are now designated as AFS, are recognized in "other comprehensive income". As of September 30, 2014, the Company does not have any MBS designated as trading.

(2) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $10,160,502 and $4,274,957, respectively, as of December 31, 2013.

11

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

The following table presents certain information for those Agency MBS in an unrealized loss position as of September 30, 2014 and December 31, 2013:

	September 30, 2014						December 31, 2013
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	155,501	$	(1,142	)	25	$	1,912,937	$	(43,543	)	150
Non-Agency MBS	74,239		(427		)	17	162,558		(5,435		)	39
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	1,701,638	$	(30,299	)	129	$	670,402	$	(20,433	)	67
Non-Agency MBS	31,348		(313		)	8	6,310		(155		)	6

Because the principal and interest related to Agency MBS are guaranteed by the government-sponsored entities Fannie Mae and Freddie Mac which have the implicit guarantee of the U.S. government, the Company does not consider any of the unrealized losses on its Agency MBS to be credit related. Although the unrealized losses are not credit related, the Company assesses its ability and intent to hold any Agency MBS with an unrealized loss until the recovery in its value. This assessment is based on the amount of the unrealized loss and significance of the related investment as well as the Company’s current leverage and anticipated liquidity. Based on this analysis, the Company has determined that the unrealized losses on its Agency MBS as of September 30, 2014 and December 31, 2013 were temporary.

The Company also reviews any non-Agency MBS in an unrealized loss position to evaluate whether any decline in fair value represents an OTTI. The evaluation includes a review of the credit ratings of these non-Agency MBS and the seasoning of the mortgage loans collateralizing these securities as well as the estimated future cash flows which include projected losses. The Company performed this evaluation for the non-Agency MBS in an unrealized loss position and has determined that there have not been any adverse changes in the timing or amount of estimated future cash flows that necessitate a recognition of OTTI amounts as of September 30, 2014 or December 31, 2013.

NOTE 4 – REPURCHASE AGREEMENTS

The following tables present the components of the Company’s repurchase agreements as of September 30, 2014 and December 31, 2013 by the fair value and type of securities pledged as collateral:

	September 30, 2014
Collateral Type	Balance		Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,081,924	0.36	%	2,168,095
Agency CMBS	258,024		0.33	%	302,352
Agency CMBS IOs	351,518		0.94	%	411,686
Non-Agency RMBS	7,724		1.67	%	8,803
Non-Agency CMBS	198,203		1.16	%	240,802
Non-Agency CMBS IO	242,458		1.03	%	288,202
Securitization financing bonds	10,403		1.50	%	11,885
	$	3,150,254	0.53	%	$	3,431,825

12

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

	December 31, 2013
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,522,503		0.42	%	2,598,158
Agency CMBS	246,849			0.39	%	306,318
Agency CMBS IOs	369,948			1.16	%	449,072
Non-Agency RMBS	10,569			1.80	%	12,746
Non-Agency CMBS	303,674			1.27	%	367,859
Non-Agency CMBS IOs	106,803			1.27	%	136,227
Securitization financing bonds	20,651			1.59	%	19,686
Deferred costs	(243		)	n/a		n/a
	$	3,580,754		0.61	%	$	3,890,066

The combined weighted average original term to maturity for the Company’s repurchase agreements was 106 days as of September 30, 2014 compared to 114 days as of December 31, 2013. The following table provides a summary of the original maturities as of September 30, 2014 and December 31, 2013:

Original Maturity	September 30, 2014		December 31, 2013
Less than 30 days	$	574,164	$	4,736
30 to 90 days	566,959		1,176,631
91 to 180 days	1,514,454		1,439,225
181 to 364 days	329,232		960,405
1 year or longer	165,445		—
Deferred costs	—		(243		)
	$	3,150,254	$	3,580,754

As of September 30, 2014, shareholders' equity at risk did not exceed 10% for any of the Company's counterparties. The Company had $131,275 of its repurchase agreement balance as of September 30, 2014 outstanding under a two-year repurchase facility with Wells Fargo Bank National Association. This facility provides an aggregate maximum borrowing capacity of $250,000 and matures on August 6, 2015, subject to early termination provisions contained in the master repurchase agreement. The facility is collateralized primarily by CMBS IO, and its weighted average borrowing rate as of September 30, 2014 was 1.06%.

As of September 30, 2014, the Company had repurchase agreement amounts outstanding with 21 of its 33 available counterparties. The Company's counterparties, as set forth in the master repurchase agreement with the counterparty, require the Company to comply with various customary operating and financial covenants, including, but not limited to, minimum net worth, maximum declines in net worth in a given period, and maximum leverage requirements as well as maintaining the Company's REIT status. In addition, some of the agreements contain cross default features, whereby default under an agreement with one lender simultaneously causes default under agreements with other lenders. To the extent that the Company fails to comply with the covenants contained in these financing agreements or is otherwise found to be in default under the terms of such agreements, the counterparty has the right to accelerate amounts due under the master repurchase agreement. The Company was in compliance with all covenants as of September 30, 2014.

Please see Note 6 for the Company's disclosures related to offsetting assets and liabilities.

13

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

NOTE 5 – DERIVATIVES

     The Company utilizes derivative instruments to economically hedge a portion of its exposure to market risks, primarily interest rate risk. The Company primarily uses pay-fixed interest rate swaps and Eurodollar contracts to hedge its exposure to changes in interest rates and uses receive-fixed interest rate swaps to offset a portion of its pay-fixed interest rate swaps in order to manage its overall hedge position. The objective of the Company's risk management strategy is to mitigate declines in book value resulting from fluctuations in the fair value of the Company's assets from changing interest rates and to protect the Company's earnings from rising interest rates. Please refer to Note 1 for information related to the Company's accounting policy for its derivative instruments.

The table below summarizes information about the Company’s derivative instruments treated as trading instruments on its consolidated balance sheet as of the dates indicated:  

	September 30, 2014
	Derivative Assets				Derivative Liabilities
Trading Instruments	Fair Value		Notional		Fair Value			Notional
Interest rate swaps	$	6,958	$	800,000	$	(437	)	$	150,000
Eurodollar futures (1)	339		3,900,000		(17,621		)	12,700,000
Total	$	7,297	$	4,700,000	$	(18,058	)	$	12,850,000

	December 31, 2013
	Derivative Assets				Derivative Liabilities
Trading Instruments	Fair Value		Notional		Fair Value			Notional
Interest rate swaps	$	18,488	$	575,000	$	(1,336	)	$	215,000
Eurodollar futures (1)	—		—		(5,345		)	9,000,000
Total	$	18,488	$	575,000	$	(6,681	)	$	9,215,000

(1) The Eurodollar futures aggregate notional amount represents the total notional of the 3-month contracts with expiration dates from 2015 to 2020. The maximum notional outstanding for any future 3-month period did not exceed $1,300,000 as of September 30, 2014 and $1,175,000 as of December 31, 2013.

The following table summarizes the contractual maturities remaining for the Company’s outstanding interest rate swap agreements as of September 30, 2014:

Remaining Maturity	Pay-Fixed Interest Rate Swaps		Pay-Fixed Weighted-Average Rate(1)		Receive Fixed Interest Rate Swaps		Receive-Fixed Weighted-Average Rate
37-48 months	$	185,000	0.92	%	$	—	—	%
49-60 months	235,000		1.45	%	250,000		1.91	%
61-72 months	25,000		1.61	%	—		—	%
73-84 months	50,000		2.20	%	—		—	%
85-96 months	—		—	%	—		—	%
97-108 months	30,000		1.93	%	—		—	%
109-120 months	150,000		2.17	%	25,000		2.71	%

The following table summarizes the volume of activity related to derivative instruments for the periods indicated:

14

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

For the nine months ended September 30, 2014:	Beginning of Period Notional Amount		Additions		Settlement, Termination, Expiration or Exercise			End of Period Notional Amount
Receive-fixed interest rate swaps	$	—	$	275,000	$	—		$	275,000
Pay-fixed interest rate swaps	790,000		75,000		(190,000		)	675,000
Eurodollar futures	9,000,000		7,600,000		—			16,600,000
	$	9,790,000	$	7,950,000	$	(190,000	)	$	17,550,000

The table below provides detail of the Company's "gain (loss) on derivative instruments, net" by type of interest rate derivative for the periods indicated:

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
Type of Derivative Instrument	2014		2013			2014			2013
Receive-fixed interest rate swaps	$	339	$	—		$	339		$	—
Pay-fixed interest rate swaps	646		(6,225		)	(20,056		)	5,111
Eurodollar futures	3,857		(17,794		)	(11,937		)	(17,794		)
Gain (loss) on derivative instruments, net	$	4,842	$	(24,019	)	$	(31,654	)	$	(12,683	)

Effective June 30, 2013, the Company de-designated certain interest rate swap agreements as cash flow hedges under ASC Topic 815. There is a net unrealized loss of $4,026 remaining in AOCI on the Company's consolidated balance sheet as of September 30, 2014 which represents the activity related to these interest rate swap agreements while they were previously designated as cash flow hedges, and this amount will be recognized in the Company's net income as a portion of "interest expense" over the remaining contractual life of the agreements. All forecasted transactions associated with interest rate swap agreements previously designated as cash flow hedges are expected to occur. No amounts have been reclassified to net income in any period in connection with forecasted transactions that are no longer considered probable of occurring. The Company estimates the portion of existing net unrealized loss on discontinued cash flow hedges expected to be reclassified to net income within the next 12 months is $4,156.

The table below describes the components of the reclassification adjustments out of AOCI related to certain interest rate swaps that were formerly designated as cash flow hedges and recognized as a portion of "interest expense" on the Company statements of comprehensive income for the periods indicated:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Reclassification adjustment due to amortization of de-designated cash flow hedges	$	1,442	$	2,583	$	5,339	$	2,583
Reclassification adjustment due to recognition of interest expense from cash flow hedges	—		—		—		8,796
Total reclassification adjustment related to cash flow hedges	$	1,442	$	2,583	$	5,339	$	11,379

Many of the Company's interest rate swaps were entered into under bilateral agreements which contain various covenants related to the Company’s credit risk. Specifically, if the Company defaults on any of its indebtedness, including those circumstances whereby repayment of the indebtedness has not yet been accelerated by the lender, or is declared in default of any of its covenants with any counterparty, then the Company could also be declared in default under the bilateral agreement. Additionally, these agreements allow those counterparties to require settlement of its outstanding derivative transactions if the Company fails to earn GAAP net income excluding derivative gains and losses greater than one dollar as measured on a rolling two quarter basis. These

15

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

interest rate agreements also contain provisions whereby, if the Company fails to maintain a minimum net amount of shareholders’ equity, then the Company may be declared in default on its derivative obligations. The Company was in compliance with all covenants under bilateral agreements on September 30, 2014.

Please see Note 6 for the Company's disclosures related to offsetting assets and liabilities.

NOTE 6 – OFFSETTING ASSETS AND LIABILITIES

The Company's derivatives and repurchase agreements are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its assets and liabilities subject to these arrangements on a gross basis. The following tables present information regarding those assets and liabilities subject to such arrangements as if the Company had presented them on a net basis as of September 30, 2014 and December 31, 2013:

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Received as Collateral			Cash Received as Collateral
September 30, 2014:
Derivative assets	$	7,297	$	—	$	7,297	$	(478	)	$	(2,672	)	$	4,147
December 31, 2013:
Derivative assets	$	18,488	$	—	$	18,488	$	(193	)	$	(12,141	)	$	6,154

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Posted as Collateral			Cash Posted as Collateral
September 30, 2014:
Derivative liabilities	$	18,058	$	—	$	18,058	$	(777	)	$	(17,281	)	$	—
Repurchase agreements	3,150,254		—		3,150,254		(3,150,254		)	—			—
	$	3,168,312	$	—	$	3,168,312	$	(3,151,031	)	$	(17,281	)	$	—
December 31, 2013:
Derivative liabilities	$	6,681	$	—	$	6,681	$	(1,299	)	$	(5,382	)	$	—
Repurchase agreements	3,580,754		—		3,580,754		(3,580,754		)	—			—
	$	3,587,435	$	—	$	3,587,435	$	(3,582,053	)	$	(5,382	)	$	—

(1) Amount disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.

16

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

NOTE 7 – FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 clarifies that fair value should be based on the assumptions market participants would use when pricing an asset or liability and also requires an entity to consider all aspects of nonperformance risk, including the entity's own credit standing, when measuring fair value of a liability. ASC Topic 820 established a valuation hierarchy of three levels as follows:

• Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

• Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.  

• Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date.  Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.  

The following table presents the fair value of the Company’s assets and liabilities presented on its consolidated balance sheets, segregated by the hierarchy level of the fair value estimate, that are measured at fair value on a recurring basis as of the dates indicated:

	September 30, 2014
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	3,615,393	$	—	$	3,563,819	$	51,574
Derivative assets	7,297		339		6,958		—
Total assets carried at fair value	$	3,622,690	$	339	$	3,570,777	$	51,574
Liabilities:
Derivative liabilities	$	18,058	$	17,621	$	437	$	—
Total liabilities carried at fair value	$	18,058	$	17,621	$	437	$	—

	December 31, 2013
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	4,018,161	$	—	$	3,944,681	$	73,480
Derivative assets	18,488		—		18,488		—
Total assets carried at fair value	$	4,036,649	$	—	$	3,963,169	$	73,480
Liabilities:
Derivative liabilities	$	6,681	$	5,345	$	1,336	$	—
Total liabilities carried at fair value	$	6,681	$	5,345	$	1,336	$	—

17

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

The Company did not have assets or liabilities measured at fair value on a non-recurring basis as of September 30, 2014 or December 31, 2013.

The Company's derivative assets and liabilities include interest rate swaps and Eurodollar futures. Interest rate swaps are valued using the income approach with the primary input being the forward interest rate swap curve, which is considered an observable input and thus their fair values are considered Level 2 measurements. Eurodollar futures are valued based on closing exchange prices on these contracts. Accordingly, these financial futures are classified as Level 1.

Agency MBS, as well a majority of non-Agency MBS, are substantially similar to securities that either are currently actively traded or have been recently traded in their respective market. Their fair values are derived from an average of multiple dealer quotes and thus are considered Level 2 fair value measurements. The Company’s remaining non-Agency MBS are comprised of securities for which there are not substantially similar securities that trade frequently, and their fair values are therefore considered Level 3 measurements. The Company determines the fair value of its Level 3 securities by discounting the estimated future cash flows derived from cash flow models using assumptions that are confirmed to the extent possible by third party dealers or other pricing indicators. Significant inputs into those pricing models are Level 3 in nature due to the lack of readily available market quotes. Information utilized in those pricing models include the security’s credit rating, coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected credit losses, and credit enhancement as well as certain other relevant information. Significant changes in any of these inputs in isolation would result in a significantly different fair value measurement. Generally Level 3 assets are most sensitive to the default rate and severity assumptions.

The table below presents information about the significant unobservable inputs used in the fair value measurement for the Company's Level 3 non-Agency CMBS and RMBS as of September 30, 2014:

	Quantitative Information about Level 3 Fair Value Measurements (1)
	Prepayment Speed	Default Rate		Severity		Discount Rate
Non-Agency CMBS	20 CPY	2.0	%	35.0	%	9.4	%
Non-Agency RMBS	10 CPR	1.0	%	20.0	%	6.6	%

(1) Data presented are weighted averages.

The following table presents the activity of the instruments fair valued at Level 3 during the three and nine months ended September 30, 2014:

	Level 3 Fair Values
	Three Months Ended									Nine Months Ended
	September 30, 2014									September 30, 2014
	Non-Agency CMBS			Non-Agency RMBS			Total assets			Non-Agency CMBS			Non-Agency RMBS			Total assets
Balance as of beginning of period	$	62,744		$	2,498		$	65,242		$	70,733		$	2,747		$	73,480
Unrealized gain (loss) included in OCI	878			(15		)	863			1,078			(138		)	940
Principal payments	(14,290		)	(298		)	(14,588		)	(22,598		)	(753		)	(23,351		)
Accretion	57			—			57			176			329			505
Balance as of end of period	$	49,389		$	2,185		$	51,574		$	49,389		$	2,185		$	51,574

18

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

The following table presents a summary of the recorded basis and estimated fair values of the Company’s financial instruments as of the dates indicated:

	September 30, 2014				December 31, 2013
	Recorded Basis		Fair Value		Recorded Basis		Fair Value
Assets:
Mortgage-backed securities	$	3,615,393	$	3,615,393	$	4,018,161	$	4,018,161
Mortgage loans held for investment, net (1)	41,454		36,590		55,423		46,383
Derivative assets	7,297		7,297		18,488		18,488
Liabilities:
Repurchase agreements (2)	$	3,150,254	$	3,150,254	$	3,580,754	$	3,580,997
Non-recourse collateralized financing (1)	11,194		10,757		12,914		12,414
Derivative liabilities	18,058		18,058		6,681		6,681

(1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate fair value of the Company's Level 3 non-Agency MBS.

(2) The difference between the recorded basis of repurchase agreements and their fair value as of December 31, 2013 is the unamortized deferred costs remaining for the 2-year repurchase facility.

NOTE 8 – SHAREHOLDERS' EQUITY

Preferred Stock

The Company has 2,300,000 shares of its 8.50% Series A Cumulative Redeemable Preferred Stock and 2,250,000 shares of its 7.625% Series B Cumulative Redeemable Preferred Stock issued and outstanding as of September 30, 2014 (collectively, the "Preferred Stock"). The Preferred Stock has no maturity and will remain outstanding indefinitely unless redeemed or otherwise repurchased or converted into common stock pursuant to the terms of the Preferred Stock. Except under certain limited circumstances intended to preserve the Company's REIT status, upon the occurrence of a change in control as defined in Article IIIA, Section 7(d) of the Company’s Articles of Incorporation, or to avoid the direct or indirect imposition of a penalty tax in respect of, or to protect the tax status of, any of the Company’s real estate mortgage investment conduits (“REMIC”) interests or a REMIC in which the Company may acquire an interest (as permitted by the Company’s Articles of Incorporation), the Company may not redeem the Series A Preferred Stock prior to July 31, 2017 or the Series B Preferred Stock prior to April 30, 2018. On or after these dates, at any time and from time to time, the Preferred Stock may be redeemed in whole, or in part, at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year. Because the Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company's consolidated balance sheet. The Company announced that it will pay its regular quarterly dividends on its Preferred Stock for the third quarter on October 15, 2014 to shareholders of record as of October 1, 2014.

Common Stock

The following table presents a summary of the changes in the number of common shares outstanding for the periods presented:

19

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

	Nine Months Ended
	September 30,
	2014		2013
Balance as of beginning of period	54,310,484		54,268,915
Common stock issued under DRIP	12,459		509,831
Common stock issued under ATM program	—		180,986
Common stock issued or redeemed under stock and incentive plans	471,210		270,158
Common stock forfeited for tax withholding on share-based compensation	(59,336	)	(52,385	)
Common stock repurchased during the period	—		(751,456	)
Balance as of end of period	54,734,817		54,426,049

The Company's Dividend Reinvestment and Share Purchase Plan ("DRIP") allows registered shareholders to automatically reinvest some or all of their quarterly common stock dividends in shares of the Company’s common stock and provides an opportunity for investors to purchase shares of the Company’s common stock, potentially at a discount to the prevailing market price. Of the 3,000,000 shares reserved for issuance under the Company's DRIP, there were 2,454,439 shares remaining for issuance as of September 30, 2014. The Company declared a third quarter common stock dividend of $0.25 per share payable on October 31, 2014 to shareholders of record as of October 3, 2014. There was no discount for shares purchased through the DRIP during the third quarter of 2014.

The Company had approximately 7,416,520 shares of common stock that remain available to offer and sell through its sales agent, JMP Securities LLC, under its "at the market", or "ATM" program, as of September 30, 2014.

Of the $50,000 authorized by the Company's Board of Directors for the repurchase of its common stock through December 31, 2014, approximately $42,145 remains available for repurchase at the Company's option as of September 30, 2014.

2009 Stock and Incentive Plan. Of the 2,500,000 shares of common stock authorized for issuance under its 2009 Stock and Incentive Plan, the Company had 1,078,908 available for issuance as of September 30, 2014. Total stock-based compensation expense recognized by the Company for the three and nine months ended September 30, 2014 was $690 and $2,045 compared to $612 and $1,726 for the three and nine months ended September 30, 2013.

The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Restricted stock outstanding as of beginning of period	746,830		526,803		520,969		448,283
Restricted stock granted	—		—		457,538		255,158
Restricted stock vested	(2,917	)	(2,917	)	(234,594	)	(179,555	)
Restricted stock outstanding as of end of period	743,913		523,886		743,913		523,886

The combined grant date fair value of the restricted stock issued by the Company for the nine months ended September 30, 2014 was $3,703 compared to $2,708 for the nine months ended September 30, 2013. The following table presents the amortization schedule for the Company's non-vested restricted stock remaining to be amortized into compensation expense as of September 30, 2014:

20

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

	Restricted Stock Amortization To Be Recognized
Within 12 months	$	2,411
13-24 months	1,663
25-36 months	750
37-48 months	145
Total restricted stock amortization remaining	$	4,969

NOTE 9 – SUBSEQUENT EVENTS

Management has evaluated events and circumstances occurring as of and through the date this Quarterly Report on Form 10-Q was filed with the SEC and has determined that there have been no significant events or circumstances that qualify as a "recognized" or "nonrecognized" subsequent event as defined by ASC Topic 855.

21

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our unaudited financial statements and the accompanying notes included in Item 1. “Financial Statements” in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2013. References herein to “Dynex,” the “Company,” “we,” “us,” and “our” include Dynex Capital, Inc. and its consolidated subsidiaries, unless the context otherwise requires. In addition to current and historical information, the following discussion and analysis contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to our future business, financial condition or results of operations. For a description of certain factors that may have a significant impact on our future business, financial condition or results of operations, see “Forward-Looking Statements” at the end of this discussion and analysis.

EXECUTIVE OVERVIEW

Company Overview

We are an internally managed mortgage real estate investment trust, or mortgage REIT, which invests in mortgage assets on a leveraged basis. Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "DX". We also have two series of preferred stock outstanding, our 8.50% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") which is traded on the NYSE under the symbol "DXPRA", and our 7.625% Series B Cumulative Redeemable Preferred Stock (the "Series B Preferred Stock") which is traded on the NYSE under the symbol "DXPRB". Our objective is to provide attractive risk-adjusted returns to our shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. We seek to provide returns to our shareholders primarily through regular quarterly dividends and also through capital appreciation.

We were formed in 1987 and commenced operations in 1988. Beginning with our inception through 2000, our operations largely consisted of originating and securitizing various types of loans, principally single-family and commercial mortgage loans and manufactured housing loans. Since 2000, we have been investing in Agency and non-Agency mortgage-backed securities (“MBS”), and we are no longer originating or securitizing mortgage loans. MBS consist of residential MBS (“RMBS”) and commercial MBS (“CMBS”), including CMBS interest-only ("IO") securities. Agency MBS have a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity ("GSE") such as Fannie Mae and Freddie Mac. Non-Agency MBS have no such guaranty of payment.

Our primary source of income is net interest income, which is the excess of the interest income earned on our investments over the cost of financing these investments. We invest our capital pursuant to our Operating Policies as approved by our Board of Directors which include an Investment Policy and Investment Risk Policy as discussed in Part I, Item 1, "Business" under "Company Overview-Operating Policies and Restrictions" in our annual Report on Form 10-K for the year ended December 31, 2013. Our investment policy permits investments in any type of Agency MBS and investment grade non-Agency MBS, legacy securitized mortgage loans, and legacy whole loans. In addition, the Company may make investments not covered by our Investment Policy with prior authorization of the Investment Committee of our Board of Directors.

RMBS. Our Agency RMBS investments include MBS collateralized by adjustable-rate mortgage loans ("ARMS"), which have interest rates that generally will adjust at least annually to an increment over a specified interest rate index, and hybrid adjustable-rate mortgage loans ("hybrid ARMs"), which are loans that have a fixed rate of interest for a specified period (typically three to ten years) and then adjust their interest rate at least annually to an increment over a specified interest rate index as further discussed below. Agency ARMs also include hybrid Agency ARMs that are past their fixed-rate periods or within twelve months of their initial reset period. We may also invest in fixed-rate Agency RMBS from time to time. Additionally, we invest in non-Agency RMBS which generally resemble similar types of Agency ARMs, but lack a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity.

Interest rates on loans collateralizing Agency and non-Agency ARMs are based on specific index rates, such as the London Interbank Offered Rate, or LIBOR, the one-year constant maturity treasury rate, or CMT, the Federal Reserve U.S. 12-month

22

cumulative average one-year CMT, or MTA, or the 11th District Cost of Funds Index, or COFI. These loans will typically have interim and lifetime caps on interest rate adjustments, or interest rate caps, limiting the amount that the rates on these loans may reset in any given period.

CMBS. Our Agency and non-Agency CMBS are collateralized by first mortgage loans and are substantially comprised of fixed-rate securities. The majority of the loans collateralizing our CMBS are secured by multifamily properties. Typically these loans have some form of prepayment protection provisions (such as prepayment lock-out) or prepayment compensation provisions (such as yield maintenance or prepayment penalty). Yield maintenance and prepayment penalty requirements are intended to create an economic disincentive for the loans to prepay.

CMBS IO. A portion of our Agency and non-Agency CMBS also include IO securities which represent the right to receive interest payments (but not principal cash flows) based on the unpaid principal balance of the underlying pool of mortgage loans. As these securities have no principal associated with them, the interest payments received are based on the unpaid principal balance of the underlying pool of mortgage loans, which is often referred to as the notional amount. CMBS IO securities generally have some level of prepayment protection in the form of lock-outs, prepayment penalties, or yield maintenance associated with the underlying loans similar to CMBS described above.

Factors that Affect Our Results of Operations and Financial Condition

The performance of our investment portfolio, including the amount of net interest income we earn and fluctuations in investment values, will depend on multiple factors, many of which are beyond our control. These factors include, but are not limited to, the absolute level of interest rates, trends of interest rates, the relative steepness of interest rate curves, actual and estimated future prepayment rates on our investments, competition for investments, economic conditions and their impact on the credit performance of our investments (including multifamily, residential and commercial mortgage markets), and market required yields as reflected by market credit spreads. In addition, the performance of our investment portfolio, the cost and availability of financing and the availability of investments at acceptable return levels could be influenced by actions and policy measures of the U.S. government including the Federal Housing Finance Administration, the U. S. Department of the Treasury (the "Treasury"), and the Board of Governors of the Federal Reserve System (the "Federal Reserve") and could also be influenced by other central banks around the world.

Our business model may also be impacted by other factors such as the availability and cost of financing and the state of the overall credit markets. Reductions in the availability of financing for our investments could significantly impact our business and force us to sell assets that we otherwise would not sell, potentially at losses depending on market conditions. Recent regulatory developments impacting large U.S. domiciled banks and their broker dealer subsidiaries have in some instances reduced their capacity to lend. Broadly, U.S. and international regulators are seeking to force regulated financial institutions to hold more capital against their assets, including reverse repurchase agreements. We have not yet seen a reduction in the availability of financing. We also maintain a diverse set of counterparties including broker dealer subsidiaries of non-U.S. domiciled banks and independent dealers to attempt to mitigate this risk. Other factors also impacting our business include changes in regulatory requirements, including requirements to qualify for registration under the Investment Company Act of 1940, and REIT requirements.

As discussed above, investing in mortgage-related securities on a leveraged basis subjects us to a number of risks including interest rate risk, prepayment and reinvestment risk, credit risk, market value risk and liquidity risk, which are discussed in "Liquidity and Capital Resources" within this Item 2 and in Part I, Item 3 of this Quarterly Report on Form 10-Q as well as in Item 1A, "Risk Factors" of Part I, and in Item 7A, "Quantitative and Qualitative Disclosures about Market Risk" of Part II of our Annual Report on Form 10-K for the year ended December 31, 2013. Please see these Items for a detailed discussion of these risks and the potential impact on our results of operations and financial condition.

Highlights of the Third Quarter of 2014

Demand for fixed income assets remained strong during the third quarter of 2014 as volatility remained subdued for most of the quarter. Interest rates in the two to seven year part of the U.S Treasury curve rose while the ten-year Treasury fell as investors positioned for possible changes in Federal Open Market Committee ("FOMC") monetary policy and for the end of its long-term asset purchases. We took advantage of the low volatility environment to sell certain assets in the portfolio most at risk for spread widening from a return of volatility. We sold $233.7 million in CMBS and CMBS IO during the third quarter of 2014 and realized

23

net gains on the sales of these investments of $10.3 million. The sales, coupled with principal payments received on Agency RMBS, resulted in a decline in our debt to shareholders' equity ratio to 5.2x as of September 30, 2014 from 5.6x as of June 30, 2014. Partially as a result of the net gains on the sales of these investments, we reported GAAP net income to common shareholders of $0.52 per common share during the third quarter of 2014 versus core net operating income to common shareholders of $0.25 per common share and a common stock dividend of $0.25 during the same period. Our book value per common share increased modestly to $9.14 per common share as of September 30, 2014 as spread tightening offset declines in the fair values of our investments, net of hedges, due to higher interest rates during the quarter.    

In addition to selling assets, we entered into receive-fixed interest rate swaps to offset a portion of our pay-fixed interest rate swaps during the third quarter of 2014. This repositioning of our hedging portfolio has modestly lowered our overall exposure to higher rates and puts us in a more neutral position to yield curve shifts. Our duration exposure remains predominantly on the short-end of the curve as we continue to expect the FOMC to not raise the targeted Federal Funds rate until 2016. During the quarter we lengthened the maturities of a portion of our repurchase agreements which is consistent with our view that financing costs, particularly on Agency RMBS, may rise independent of any FOMC action. We have been concerned that U.S. domiciled financial institutions may attempt to pass on higher regulatory costs to repurchase agreement borrowers.

Subsequent to September 30, 2014, the U.S. Treasury curve has rallied with the two-year rate down approximately 0.04% to 0.54% and the ten-year rate down approximately 0.13% to 2.39% as of November 6, 2014. The Treasury market has rallied in response to expectations of slower global growth and lower inflation expectations. Credit spreads widened in sympathy with the rally, and we have continued to sell CMBS into the fourth quarter.

Our GAAP net interest spread was down 0.01% from the second quarter of 2014 to the third quarter of 2014 and our adjusted net interest spread continued its recent trend of a modest quarter-to-quarter increase. These measures are discussed further in "Results of Operations". The following table summarizes the average annualized effective yield by type of MBS investment for the third quarter of 2014 and for each of the preceding four quarters:

	Three Months Ended
	September 30, 2014	June 30, 2014	March 31, 2014	December 31, 2013	September 30, 2013
Average annualized effective yield:
RMBS	1.82%	1.85%	1.87%	1.85%	1.99%
CMBS	4.45%	4.66%	4.61%	4.65%	4.78%
CMBS IO	4.14%	4.21%	4.21%	4.47%	4.41%
All other investments	5.16%	5.17%	5.17%	5.26%	5.36%
Total average annualized effective yield	2.73%	2.79%	2.74%	2.72%	2.82%
Costs of financing	(0.70)%	(0.75)%	(0.87)%	(0.90)%	(0.88)%
GAAP net interest spread	2.03%	2.04%	1.87%	1.82%	1.94%
Effective borrowing cost (1)	(0.80)%	(0.87)%	(0.86)%	(0.95)%	(1.17)%
Adjusted net interest spread (1)	1.93%	1.92%	1.88%	1.77%	1.65%

(1) Represents a non-GAAP financial measure. Please refer to the discussion regarding the use of non-GAAP financial measures and to the corresponding reconciliations of GAAP to non-GAAP financial measures provided in "Results of Operations" within this Item 2.

Trends and Recent Market Impacts

There are certain conditions and prospective trends in the marketplace that have impacted our current financial condition and results of operations and which may continue to impact us in the future. Conditions and trends that had significant developments during the third quarter of 2014 are discussed below.

24

Federal Reserve Monetary Policy

The FOMC ended its purchases of U.S. Treasury and fixed-rate Agency MBS under its asset purchase program known as "QE3" in October 2014. At its peak, the FOMC was purchasing $85 billion per month in securities. The FOMC will continue to reinvest principal payments received on fixed-rate Agency MBS even though QE3 has ended. Other than this reinvestment, there is no major marginal buyer in the Agency MBS marketplace that is a GSE such as Fannie Mae or Freddie Mac for the first time in decades. At this point the impact on the Agency MBS market resulting from the exit of the FOMC as a marginal buyer is unclear as well as any reduction in liquidity due to the FOMC's exit.

Also uncertain is the outlook for the FOMC's policy with respect to the federal funds target rate. In its latest press release, the FOMC reiterated its commitment to maintaining a highly accommodative stance of monetary policy, and the FOMC repeated its previous stance that labor market conditions, inflation data, and financial developments may mean that the current target range for the federal funds rate will remain appropriate. The Committee noted that the current target range for the federal funds rate will likely be appropriate for a considerable time, particularly if projected inflation continues to run below the FOMC's 2% longer-run goal and provided that longer-term inflation expectations remain well anchored. The FOMC has indicated that when it decides to begin to remove monetary policy accommodation, it will take a balanced approach consistent with its longer-run goals of maximum employment and inflation of 2%. The FOMC has also stated that, even after employment and inflation are near mandate-consistent levels, economic conditions may, for some time, warrant keeping the target federal funds rate below levels the FOMC views as normal in the longer run. Currently, market expectations are for the FOMC to begin to tighten monetary policy in mid-2015. However, market expectations with respect to the target rate have been volatile given uneven economic performance in the U.S., the lack of consistent global economic growth, and current and developing geopolitical risks.

Asset Credit Spreads

Asset credit spreads are defined as the difference between the yields on securities with credit, prepayment or other risks and yields on benchmark securities without these risks (typically Treasuries or swaps), and that reflects the relative riskiness of owning the securities versus the benchmark. Changes in asset credit spreads result from changes in the perceived riskiness of an investment versus its benchmark. Asset credit spreads have tightened dramatically in 2014 due in part to Federal Reserve policy, supply and demand imbalances leading to increased competition for assets, and global market liquidity from historic actions taken by global central banks. These factors have contributed to very low interest rates and a lower volatility environment, and investors in fixed income securities have bid asset prices up as a result as they pursue assets yields. The tight credit spread environment is one of the primary reasons that the Company sold certain CMBS and CMBS IO assets during the third quarter of 2014 and continues to sell similar securities in the fourth quarter of 2014.

GSE Reform

Policy makers in Washington DC continue to debate the future of Fannie Mae and Freddie Mac's participation in the U.S. mortgage market. Several bills have been introduced in the U.S. Senate and the U.S. House of Representatives regarding the reform and/or dissolution of the GSEs. Any changes to the structure of the GSEs, or the revocations of their charters, if enacted, may have broad adverse implications for the MBS market and our business, results of operations, and financial condition. We expect such proposals to be the subject of significant discussion, and it is not yet possible to determine whether such proposals will be enacted. GSE reform has been a very slow process given the continued softness in the housing market and the subdued pace of overall economic growth. Recently, the Federal Housing Finance Agency ("FHFA") has offered details on a single MBS security platform that would combine elements of Fannie Mae's and Freddie Mac's current MBS features, which has a goal of eliminating pricing discrepancies in the two entities' securities and to increase liquidity to benefit the housing market. We expect that all of these factors will continue to influence the pace of GSE reform, but we do not expect any meaningful developments in GSE reform in the near term. For further discussion of the uncertainties and risks related to GSE reform, please refer to "Risk Factors" contained within Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2013.

Regulatory Uncertainty and Reform

Certain rules recently adopted or proposed by regulators of financial institutions require such financial institutions to maintain minimum amounts of capital relative to their assets. Final rules were adopted during the second quarter of 2014 and

25

updated in September 2014 by the Federal Reserve, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency to strengthen the leverage ratio standards for the largest, most systemically significant U.S. banking organizations defined as bank holding companies with more than $700 billion in consolidated total assets or $10 trillion in assets under custody. Under the final rules, as updated, these entities will be required to maintain a tier 1 capital leverage buffer of at least 2% above the minimum supplementary leverage ratio requirement of 3%, for a total of 5%. Subsidiaries of these institutions must maintain at least a 6% supplementary leverage ratio to be considered well capitalized under applicable bank regulations. The effective date of the final rule is January 1, 2018. The impact on our business from the enactment of this regulation is uncertain. Current required capital levels are lower, and these institutions could be forced to reduce overall leverage, including reducing repurchase agreement financing, in order to comply with the supplemental leverage ratio requirement, which could in turn limit the amount available for us to borrow or could increase our overall cost of financing. There are various other recently adopted or proposed rules and regulatory priorities, including final rules that implement liquidity coverage ratio requirements for large and internationally active banking organizations, and a regulatory initiative announced by the Federal Reserve to implement risk-based capital surcharges for financial institutions that are overly-reliant on short-term wholesale funding. These regulatory developments could impact all regulated financial institutions in ways that may influence the cost and availability of financing.

In addition, the Federal Reserve has expressed concern over the generally unregulated nature of short-term wholesale funding markets including the repurchase agreement markets. In a speech to the Federal Reserve Bank of Atlanta Financial Markets Conference on April 15, 2014, Ms. Yellen, Chair of the Federal Reserve, noted that the Federal Reserve is actively considering additional measures that could address risks in the short-term wholesale funding markets in the event of a crisis such as was experienced in 2008 and 2009.Various other suggestions have been made including imposing capital surcharges and guarantees as well as money market mutual fund reform (money market mutual funds are a large supplier of liquidity to the repurchase markets). The outcome of any of these suggestions are uncertain but any capital surcharges (including to fund guarantees for certain types of financing transactions) or other reductions in repurchase agreement availability could have a material effect on the availability and cost of financing. In response to these regulatory efforts, we are maintaining a diverse counterparty funding base and also seeking to diversify our investment funding.

CRITICAL ACCOUNTING POLICIES

The discussion and analysis of our financial condition and results of operations are based in large part upon our consolidated financial statements, which have been prepared in accordance with GAAP.  The preparation of our consolidated financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities. We base these estimates and judgments on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual results, however, may differ from the estimated amounts we have recorded. The discussion and analysis of our financial condition and results of operations also consider certain non-GAAP measures as described in "Executive Overview".

Critical accounting policies are defined as those that require management's most difficult, subjective or complex judgments, and which may result in materially different results under different assumptions and conditions. Our accounting policies that require the most significant management estimates, judgments, or assumptions, or that management believes includes the most significant uncertainties, and are considered most critical to our results of operations or financial position relate to fair value measurements, amortization of investment premiums, and other-than-temporary impairments. Our critical accounting policies are discussed in our Annual Report on Form 10-K for the year ended December 31, 2013 under “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies”. There have been no significant changes in our critical accounting policies during the three or nine months ended September 30, 2014.

FINANCIAL CONDITION

The following tables outline our investment allocation based on fair value as of September 30, 2014 and as of the end of each of the four preceding quarters:

26

	September 30, 2014	June 30, 2014	March 31, 2014	December 31, 2013	September 30, 2013
Agency RMBS and CMBS	72.0%	70.3%	71.9%	74.2%	75.0%
Agency CMBS IO	11.3%	11.2%	11.7%	11.3%	11.3%
Non-Agency RMBS and CMBS	7.7%	10.3%	9.8%	9.4%	9.2%
Non-Agency CMBS IO	7.9%	6.9%	5.2%	3.7%	3.0%
Other investments	1.1%	1.3%	1.4%	1.4%	1.5%

	September 30, 2014	June 30, 2014	March 31, 2014	December 31, 2013	September 30, 2013
RMBS	63.9%	62.8%	64.5%	67.3%	68.5%
CMBS	16.9%	19.1%	18.5%	17.7%	17.2%
CMBS IO	19.2%	18.1%	17.0%	15.0%	14.3%

Our portfolio continues to be weighted toward Agency MBS investments, principally hybrid ARMs and ARMs. Non-Agency MBS as a percentage of our total MBS for the third quarter of 2014 declined from the prior quarter while our RMBS and CMBS IO investments as a percentage of our total MBS for the third quarter of 2014 increased slightly from the prior quarter. For much of 2014, we have been investing principal payments received on Agency RMBS into CMBS and CMBS IO. During the third quarter of 2014, however, we sold certain non-Agency CMBS and Agency CMBS IO investments in order to reduce our portfolio spread risk and to monetize gains from their increased market value. We used the majority of the proceeds from these sales to repay repurchase agreement borrowings and reduce our leverage.

Agency MBS

Our investments in Agency RMBS are collateralized primarily by ARMs and hybrid ARMs. Our investments in Agency CMBS and CMBS IO are collateralized primarily by fixed rate mortgage loans which generally have some form of prepayment protection provisions (such as prepayment lock-outs) or prepayment compensation provisions (such as yield maintenance or prepayment penalties).

Activity related to our Agency MBS for the nine months ended September 30, 2014 is as follows:

($ in thousands)	RMBS			CMBS			CMBS IO (1)			Total
Balance as of January 1, 2014	$	2,692,150		$	331,501		$	460,327		$	3,483,978
Purchases	75,590			20,628			107,752			203,970
Principal payments	(355,137		)	(12,071		)	—			(367,208		)
Sales	(122,413		)	—			(106,077		)	(228,490		)
Change in net unrealized gain	30,126			1,889			4,269			36,284
Net premium amortization	(23,012		)	(3,616		)	(54,554		)	(81,182		)
Balance as of September 30, 2014	$	2,297,304		$	338,331		$	411,717		$	3,047,352

(1) Amounts shown for CMBS IO represent premium only and exclude underlying notional values.

Our investment in Agency MBS as of September 30, 2014 has decreased since December 31, 2013 as principal payments and sales have outpaced purchases. In recent quarters, we have purchased Agency CMBS and CMBS IO given their better absolute return and value relative to Agency RMBS in the current market environment. Agency CMBS and CMBS IO generally have prepayment protection provisions, and we view these investments as having a more stable cash flow profile than Agency RMBS. Our sales of Agency MBS during 2014 have consisted of certain ARMs with low yields and seasoned CMBS IO with higher prepayment risk profiles.

27

As of September 30, 2014, 75% of our Agency MBS issued securities are variable-rate MBS with the remainder fixed-rate MBS compared to 77% variable-rate Agency MBS as of December 31, 2013. As of September 30, 2014, approximately 97% of our variable-rate Agency RMBS portfolio resets based on one-year LIBOR. The following table presents the reset margin and weighted average coupon (“WAC”) by weighted average months to reset ("MTR") for the variable-rate portion of our Agency RMBS portfolio based on par value as of the periods indicated:

	September 30, 2014						December 31, 2013
($ in thousands)	Par Value		Reset Margin		WAC		Par Value		Reset Margin		WAC
0-12 MTR	$	517,498	1.77	%	2.93	%	$	575,763	1.79	%	2.97	%
13-36 MTR	251,967		1.85	%	4.01	%	276,862		1.84	%	3.89	%
37-60 MTR	482,374		1.79	%	3.22	%	619,887		1.79	%	3.57	%
61-84 MTR	247,873		1.81	%	3.61	%	171,839		1.80	%	3.01	%
85-120 MTR	682,956		1.65	%	2.77	%	928,580		1.74	%	2.99	%
ARMs and Hybrid ARMs	2,182,668		1.75	%	3.15	%	2,572,931		1.78	%	3.22	%
Fixed	17,481				2.51	%	18,637				2.51	%
Total	$	2,200,149			3.14	%	$	2,591,568			3.22	%

The rate at which we amortize the premiums we pay for our investments is impacted by the current and forecasted constant prepayment rate ("CPR"), which is a measure of the annualized percentage of the principal balance of a pool of loans that is expected to be paid off prematurely in a given period. Please refer to the "Prepayment and Reinvestment Risk" section of Item 3, "Quantitative and Qualitative Disclosures About Market Risk" for more information. The following table provides the CPRs on our Agency RMBS for the periods indicated:

	Three Months Ended
	September 30, 2014		June 30, 2014		March 31, 2014		December 31, 2013		September 30, 2013
Agency RMBS	15.3	%	14.1	%	12.7	%	14.3	%	23.8	%

We believe we have been experiencing relatively low prepayments on our Agency RMBS investments since the third quarter of 2013 due to higher mortgage rates impacting refinancing activity and constrained lending conditions in the single family mortgage market as well as the seasoning of our RMBS. We believe the slight increase in CPR for the third quarter of 2014 versus the second quarter of 2014 was due to refinancing activity from lower overall mortgage rates in recent months. Given the seasoning of our Agency RMBS, we are not expecting materially higher prepayments in the fourth quarter of 2014.

Non-Agency MBS

Non-Agency MBS are primarily investment grade securities (rated 'BBB' or better by at least one nationally recognized statistical ratings organizations). We typically purchase newer issue non-Agency MBS and have not generally purchased heavily discounted seasoned MBS. During the first nine months of 2014, we sold $158.8 million in amortized cost basis of non-Agency CMBS and CMBS IO which generated a net gain of $9.1 million, given the high valuation on these investments relative to their risk profile and in an effort to reduce exposure to spread risk.

Activity related to our non-Agency MBS for the nine months ended September 30, 2014 is as follows:

28

($ in thousands)	RMBS			CMBS			CMBS IO (1)			Total
Balance as of January 1, 2014	$	13,765		$	369,281		$	151,137		$	534,183
Purchases	7,496			65,797			169,387			242,680
Principal payments	(11,822		)	(23,558		)	—			(35,380		)
Sales	—			(146,322		)	(12,513		)	(158,835		)
Change in net unrealized gain	(221		)	4,196			4,704			8,679
Net accretion (amortization)	337			879			(24,502		)	(23,286		)
Balance as of September 30, 2014	$	9,555		$	270,273		$	288,213		$	568,041

(1) Amounts shown for CMBS IO represent premium only and exclude underlying notional values.

The following table shows purchase price and related premium (discount) on purchases of our non-Agency MBS during the nine months ended September 30, 2014 by credit rating at the time of purchase:

	Nine Months Ended
	September 30, 2014
Credit Rating At Purchase	Purchase Price		Premium (Discount)
($ in thousands)
AAA (1)	$	203,430	$	166,430
AA	15,906		(50		)
A or BBB (2)	12,896		(374		)
Non-investment grade or not rated(1)	10,448		2,948
Total purchases	$	242,680	$	168,954

(1) For CMBS IO, premium is equal to purchase price as these securities have no principal associated with them. Of the $203.4 million of purchases of AAA-rated non-Agency MBS, $166.4 million is for CMBS IO with a total notional of $3.1 billion purchased during the nine months ended September 30, 2014.

(2) Management does not anticipate any material credit losses on non-Agency MBS that were purchased at a discount during the nine months ended September 30, 2014.

The following table presents the par/notional value, amortized cost, and weighted average months to estimated maturity of our non-Agency CMBS and CMBS IO investments as of September 30, 2014 by year of origination:

29

	September 30, 2014
Year of Origination	Par/Notional Value		Amortized Cost		Months to Estimated Maturity (1)
($ in thousands)
Non-Agency CMBS:
Prior to 2000	$	56,441	$	48,215	44
2009	36,426		37,338		28
2010	24,400		23,340		63
2011	94,718		90,772		54
2012	—		—		0
2013	1,692		1,692		61
2014	52,919		52,866		11
	$	266,596	$	254,223	40
Non-Agency CMBS IO:
2010	$	55,775	$	3,240	71
2011	449,266		18,377		80
2012	1,399,586		43,806		92
2013	3,355,971		71,676		103
2014	1,986,234		145,791		123
	$	7,246,832	$	282,890	110

(1) Months to estimated maturity is an average weighted by the amortized cost of the investment.

The following tables present information for our non-Agency CMBS and CMBS IO investments by credit rating as of September 30, 2014 and December 31, 2013:

	September 30, 2014
	Non-Agency CMBS							Non-Agency CMBS IO
($ in thousands)	Fair Value		Net Unrealized Gain			Related Borrowings		Fair Value		Net Unrealized Gain			Related Borrowings
AAA	$	36,814	$	(119	)	$	—	$	284,126	$	5,280		$	238,972
AA	75,343		1,748			61,781		1,140		48			971
A	121,254		13,011			111,655		—		—			—
Below A/Not Rated	36,862		1,411			24,767		2,947		(5		)	2,515
	$	270,273	$	16,051		$	198,203	$	288,213	$	5,323		$	242,458

30

	December 31, 2013
	Non-Agency CMBS							Non-Agency CMBS IO
($ in thousands)	Fair Value		Net Unrealized Gain (Loss)			Related Borrowings		Fair Value		Net Unrealized Gain		Related Borrowings
AAA	$	40,379	$	2,126		$	35,637	$	149,692	$	555	$	106,787
AA	40,022		62			35,402		1,445		65		16
A	237,261		10,307			194,952		—		—		—
Below A/Not Rated	51,619		(641		)	37,683		—		—		—
	$	369,281	$	11,854		$	303,674	$	151,137	$	620	$	106,803

The following table presents the geographic diversification of the collateral underlying our non-Agency CMBS and CMBS IO by the top 5 states as of September 30, 2014:

	September 30, 2014
($ in thousands)	Market Value of Collateral		Percentage
California	$	69,997	13.3	%
Texas	55,825		10.6	%
Florida	44,429		8.4	%
New York	35,175		6.7	%
Georgia	28,037		5.3	%
Remaining states (not exceeding 4.7% individually)	293,611		55.7	%
	$	527,074	100.0	%

Derivative Assets and Liabilities

Our derivative assets and liabilities consist of interest rate swap agreements and Eurodollar futures, both of which are viewed by us as economic hedges of our exposure to fluctuations in interest rates. Eurodollar futures represent forward starting 3-month LIBOR contracts and allow us to synthetically replicate swap curves and/or hedge specific points on the swap curve where we may have duration risk by shorting contracts at various points of the LIBOR curve. During the third quarter of 2014, we entered into receive-fixed interest rate swaps to offset a portion of our pay-fixed interest rate swaps in order to manage our overall hedge position. As of September 30, 2014, the weighted average notional amount of interest rate derivatives that will be effective for future periods are shown in the following table:

31

Effective Period	Pay-Fixed Interest Rate Swaps		Pay-Fixed Weighted Average Rate (1)		Interest Rate Swaps-Fixed Receive		Receive-Fixed Weighted Average Rate (1)		Eurodollar Futures		Eurodollar Futures Weighted-Average Rate (1)
($ in thousands)
Remainder of 2014	$	675,000	1.55	%	$	275,000	1.99	%	$	—	—	%
Effective 2015	675,000		1.55	%	275,000		1.99	%	381,096		0.87	%
Effective 2016	675,000		1.55	%	275,000		1.99	%	1,292,691		1.67	%
Effective 2017	563,178		1.67	%	275,000		1.99	%	1,113,767		2.99	%
Effective 2018	490,000		1.78	%	275,000		1.99	%	681,027		3.74	%
Effective 2019	282,041		2.02	%	199,863		2.01	%	487,055		4.00	%
Effective 2020	241,216		2.12	%	25,000		2.71	%	194,604		4.56	%
Effective 2021	189,178		2.13	%	25,000		2.71	%	—		—	%
Effective 2022	180,000		2.13	%	25,000		2.71	%	—		—	%
Effective 2023	159,370		2.15	%	25,000		2.71	%	—		—	%
Effective 2024	38,661		2.18	%	17,896		2.71	%	—		—	%

(1) Weighted average rate is based on the weighted average notional outstanding.

Please refer to Note 5 of the Notes to the Unaudited Consolidated Financial Statements contained with this Quarterly Report on Form 10-Q as well as "Gain (Loss) on Derivative Instruments, Net" within "Results of Operations" contained within this Item 2 for additional information related to our derivative assets and liabilities.

Repurchase Agreements

Our repurchase agreement borrowings have decreased $430.5 million from December 31, 2013 to September 30, 2014 because we have slowed our reinvestment of principal payments and sale proceeds received on our MBS. In addition, the majority of our purchases during the past nine months have been for non-Agency investments for which we typically borrow a lower percentage of the asset's value. Please refer to Note 4 of the Notes to the Unaudited Consolidated Financial Statements contained within this Quarterly Report on Form 10-Q as well as "Interest Expense, Annualized Cost of Funds, and Effective Borrowings Costs" within "Results of Operations" and “Liquidity and Capital Resources” contained within this Item 2 for additional information relating to our repurchase agreements.

Shareholders' Equity

Shareholders' equity increased $28.2 million since December 31, 2013 primarily as a result of generating $67.5 million in total comprehensive income, of which $17.2 million is net income to common shareholders and $50.3 million is other comprehensive income primarily resulting from increases in the fair value of our MBS investments. Additionally, stock issuances, net of capitalized costs and other items increased shareholders' equity by approximately $1.7 million. These increases were offset by common dividends declared of $41.0 million.

The following table provides detail on the increase in AOCI from changes in fair value of our MBS investments during the nine months ended September 30, 2014:

32

	Nine Months Ended
($ in thousands)	September 30, 2014
Agency:
RMBS	$	30,126
CMBS	1,865
CMBS IO	4,270
Non-Agency:
RMBS	(221		)
CMBS	4,196
CMBS IO	4,703
Total change in fair value of MBS investments, net of net gain on sales of MBS realized in net income	44,939
Reclassification adjustment for amortization of de-designated cash flow hedges	5,339
Increase in AOCI	$	50,278

Supplemental Information

The tables below present the allocation of our shareholders' equity to our assets and liabilities. The allocation of shareholders' equity is determined by subtracting the associated financing for each asset from that asset's carrying basis:

	As of September 30, 2014
($ in thousands)	Asset Carrying Basis		Associated Financing(1)/ Liability Carrying Basis		Allocated Shareholders’ Equity			% of Shareholders’ Equity
Agency MBS	$	3,047,352	$	2,691,466	$	355,886		58.0	%
Non-Agency MBS	568,041		448,385		119,656			19.5	%
Mortgage loans held for investment, net	41,454		21,597		19,857			3.2	%
Derivative assets (liabilities)	7,297		18,058		(10,761		)	(1.7	)%
Cash and cash equivalents	56,639		—		56,639			9.2	%
Restricted cash	32,755		—		32,755			5.3	%
Other assets/other liabilities	59,973		19,958		40,015			6.5	%
	$	3,813,511	$	3,199,464	$	614,047		100.0	%

33

	As of December 31, 2013
($ in thousands)	Asset Carrying Basis		Associated Financing(1)/ Liability Carrying Basis		Allocated Shareholders’ Equity		% of Shareholders’ Equity
Agency MBS	$	3,483,978	$	3,149,470	$	334,508	57.1	%
Non-Agency MBS	534,183		420,991		113,192		19.3	%
Mortgage loans held for investment, net	55,423		33,565		21,858		3.7	%
Derivative assets (liabilities)	18,488		6,681		11,807		2.0	%
Restricted cash	69,330		—		69,330		11.8	%
Cash and cash equivalents	13,385		—		13,385		2.4	%
Other assets/other liabilities	42,350		20,554		21,796		3.7	%
	$	4,217,137	$	3,631,261	$	585,876	100.0	%

 (1) Associated financing related to investments includes repurchase agreements as well as payables pending for unsettled trades, if any, as of the date indicated, and non-recourse collateralized financing. Associated financing for derivative instruments represents the fair value of the derivative instruments in a liability position.

The tables below present the allocation of our invested capital by type of investment:

	As of September 30, 2014
($ in thousands)	Asset Carrying Basis		Associated Financing		Invested Capital Allocation		% of Allocated Invested Capital
RMBS and loans	$	2,338,137	$	2,111,245	$	226,892	45.8	%
CMBS and loans	618,780		456,227		162,553		32.8	%
CMBS IO	699,930		593,976		105,954		21.4	%
	$	3,656,847	$	3,161,448	$	495,399	100.0	%

	As of December 31, 2013
($ in thousands)	Asset Carrying Basis		Associated Financing		Invested Capital Allocation		% of Allocated Invested Capital
RMBS and loans	$	2,741,124	$	2,558,395	$	182,729	38.9	%
CMBS and loans	720,996		569,123		151,873		32.4	%
CMBS IO	611,464		476,508		134,956		28.7	%
	$	4,073,584	$	3,604,026	$	469,558	100.0	%

34

RESULTS OF OPERATIONS

The following discussion includes non-GAAP financial measures which exclude certain GAAP items. Please read the section "Non-GAAP Financial Measures" contained at the end of this section for additional important information.

GAAP net income to common shareholders for the three months ended September 30, 2014 increased $35.5 million versus the three months ended September 30, 2013, primarily as a result of favorable increases in the fair value of derivative instruments, net of $25.7 million. In addition, MBS were sold at a gain of $9.1 million during the three months ended September 30, 2014 compared to a loss of $(0.8) million during the three months ended September 30, 2013. These benefits offset a decline of $3.0 million in net interest income for the three months ended September 30, 2014 versus the same period in 2013. For the nine months ended September 30, 2014 as compared to the same period in 2013, the majority of the change in GAAP net income to common shareholders is primarily due to unfavorable changes in the fair value of derivative instruments of $17.7 million and lower net interest income of $6.8 million. The declines in net interest income for both the three and nine months ended September 30, 2014 as compared to the same periods in 2013 are due to a decline in the average interest-earning investment balances and lower effective yields.

Core net operating income to common shareholders (a non-GAAP financial measure) was $1.1 million less for the three months ended September 30, 2014 compared to the same period in 2013 and $6.6 million less for the nine months ended September 30, 2014 compared to the same period in 2013. These decreases are primarily due to lower adjusted net interest income (a non-GAAP financial measure) of $0.9 million and $5.3 million, respectively. Core net operating income to common shareholders excludes changes in fair value of derivative instruments and net gains on sale of investments as well as other items. Please refer to the reconciliation of GAAP net income (loss) to common shareholders to core net operating income to common shareholders at the end of this section.

Interest Income and Asset Yields

The following tables present interest income and weighted average yields by type of MBS investment for the periods indicated:

	Three Months Ended
	September 30,
	2014						2013
($ in thousands)	Interest Income		Average Balance (1)		Effective Yield (2)		Interest Income		Average Balance (1)		Effective Yield (2)
Agency RMBS	$	10,446	$	2,411,409	1.80	%	$	15,093	$	2,985,731	1.98	%
Agency CMBS	2,747		326,068		3.48	%	2,874		316,190		3.56	%
Agency CMBS IO	4,506		405,987		4.24	%	5,589		488,150		4.40	%
Total Agency	17,699		3,143,464		2.29	%	23,556		3,790,071		2.42	%
Non-Agency RMBS	$	134	$	11,172	4.61	%	$	167	$	12,898	4.86	%
Non-Agency CMBS	4,663		345,544		5.37	%	5,446		379,372		5.80	%
Non-Agency CMBS IO	2,711		269,409		3.99	%	1,651		125,727		4.45	%
Total Non-Agency	7,508		626,125		4.76	%	7,264		517,997		5.45	%
Total MBS portfolio	$	25,207	$	3,769,589	2.70	%	$	30,820	$	4,308,068	2.78	%

35

	Nine Months Ended
	September 30,
	2014						2013
($ in thousands)	Interest Income		Average Balance (1)		Effective Yield (2)		Interest Income		Average Balance (1)		Effective Yield (2)
Agency RMBS	$	33,479	$	2,517,939	1.79	%	$	43,399	$	2,847,667	2.01	%
Agency CMBS	8,827		325,151		3.57	%	8,923		328,115		3.59	%
Agency CMBS IO	14,437		435,889		4.36	%	20,345		542,314		4.87	%
Total Agency	56,743		3,278,979		2.31	%	72,667		3,718,096		2.57	%
Non-Agency RMBS	$	808	$	13,792	6.99	%	$	472	$	12,048	5.19	%
Non-Agency CMBS	14,821		357,240		5.52	%	18,491		435,019		5.66	%
Non-Agency CMBS IO	6,732		217,884		4.09	%	4,197		114,991		4.75	%
Total Non-Agency	22,361		588,916		5.03	%	23,160		562,058		5.47	%
Total MBS portfolio	$	79,104	$	3,867,895	2.72	%	$	95,827	$	4,280,154	2.95	%

(1) Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.

(2) Effective yields are based on annualized amounts. Recalculation of effective yields may not be possible using data provided because certain components of interest income use a 360-day year for the calculation while others use actual number of days in the year.

The following table presents the estimated impact of changes in average yields and average balances on the decrease in interest income for the three and nine months ended September 30, 2014 compared to the three and nine months ended September 30, 2013:

	Three Months Ended									Nine Months Ended
	September 30, 2014 vs. September 30, 2013									September 30, 2014 vs. September 30, 2013
				Due to Change in									Due to Change in
($ in thousands)	Increase (Decrease)			Average Balance (1)			Average Yield			Increase (Decrease)			Average Balance(1)			Average Yield
Agency MBS	$	(5,857	)	$	(3,958	)	$	(1,899	)	$	(15,924	)	$	(8,093	)	$	(7,831	)
Non-Agency MBS	244			1,458			(1,214		)	(799		)	1,085			(1,884		)
Total	$	(5,613	)	$	(2,500	)	$	(3,113	)	$	(16,723	)	$	(7,008	)	$	(9,715	)

(1) Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.

Interest income from Agency MBS for the three and nine months ended September 30, 2014 decreased compared to the respective periods in 2013 because our Agency portfolio is smaller and is earning a lower average effective yield. The smaller Agency portfolio is due to our sales of Agency MBS as well as slower replacement of Agency MBS through reinvestment of proceeds from sales and principal payments. The lower average effective yields are primarily the result of the lower interest rate environment during 2014 as compared to 2013. For example, the weighted average coupon ("WAC") rate (a measure of gross interest income) on our Agency RMBS portfolio, our largest investment, was 0.14% lower for the three months ended September 30, 2014 compared to the same period in 2013 due to purchases of Agency RMBS during the past twelve months with lower coupons and ARM interest rate resets in a lower interest rate environment. In addition, we have sold some higher yielding Agency CMBS IO during 2014 in part to reduce exposure to prepayment risk and in part to rotate capital into non-Agency CMBS IO.

Interest income from non-Agency MBS for the third quarter of 2014 increased slightly compared to the third quarter of 2013 due to a higher average balance of investments, specifically non-Agency CMBS IO. Although the average balance of non-

36

Agency CMBS IO more than doubled for the third quarter of 2014 compared to the same period in 2013, the average effective yield is significantly lower for those investments for the third quarter of 2014 compared to the same period in 2013, which is primarily due to purchases of non-Agency CMBS IO at lower WACs. The WAC on our non-Agency CMBS IO portfolio as of September 30, 2014 was approximately 0.69% compared to 0.87% as of September 30, 2013. Interest income from non-Agency MBS for the nine months ended September 30, 2014 decreased approximately $0.8 million compared to the same period in 2013 due to lower average effective yields offset partially by the higher average balance of non-Agency CMBS IO investments.

The following table presents the components of our interest income by MBS investment type for the periods indicated:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
($ in thousands)	2014			2013			2014			2013
Agency MBS:
Gross interest income	$	45,824		$	50,738		$	138,033		$	157,424
Net premium amortization	(28,125		)	(27,182		)	(81,290		)	(84,757		)
Total interest income	$	17,699		$	23,556		$	56,743		$	72,667
Average balance of unamortized premium, net	$	554,370		$	680,492		$	592,828		$	722,914
Non-Agency MBS:
Gross interest income	$	17,263		$	12,382		$	45,956		$	36,289
Net premium amortization	(9,755		)	(5,118		)	(23,595		)	(13,129		)
Total interest income	$	7,508		$	7,264		$	22,361		$	23,160
Average balance of unamortized premium, net	$	253,106		$	108,028		$	200,405		$	97,204

Although prepayments on Agency RMBS and the average balance of unamortized premium, net were lower for the third quarter of 2014 compared to third quarter of 2013, net premium amortization for Agency MBS increased $0.9 million. This increase resulted primarily from the acceleration of approximately $1.8 million of premium amortization on Agency CMBS IO as a result of accelerated principal payments for which we received prepayment penalty income of $2.0 million. Net premium amortization on Agency MBS decreased for the nine months ended September 30, 2014 compared to the same period in 2013 due to the lower average balance of net unamortized premium. Our sales of Agency MBS have been higher than our purchases during the first nine months of 2014, resulting in a declining premium balance.

For the three and nine months ended September 30, 2014, net premium amortization for non-Agency investments increased significantly compared to the respective periods in 2013 due to the sizable increase in our non-Agency CMBS IO investments which consist entirely of premium.

Interest Expense, Annualized Cost of Funds, and Effective Borrowing Costs

The following table summarizes the components of interest expense as well as average balances and annualized cost of funds for the periods indicated:

37

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
($ in thousands)	2014			2013			2014			2013
Repurchase agreements	$	4,586		$	5,893		$	14,848		$	18,480
Interest rate swap expense from cash flow hedging	—			—			—			8,796
Amortization of de-designated cash flow hedges (1)	1,442			2,583			5,339			2,583
Non-recourse collateralized financing and other expenses	30			242			76			761
Total interest expense	$	6,058		$	8,718		$	20,263		$	30,620
Average balance of repurchase agreements	$	3,352,599		$	3,836,249		$	3,434,354		$	3,831,123
Average balance of non-recourse collateralized financing	11,626			23,404			12,204			26,388
Average balance of borrowings	$	3,364,225		$	3,859,653		$	3,446,558		$	3,857,511
Annualized cost of funds (2)	0.70		%	0.88		%	0.78		%	1.05		%

(1) Amount recorded in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Rates shown are based on annualized interest expense amounts divided by average balance of borrowings. Recalculation of annualized cost of funds using total interest expense shown in the table may not be possible because certain expense items use a 360-day year for the calculation while others use actual number of days in the year.

The following table presents the estimated impact of changes in the average balance of repurchase agreement borrowings and average borrowing rates on the decrease in interest expense for the three and nine months ended September 30, 2014 compared to the three and nine months ended September 30, 2013:

	Three Months Ended									Nine Months Ended
	September 30, 2014 vs. September 30, 2013									September 30, 2014 vs. September 30, 2013
				Due to Change in									Due to Change in
(amounts in thousands)	Decrease in Interest Expense			Average Balance			Average Borrowing Rate			Decrease in Interest Expense			Average Balance			Average Borrowing Rate
Repurchase agreements	$	(1,307	)	$	(743	)	$	(564	)	$	(3,632	)	$	(1,914	)	$	(1,718	)

Our average balances of repurchase agreement borrowings are lower given our smaller investment portfolio and the overall shift in our portfolio mix to CMBS and CMBS IO investments for which we typically finance a smaller amount of the asset's fair value. Our repurchase agreement borrowing rates have been declining as a result of the tighter spread environment and the ample liquidity in the financing markets that has increased competition among our repurchase agreement counterparties. Although the current tight spread environment has favorably impacted the availability and cost of repurchase agreement financing, we continue to monitor regulatory developments, such as those discussed in "Executive Overview", that will impact certain large financial institutions.

Our annualized cost of funds does not incorporate our total net periodic interest costs of derivative instruments. Because we view our interest rate derivative instruments as economic hedges of our exposure to higher interest rates, management utilizes a non-GAAP financial measure "effective borrowing costs". The tables below present a reconciliation of GAAP interest expense and annualized costs of funds to our effective borrowing costs and related rates during the periods indicated:

38

	Three Months Ended
	September 30,
	2014					2013
($ in thousands)	Amount			Rate (3)		Amount			Rate (3)
GAAP interest expense/annualized cost of funds	$	6,058		0.70	%	$	8,718		0.88	%
Amortization of de-designated cash flow hedges (1)	(1,442		)	(0.17	)%	(2,583		)	(0.26	)%
Net periodic interest costs from derivative instruments (2)	2,271			0.27	%	5,471			0.55	%
Effective borrowing costs/rate	$	6,887		0.80	%	$	11,606		1.17	%

	Nine Months Ended
	September 30,
	2014					2013
($ in thousands)	Amount			Rate (3)		Amount			Rate (3)
GAAP interest expense/annualized cost of funds	$	20,263		0.78	%	$	30,620		1.05	%
Amortization of de-designated cash flow hedges (1)	(5,339		)	(0.21	)%	(2,583		)	(0.09	)%
Net periodic interest costs from derivative instruments (2)	7,154			0.27	%	5,918			0.19	%
Effective borrowing costs/rate (4)	$	22,078		0.84	%	$	33,955		1.15	%

(1) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Amount equals the net interest payments (including accrued amounts) related to interest rate derivatives during the period which are recorded in "gain (loss) on derivative instruments, net" and not already included in "interest expense" in accordance with GAAP.

(3) Rates shown are based on annualized interest expense amounts divided by average balance of borrowings. Recalculation of annualized cost of funds and effective borrowing rates using interest expense shown in the table may not be possible because certain expense items use a 360-day year for the calculation while others use actual number of days in the year. 

Our effective borrowing costs for the three and nine months ended September 30, 2014 are lower than the same periods in 2013. In addition to lower interest expense from repurchase agreements for the reasons discussed above, we also had lower net periodic interest costs from our derivative instruments. Please refer to the discussion of these lower net periodic interest costs within "Gain (Loss) on Derivative Instruments, Net" contained within "Results of Operations".

Net Interest Income and Net Interest Spread

Management uses the non-GAAP financial measures "adjusted net interest income" and "adjusted net interest spread" because these measures include net periodic interest cost of derivative instruments which economically hedge our interest rate risk but which are not included in net interest income for GAAP purposes. The following tables reconcile GAAP net interest income and related net interest spread to our adjusted net interest income and adjusted net interest spread for the periods indicated:

39

	Three Months Ended
	September 30,
	2014					2013
($ in thousands)	Amount			Yield		Amount			Yield
GAAP interest income	$	26,000		2.73	%	$	31,666		2.82	%
GAAP interest expense	6,058			0.70	%	8,718			0.88	%
Net interest income/spread	19,942			2.03	%	22,948			1.94	%
Amortization of de-designated cash flow hedges (1)	1,442			0.17	%	2,583			0.26	%
Net periodic interest costs of derivative instruments (2)	(2,271		)	(0.27	)%	(5,471		)	(0.55	)%
Adjusted net interest income/spread	$	19,113		1.93	%	$	20,060		1.65	%
Average interest earning assets (3)	$	3,820,898				$	4,371,485
Average balance of borrowings (4)	$	3,364,225				$	3,859,653

	Nine Months Ended
	September 30,
	2014					2013
($ in thousands)	Amount			Yield		Amount			Yield
GAAP interest income	$	81,359		2.76	%	$	98,538		2.98	%
GAAP interest expense	20,263			0.78	%	30,620			1.05	%
Net interest income/spread	61,096			1.98	%	67,918			1.93	%
Amortization of de-designated cash flow hedges (1)	5,339			0.21	%	2,583			0.09	%
Net periodic interest costs of derivative instruments (2)	(7,154		)	(0.27	)%	(5,918		)	(0.19	)%
Adjusted net interest income/spread	$	59,281		1.92	%	$	64,583		1.83	%
Average interest earning assets (3)	$	3,921,974				$	4,346,283
Average balance of borrowings (4)	$	3,446,558				$	3,857,511

(1) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Amount equals the net interest payments (including accrued amounts) related to interest rate derivatives during the period which are recorded in "gain (loss) on derivative instruments, net" and not already included in "interest expense" in accordance with GAAP.

(3) Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.

(4) Average balances are calculated as a simple average of the daily borrowings outstanding for both repurchase agreement and non-recourse collateralized financing.

Our net interest income and adjusted net interest income decreased for the three and nine months ended September 30, 2014 compared to the same periods in 2013 due to smaller average interest earning asset balances and lower effective yields earned on our investments, as discussed above under "Interest Income and Asset Yields". The impact of smaller average interest earning asset balances and lower effective yields was partially offset by lower overall annualized cost of funds and lower effective borrowing costs as further discussed above under "Interest Expense, Annualized Cost of Funds, and Effective Borrowing Costs" and below under "Gain(Loss) on Derivative Instruments, Net".

40

Gain (Loss) on Derivative Instruments, Net

The following table provides information on the components of our "gain (loss) on derivative instruments, net" for the periods indicated:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
($ in thousands)	2014			2013			2014			2013
Net periodic interest costs of derivative instruments (1)	$	(2,271	)	$	(5,471	)	$	(7,154	)	$	(5,918	)
Change in fair value of derivative instruments, net	7,113			(18,548		)	(24,500		)	(6,765		)
Gain (loss) on derivative instruments, net	$	4,842		$	(24,019	)	$	(31,654	)	$	(12,683	)

(1) Amount equals the net interest payments (including accrued amounts) related to interest rate derivatives during the period which are recorded in "(loss) gain on derivative instruments, net" and not already included in "interest expense" in accordance with GAAP.

We experienced a net gain on derivative instruments for the three months ended September 30, 2014 as a result of favorable changes in their fair value due to an increase in interest rates during the period. For the nine months ended September 30, 2014, however, we experienced a net loss on derivative instruments because interest rates have been declining for most of 2014 across the interest rate swap curve where the preponderance of our derivative instruments are economically hedging our interest rate risk.

The loss on derivatives, net for the three and nine months ended September 30, 2013 was primarily due to unfavorable changes in fair value of Eurodollar futures we added during the third quarter of 2013. Interest rates were higher on average when we entered into the Eurodollar contracts than interest rates as of September 30, 2013.

The notional amount of derivative instruments outstanding from period to period fluctuate based on the composition of our investment portfolio and the current interest rate environment as well as management's expectation of future interest rates. During the three and nine months ended September 30, 2014, we held an average effective notional amount of derivative instruments of $636.4 million and $731.9 million, respectively, compared to $1,700.4 million and $1,585.8 million for the three and nine months ended September 30, 2013, respectively. We have reduced the average notional amount outstanding on our derivative instruments since 2013 because our current expectation is that interest rates will remain at or near current levels for the remainder of 2014 and into 2015, and also because of changes in the interest rate risk profile of our investment portfolio.

The following table provides additional detail on the net periodic interest costs by type of derivative instrument for the periods indicated:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
($ in thousands)	2014			2013			2014			2013
Receive-fixed interest rate swaps	$	(236	)	$	—		$	(236	)	$	—
Pay-fixed interest rate swaps	2,507			5,471			7,390			5,918
Total net periodic interest costs of derivative instruments included in "gain (loss) on derivative instruments, net"	$	2,271		$	5,471		$	7,154		$	5,918
Receive-fixed interest rate swaps
Average notional balance	$	62,500		$	—		$	21,062		$	—
Weighted average rate	1.94		%	—		%	1.94		%	—		%
Pay-fixed interest rate swaps
Average notional balance	$	698,913		$	1,700,424		$	752,985		$	1,585,810
Weighted average rate	1.57		%	1.64		%	1.58		%	1.60		%

41

Total net periodic interest costs of derivative instruments was significantly lower for the three and nine months ended September 30, 2014 compared to the same periods in 2013 due to the lower average notional balance outstanding at a lower weighted average net pay rate. For the nine months ended September 30, 2013, $8.8 million of net periodic interest costs is excluded from the table above because periodic interest costs were recorded within "interest expense" as a result of cash flow hedge accounting used prior to June 30, 2013. The weighted average net pay rate for all effective interest rate derivatives during the three and nine months ended September 30, 2014 was 1.54% and 1.57%, respectively, compared to 1.64% and 1.60% for the three and nine months ended September 30, 2013, respectively. The Company did not have any interest rate swaps with fixed receive rates during the three and nine months ended September 30, 2013.

Gain (Loss) on Sale of Investments, Net

The following tables provide information related to our gain (loss) on sale of investments, net for the periods indicated:

	Three Months Ended
	September 30,
	2014					2013
($ in thousands)	Amortized cost basis sold		Gain (loss) on sale of investments, net			Amortized cost basis sold		Gain (loss) on sale of investments, net
Type of Investment
Agency RMBS	$	53,921	$	(1,200	)	$	—	—
Agency CMBS	—		—			19,050		472
Agency CMBS IO	84,734		1,542			65,031		316
Non-Agency CMBS	136,441		8,133			56,913		(1,613		)
Non-Agency CMBS IO	12,513		582			—		—
	$	287,609	$	9,057		$	140,994	$	(825	)

	Nine Months Ended
	September 30,
	2014					2013
($ in thousands)	Amortized cost basis sold		(Loss) gain on sale of investments, net			Amortized cost basis sold		(Loss) gain on sale of investments, net
Type of Investment
Agency RMBS	$	122,413	$	(5,489	)	$	4,496	(254		)
Agency CMBS	—		—			32,958		553
Agency CMBS IO	106,077		1,630			145,991		1,846
Non-Agency RMBS	—		—			5,631		(340		)
Non-Agency CMBS	146,322		8,550			136,287		792
Non-Agency CMBS IO	12,513		582			—		—
	$	387,325	$	5,273		$	325,363	$	2,597

Sales of our investments occur in the ordinary course of business as we manage our risk profile and as we allocate capital to preferred investment opportunities. Agency RMBS sold during the nine months ended September 30, 2014 were at or near their interest rate reset date and were expected to underperform compared to the rest of our RMBS portfolio. These sales of Agency RMBS generated losses because they were below market yields. We also sold certain Agency CMBS IO and non-Agency CMBS during the three and nine months ended September 30, 2014 in order to reduce our portfolio exposure to spread risk and to monetize gains from their increased market value.

42

General and Administrative Expenses

General and administrative expenses were $3.9 million for the three months ended September 30, 2014 compared to $3.6 million for the three months ended September 30, 2013. These expenses were $11.9 million for the nine months ended September 30, 2014 compared to $11.2 million for the same period in 2013. The increases for both periods are primarily related to increased software costs related to portfolio and risk management and increased expenses related to the expansion of the Board of Directors.

Non-GAAP Financial Measures

In addition to our operating results presented in accordance with GAAP, this Quarterly Report on Form 10-Q contains certain non-GAAP financial measures. Management believes these non-GAAP financial measures are useful because they provide investors better transparency to the information we use in analyzing our financial and operational performance. Management also believes the presentation of these measures, when analyzed in conjunction with the our GAAP operating results, allows investors to more effectively evaluate and compare our performance to that of our peers. However, because these non-GAAP financial measures exclude certain items used to compute GAAP net income (loss) to common shareholders and GAAP interest expense, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, our GAAP results as reported in our consolidated statements of comprehensive income. In addition, because not all companies use identical calculations, our non-GAAP measures may not be comparable to similarly titled measures of other companies.

The following descriptions are for the non-GAAP measures contained herein:

•Core net operating income to common shareholders equals GAAP net income (loss) to common shareholders adjusted for amortization of accumulated other comprehensive loss on de-designated cash flow hedges included in GAAP interest expense, net change in fair value of derivative instruments which includes gains and losses on terminated derivative instruments (if applicable), gains and losses on sales of investments, and fair value adjustments on investments not classified as available for sale.

•Effective borrowing costs equal GAAP interest expense excluding the amortization of accumulated other comprehensive loss on interest rate swaps de-designated as cash flow hedges on June 30, 2013 plus net periodic interest costs on derivative instruments (including accrued amounts) which are not already included in GAAP interest expense.

•Adjusted net interest income equals GAAP net interest income less effective borrowing costs.

•Adjusted net interest spread equals average annualized yields on investments less effective borrowing rates.

Schedules reconciling effective borrowing costs, adjusted net interest income, and adjusted net interest spread to their related GAAP financial measures are provided within "Results of Operations" within Part 1, Item 2 of this Quarterly Report on Form 10-Q. The following table presents a reconciliation of our GAAP net income (loss) to our core net operating income for the periods presented:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
($ in thousands, except per share amounts)	2014			2013			2014			2013
GAAP net income (loss) to common shareholders	$	28,572		$	(6,921	)	$	17,251		$	40,902
Amortization of de-designated cash flow hedges (1)	1,442			2,583			5,339			2,583
Change in fair value of derivative instruments, net (2)	(7,113		)	18,548			24,500			6,765
(Gain) loss on sale of investments, net	(9,057		)	825			(5,273		)	(2,597		)
Fair value adjustments, net	(42		)	(150		)	(162		)	590
Core net operating income to common shareholders	$	13,802		$	14,885		$	41,655		$	48,243
Core net operating income to common shareholders per share	$	0.25		$	0.27		$	0.76		$	0.88

43

(1) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Represents net gains and losses on derivatives and excludes net periodic interest costs related to these instruments.

LIQUIDITY AND CAPITAL RESOURCES

 Our primary sources of liquidity include borrowings under repurchase arrangements, monthly principal and interest payments we receive on our investments, unencumbered Agency MBS, and unencumbered cash. Additional sources may also include proceeds from the sale of investments, equity offerings, issuances of collateralized financings, and payments received from counterparties from interest rate swap agreements. We use our liquidity to fund our investment purchases and other operating costs, to pay down borrowings, to make payments to counterparties as required under interest rate swap agreements, and to pay dividends on our common stock.

Our available liquid assets as of September 30, 2014 were $224.2 million compared to $201.2 million as of June 30, 2014 and $208.7 million as of December 31, 2013. As of September 30, 2014, our liquid assets consist of unrestricted cash and cash equivalents of $56.6 million, $165.2 million in unencumbered Agency MBS, and $2.4 million of unrestricted cash collateral received on derivative positions. Unencumbered Agency MBS are considered part of our liquid assets as we may pledge them to lenders and interest rate swap counterparties if we experience a margin call (discussed further below). We do not include unencumbered non-Agency MBS as liquid assets given the uncertainty of their liquidity in times of market stress.

We continually monitor our current and forecasted available liquidity. Our liquid assets may fluctuate from period to period based on our investment activities and whether we have recently raised, but not yet deployed, equity capital. However, we seek to maintain sufficient liquidity based on the sensitivity analysis and debt-to-equity requirements discussed below, to support our operations and meet our anticipated liquidity needs.

We perform sensitivity analysis on our liquidity based on changes in the value of our investments due to changes in interest rates, credit spreads, lender haircuts and prepayment speeds. We also closely monitor our debt-to-invested equity ratio (which is the ratio of debt financing to invested equity for any investment) as part of our liquidity management process as well as our overall enterprise level debt-to-equity. We also monitor the ratio of our available liquidity to outstanding repurchase agreement borrowings, which fluctuates due to changes in the fair value of collateral we have pledged to our lenders. On an enterprise level basis, our current operating policies limit our total liabilities-to-shareholders' equity to seven (7) times our shareholders' equity. At the individual investment level, our targeted leverage ranges from three (3) to ten (10) times our invested equity capital depending on the investment type. The maximum targets represent fixed limits for leveraging our investment capital. We may change our leverage targets based on market conditions and our perceptions of the liquidity of our investments.

On an enterprise-wide basis, our total liabilities decreased to 5.2 times shareholders' equity as of September 30, 2014 from 5.7 times as of June 30, 2014 and 6.2 times as of December 31, 2013. Over the last several quarters we have reduced our leverage due to the tighter credit spread environment and the resulting spread risk on our investments, and also due to the potential for increased regulatory risk and overall market risk as discussed below.

We have historically had ample sources of liquidity to fund our activities and operations. The ability to fund our operations in the future depends in large measure on the availability of credit through repurchase agreement financing and the liquidity of our investments. Credit markets in general are stable, and there is ample availability. However, these markets and the liquidity of our investments remain susceptible to exogenous shocks as was experienced in the financial crisis in 2008 and 2009. In addition, in recent quarters U.S. financial regulatory agencies (such as the Office of Financial Research in the U.S. Treasury and the Federal Reserve) have expressed some concern about the stability of repurchase agreement financing for mortgage REITs in a rising interest rate environment, and regulatory reform in the form of certain provisions of the Basel III capital framework (and supplemental bank capital rules) and the Dodd-Frank Wall Street Reform and Consumer Protection Act could impact the overall availability of credit by restricting the number of repurchase agreement lenders and the credit made available by such lenders. In times of severe market stress, repurchase agreement availability could be rapidly reduced and the terms on which we can borrow could be materially altered, particularly given the focus on these markets by the federal financial and banking regulators. Competition from other REITs, banks, hedge funds, and the federal government for capacity with our repurchase agreement lenders could also reduce our

44

repurchase agreement availability. While we do not anticipate such events in the near term, a reduction in our borrowing capacity could force us to sell assets in order to repay our lenders or could otherwise restrict our ability to operate our business.

Depending on our liquidity levels, the condition of the credit markets, and other factors, we may from time to time consider the issuance of debt, equity, or other securities, or sell investments, the proceeds of which could provide additional liquidity for our operations. While we will attempt to avoid dilutive or otherwise costly issuances, depending on market conditions, in order to manage our liquidity we could be forced to issue equity or debt securities which are dilutive to our capital base or our profitability.

Cash Flows For the Nine Months Ended September 30, 2014 Compared to the Nine Months Ended September 30, 2013

Cash flows provided by our operating activities were relatively unchanged at $159.7 million for the nine months ended September 30, 2014 compared to $158.0 million for the same period in 2013.

For the nine months ended September 30, 2014, we had cash provided by our investing activities of $328.8 million compared to cash of $262.0 million used by the same activities during the comparable 2013 period. This difference is primarily driven by a decrease of $868.1 million in investments purchased during the nine months ended September 30, 2014 compared to the same period in 2013. The decrease in purchases of investments was partially offset by a decrease of $338.1 million in principal payments we received on our investments.

For the nine months ended September 30, 2014, cash of $501.1 million was used for financing activities, primarily because we have been reducing our leverage through repayment of our repurchase agreement borrowings. For the nine months ended September 30, 2013, we had $87.8 million of our cash provided by financing activities, which was primarily the result of our increased repurchase agreement borrowings used to help finance our increased purchases of investments during the same period.

Repurchase Agreements

The following table presents information regarding the balances of our repurchase agreement borrowings for the periods indicated:

(amounts in thousands)	Balance Outstanding As of Period End		Average Balance Outstanding For the Quarter Ended		Maximum Balance Outstanding During the Quarter Ended
September 30, 2014	$	3,150,254	$	3,352,599	$	3,469,491
June 30, 2014	3,447,050		3,454,884		3,496,521
March 31, 2014	3,485,544		3,497,167		3,580,997
December 31, 2013	3,580,754		3,603,477		3,675,290
September 30, 2013	3,674,850		3,836,249		4,071,773

Since the end of the second quarter of 2013, our repurchase agreement borrowings and the average balances outstanding have been declining due to our smaller MBS portfolio, which has resulted from decreased investment of principal payments and sales proceeds received on MBS into new investments, as we have been conservatively managing our investment portfolio. In addition, we have been using our repurchase agreement borrowings to purchase assets for which we typically finance a lower percentage of their market value.

The weighted average original term to maturity for our repurchase agreement borrowings was 106 days as of September 30, 2014 compared to 114 days as of December 31, 2013. Throughout 2014 we have managed our maturities based on market conditions. We have recently begun to extend our maturities into 2015 as we seek to lock-in lower borrowing rates. We also expect borrowing rates to increase as repurchase agreement availability is reduced due to regulatory constraints on our lenders.

     Our repurchase agreement borrowings are generally renewable at the discretion of our lenders without guaranteed roll-over terms. Given the short-term and uncommitted nature of most of our repurchase agreement financing, we attempt to maintain unused capacity under our existing repurchase agreement credit lines with multiple counterparties which helps protect us in the event of a counterparty's failure to renew existing repurchase agreements either with favorable terms or at all. As of September 30, 2014, we had repurchase agreement borrowings outstanding with 21 of our 33 available repurchase agreement counterparties at

45

a weighted average borrowing rate of 0.53% compared to 0.61% as of December 31, 2013. Our repurchase agreement borrowings generally carry a rate of interest based on a spread to an index such as LIBOR.

For our repurchase agreement borrowings, we are required to post and maintain margin to the lender (i.e., collateral in excess of the repurchase agreement financing) in order to support the amount of the financing. This excess collateral is often referred to as a "haircut" (and which we also refer to as equity at risk). As the collateral pledged is generally MBS, the fair value of the collateral can fluctuate with changes in market conditions. If the fair value of the collateral falls below the initial haircut amount, the lender has the right to demand additional margin, or collateral, to increase the haircut back to the initial amount. These demands are typically referred to as "margin calls". There is no minimum amount of collateral value decline required before the lender could initiate a margin call, and we typically will experience margin calls for downward fluctuations in collateral values. Declines in the value of investments occur for any number of reasons including but not limited to changes in interest rates, changes in ratings on an investment, changes in actual or perceived liquidity of the investment, or changes in overall market risk perceptions. Additionally, values in Agency RMBS will also decline from the payment delay feature of those securities. Agency RMBS have a payment delay feature whereby Fannie Mae and Freddie Mac announce principal payments on Agency RMBS but do not remit the actual principal payments and interest for 20 days in the case of Fannie Mae and 40 days in the case of Freddie Mac. Because these securities are financed with repurchase agreements, the repurchase agreement lender generally makes a margin call for an amount equal to the product of their advance rate on the repurchase agreement and the announced principal payments on the Agency RMBS. This causes a temporary use of our liquidity to meet the margin call until we receive the principal payments and interest 20 to 40 days later. 

The following table presents the minimum weighted average haircut contractually required by our counterparties for Agency and non-Agency MBS pledged as collateral for our repurchase agreement borrowings as of the dates indicated:

	September 30, 2014		June 30, 2014		March 31, 2014		December 31, 2013		September 30, 2013
Agency MBS	6.8	%	6.6	%	6.9	%	6.8	%	6.7	%
Non-Agency MBS	16.9	%	18.5	%	19.8	%	20.1	%	20.0	%

The counterparties with whom we have the greatest amounts of equity at risk may vary significantly during any given period due to the short-term and generally uncommitted nature of the repurchase agreement borrowings. Equity at risk is defined as the amount pledged as collateral to the repurchase agreement counterparty in excess of the repurchase agreement amount outstanding. The following tables present the five counterparties with whom we had the greatest amounts of equity at risk as of September 30, 2014 and as of December 31, 2013:

	September 30, 2014
(amounts in thousands)	Amount Outstanding		Equity at Risk
Well Fargo Bank, N.A. and affiliates	$	252,365	$	50,695
JP Morgan Securities, LLC	293,724		47,334
South Street Financial Corporation	591,257		35,616
Bank of America Securities LLC	216,158		26,101
Credit Suisse Securities LLC	124,289		18,379
Remaining counterparties	1,672,461		103,446
	$	3,150,254	$	281,571

	December 31, 2013
(amounts in thousands)	Amount Outstanding		Equity at Risk
Well Fargo Bank, N.A. and affiliates (1)	$	371,753	$	91,769
JP Morgan Securities, LLC	240,024		39,397
South Street Financial Corporation	601,354		29,331
Credit Suisse Securities LLC	210,861		25,093
Bank of America Securities LLC	226,768		23,886
Remaining counterparties	1,930,237		102,797
	$	3,580,997	$	312,273

46

(1) Amount excludes deferred costs related to our committed two-year repurchase facility with Wells Fargo Bank National which had a remaining balance of $0.2 million as of December 31, 2013.

The following table discloses our repurchase agreement amounts outstanding and the value of the related collateral pledged by geographic region of our counterparties as of September 30, 2014:

(amounts in thousands)	Amount Outstanding		Market Value of Collateral Pledged
North America	$	1,942,668	$	2,138,462
Asia	702,467		740,396
Europe	505,119		552,967
	$	3,150,254	$	3,431,825

Our repurchase agreement counterparties require us to comply with various operating and financial covenants. The financial covenants include requirements that we maintain minimum shareholders' equity (usually a set minimum, or a percentage of the highest amount of shareholders' equity since the date of the agreement), maximum decline in shareholders' equity (expressed as a percentage decline in any given period), and limits on maximum leverage (as a multiple of shareholders' equity). Operating requirements include, among other things, requirements to maintain our status as a REIT and to maintain our listing on the NYSE. Violations of one or more of these covenants could result in the lender declaring an event of default which would result in the termination of the repurchase agreement and immediate acceleration of amounts due thereunder. In addition, some of the agreements contain cross default features, whereby default with one lender simultaneously causes default under agreements with other lenders. Violations could also restrict us from paying dividends or engaging in other transactions that are necessary for us to maintain our REIT status.

We monitor and evaluate on an ongoing basis the impact these customary financial covenants may have on our operating and financing flexibility. Currently, we do not believe we are subject to any covenants that materially restrict our financing flexibility. We have one repurchase agreement lender which requires that we maintain our enterprise level leverage as of quarter end at less than 7 times our shareholders' equity.

Derivatives

Our interest rate derivative instruments require us to post initial margin at inception and variation margin based on subsequent changes in the fair value of the derivatives. The collateral posted as margin by us is typically in the form of cash or Agency MBS. Generally, as interest rates decline due to market value changes, we will be required to post collateral with counterparties on our pay-fixed derivative instruments and receive collateral from our counterparties on our receive-fixed derivative instruments, and vice versa as interest rates increase. As of September 30, 2014, we had Agency MBS with a fair value of $0.7 million and cash of $32.8 million posted as credit support under these agreements.

Dividends

As a REIT, we are required to distribute to our shareholders amounts equal to at least 90% of our REIT taxable income for each taxable year after consideration of our tax NOL carryforwards. We generally fund our dividend distributions through our cash flows from operations. If we make dividend distributions in excess of our operating cash flows during the period, whether for purposes of meeting our REIT distribution requirements or other strategic reasons, those distributions are generally funded either through our existing cash balances or through the return of principal from our investments (either through repayment or sale). As of December 31, 2013, we had an estimated NOL carryfoward of $145.8 million. Due to an ownership shift in 2012, we were limited to $24.7 million to offset our REIT distribution requirements. An additional $13.5 million of our NOL will become available during 2014, and therefore, we expect to have $38.2 million available for the year ended December 31, 2014.

Contractual Obligations

The following table summarizes our contractual obligations by payment due date as of September 30, 2014:

47

(amounts in thousands)	Payments due by period
Contractual Obligations:	Total		< 1 year		1-3 years		3-5 years		> 5 years
Repurchase agreements (1)	$	3,154,276	$	2,988,030	$	166,246	$	—	$	—
Non-recourse collateralized financing (2)	11,381		3,066		3,911		2,246		2,158
Operating lease obligations	1,077		148		202		208		519
Total	$	3,166,734	$	2,991,244	$	170,359	$	2,454	$	2,677

(1) Includes estimated interest payments calculated using interest rates in effect as of September 30, 2014.

(2) Amounts shown are for principal only and exclude interest obligations as those amounts are not significant. Non-recourse collateralized financing represents securitization financing that is payable solely from loans and securities pledged as collateral. Payments due by period were estimated based on the principal repayments forecasted for the underlying loans and securities, substantially all of which is used to repay the associated financing outstanding.

Off-Balance Sheet Arrangements

As of September 30, 2014, we do not believe that any off-balance sheet arrangements exist that are reasonably likely to have a material effect on our current or future financial condition, results of operations, liquidity or capital resources.

RECENT ACCOUNTING PRONOUNCEMENTS

There are no recently issued accounting pronouncements which have had or are expected to have a material impact on the Company's consolidated financial statements. Please refer to Note 1 of our "Notes to the Unaudited Consolidated Financial Statements" for information regarding recently issued accounting pronouncements.

FORWARD-LOOKING STATEMENTS

Certain written statements in this Quarterly Report on Form 10-Q that are not historical facts constitute “forward-looking statements” within the meaning of Section 27A of the 1933 Act and Section 21E of the Exchange Act. Statements in this report addressing expectations, assumptions, beliefs, projections, future plans and strategies, future events, developments that we expect or anticipate will occur in the future, and future operating results are forward-looking statements. Forward-looking statements are based upon management’s beliefs, assumptions, and expectations as of the date of this report regarding future events and operating performance, taking into account all information currently available to us, and are applicable only as of the date of this report. Forward-looking statements generally can be identified by use of words such as “believe”, “expect”, “anticipate”, “estimate”, “plan” “may”, “will”, “intend”, “should”, “could” or similar expressions. We caution readers not to place undue reliance on our forward-looking statements, which are not historical facts and may be based on projections, assumptions, expectations, and anticipated events that do not materialize. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statement whether as a result of new information, future events, or otherwise.

Forward-looking statements in this Quarterly Report on Form 10-Q may include, but are not limited to:

• Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations;

• Monetary policy and regulatory initiatives of the Federal Reserve;

• Our financing and hedging strategy, including our target leverage ratios, anticipated trends in financing costs, changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;

• Our investment portfolio composition and target investments;

• Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investment portfolio;

• Our liquidity and ability to access financing, and the anticipated availability and cost of financing;

• Our use of and restrictions on using our tax NOL carryfoward;

• The status of pending litigation;

• The competitive environment in the future, including competition for investments and the availability of financing;

• Estimates of future interest expenses related to the Company's derivative instruments;

48

• The status of regulatory rule-making or review processes and the status of reform efforts and other business developments in the repurchase agreement financing market;

• Market, industry and economic trends; and

• Interest rates.

Forward-looking statements are inherently subject to risks, uncertainties and other factors that could cause our actual results to differ materially from historical results or from any results expressed or implied by such forward-looking statements. Not all of these risks and other factors are known to us. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect us. The projections, assumptions, expectations or beliefs upon which the forward-looking statements are based can also change as a result of these risks or other factors.  If such a risk or other factor materializes in future periods, our business, financial condition, liquidity and results of operations may vary materially from those expressed or implied in our forward-looking statements.

While it is not possible to identify all factors, some of the factors that may cause actual results to differ from historical results or from any results expressed or implied by forward-looking statements, or that may cause our projections, assumptions, expectations or beliefs to change, include the following:

• the risks and uncertainties referenced in this Quarterly Report on Form 10-Q, particularly those set forth under Part II, Item 1A, “Risk Factors”;

• our ability to find suitable reinvestment opportunities;

• changes in economic conditions;

• changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;

• our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;

• actual or anticipated changes in Federal Reserve monetary policy;

• adverse reactions in financial markets related to the budget deficit or national debt of the United States government; potential or actual default by the United States government on Treasury securities; and potential or actual downgrades to the sovereign credit rating of the United States;

• the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;

• the cost and availability of new equity capital;

• changes in our use of leverage;

• the quality of performance of third-party servicer providers of our loans and loans underlying our securities;

• the level of defaults by borrowers on loans we have securitized;

• changes in our industry;

• increased competition;

• changes in government regulations affecting our business;

• changes in the repurchase agreement financing markets and other credit markets;

• changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;

• government initiatives to support the U.S financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including by imposing standards for originating residential mortgage loans;

• GSE reform or other government policies and actions; and

• ownership shifts under Section 382 that further limit the use of our tax NOL carryforward.

49

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We seek to manage various risks inherent in our business strategy, which include interest rate, prepayment, reinvestment, market value, credit, and liquidity risks. These risks can and do cause fluctuations in our book value per common share and comprehensive income. We attempt to manage these risks and earn an acceptable return for our shareholders as discussed below.

Interest Rate Risk

Investing in interest-rate sensitive investments on a leveraged basis subjects us to interest rate risk primarily from the mismatch between interest-rate reset dates (or maturity) of our assets and the maturity of our liabilities. Borrowing costs on our liabilities are generally based on prevailing market rates and reset more frequently than interest rates on our assets. During a period of rising interest rates (particularly short term rates in a flattening yield curve environment), our borrowing costs will increase faster than our asset yields, negatively impacting our net interest income. The amount of the impact will depend on the composition of portfolio and on the effectiveness of our hedge instruments at the time, as well as the magnitude and the duration of the increase in interest rates. In addition, our adjustable rate assets may have limits or caps on the amount that an interest rate may reset while our liabilities do not have rate reset caps. Changes in interest rates, particularly rapid changes, may also negatively impact the market value of our investments which reduces our book value. See "Market Value Risk" below for further discussion of the risks to the market value of our investments.

While having interest rate risk is a basic tenet of our investment strategy, we attempt to manage our exposure to changes in interest rates by investing in instruments that have shorter maturities or interest reset dates, entering into hedging transactions (such as interest rate swaps and Eurodollar futures) and by managing our investment portfolio within interest rate risk tolerances set by our Board of Directors. Our current goal is to maintain a net portfolio duration (a measure of interest rate risk) within a range of 0.5 to 1.5 years. Our portfolio duration may drift outside of our target range at various times due to changes in market conditions, changes in actual or expected prepayment rates on our investments, changes in interest rates, changes in credit spreads, and activity in our investment portfolio. In addition, duration is driven by model inputs, and in the case of Agency RMBS, the most important inputs include anticipated prepayment speeds. Estimates of prepayment speeds can vary significantly by investor for the same security and therefore estimates of security and portfolio duration can vary significantly.

Effect of Changes in Interest Rates on Adjusted Net Interest Income and Market Value. The table below shows the projected sensitivity of our adjusted net interest income and the market value of our investments and derivative instruments carried at fair value as they existed as of September 30, 2014 based on an instantaneous parallel shift in market interest rates as set forth in the table and assumes the following:

• The "percentage change in adjusted net interest income" in the table below includes the anticipated impact of changes in expected prepayment speeds on our investments and also assumes that net proceeds received from pay downs on the portfolio are reinvested in MBS in amounts proportionate to the portfolio composition that existed as of September 30, 2014 and at yields consistent with those as of that date adjusted for the parallel shift in the rates below.

• The "percentage change in market value" included in the table below is based on the immediate change in market value of the investment portfolio based on the instantaneous shift in market interest rates. The projections for market value do not assume any change in credit spreads.

We are presenting only a -50 basis point parallel shift in interest rates given the low level of absolute rates at September 30, 2014. Changes in types of investments, changes in future interest rates, changes in credit spreads, changes in the shape of the yield curve, the availability of financing and/or the mix of our investments and financings including derivative instruments may cause actual results to differ significantly from the modeled results. In addition, declines in market value of our investments and derivative instruments may occur from changes in market expectations on future interest rates and/or Federal Reserve monetary policy which are not modeled in the table below. Other factors will also impact the amounts set forth below, such as whether we raise additional capital or change our investment allocations or strategies. Accordingly, amounts shown below could differ materially from actual results. There can be no assurance that assumed events used for the model below will occur, or that other events will not occur, that will affect the outcomes; therefore, the tables below and all related disclosures constitute forward-looking statements.

50

Parallel Shift in Interest Rates	Percentage change in adjusted net interest income	Percentage change in market value (1)
+100	(21.6)%	(1.0)%
+50	(9.8)%	(0.5)%
-50	4.7%	0.3%

(1) Includes changes in market value of our investments and derivative instruments, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet.

Management also considers changes in the shape of the interest rate curves in assessing and managing portfolio interest rate risk. The table below shows the projected change in market value of our investment portfolio net of hedges for changes in the shape of the U.S. Treasury curve (with similar changes to the interest rate swap curve and Eurodollar curves) as of September 30, 2014.

Basis point change in  2-year yield	Basis point change in  10-year yield	Percentage change in market value
0	+25	—%
+10	+50	(0.1)%
+10	+75	(0.2)%
+25	+75	(0.3)%
+25	0	(0.1)%
+50	0	(0.2)%
-10	-50	—%

Our adjustable rate investments have interest rates which are predominantly based on one-year LIBOR and contain periodic (or interim) and lifetime interest rate caps which limit the amount by which the interest rate may reset on the investment. The following table presents information about the lifetime and interim interest rate caps (where interim interest rate caps include both initial adjustments of interest rates which generally are 5% as well as periodic adjustments which generally are 2%) on our adjustable-rate Agency MBS portfolio as of September 30, 2014:

Lifetime Interest Rate Caps			Interim Interest Rate Caps
	% of Total			% of Total
>7.4% to 10.0%	87.8	%	1.0%	0.7	%
>10.0% to 11.0%	8.9	%	2.0%	16.4	%
>11.0% to 12.1%	3.3	%	5.0%	82.9	%
	100.0	%		100.0	%

Market Value Risk

Market value risk generally represents the risk of loss in value of our investment securities and derivatives due to fluctuations in interest rates, prepayment rates and credit spreads. Securities in our investment portfolio and derivative instruments are reflected at their estimated fair value on our consolidated balance sheet. Changes in the fair value of our derivative instruments are recorded within "net income" on our consolidated statement of comprehensive income while changes in the fair value of our investments are recorded within "other comprehensive income" on our consolidated statement of comprehensive income. As demonstrated in the tables above in the discussion of interest rate risk, in a rising interest rate environment, the fair value of our securities tends to decrease; conversely, in a decreasing interest rate environment, the fair value of our securities tends to increase. The fair value of our securities will also fluctuate due to changes in credit spreads (which represent the market's valuation of the perceived riskiness of assets relative to risk-free rates), changes in actual prepayments or expected prepayments, the perceived liquidity of the investment, actual or expected credit performance, and other factors. We attempt to manage market value risk by

51

managing our exposure to these factors (although we may not actively attempt to manage market value risk from changes in credit spreads). For example, the types of derivative instruments we are currently using to hedge the interest rates on our debt tend to increase in value when our investment portfolio decreases in value, although not a one-to-one correlation. 

Fluctuations in credit spreads typically vary based on the type of investments. Though market conditions and technical factors such as FOMC monetary policy may impact Agency MBS credit spreads, they will generally have less volatility than non-Agency MBS. The table below is an estimate of the projected change in our portfolio market value given the indicated change in market credit spreads as of September 30, 2014:

Basis Point Change in Market Credit Spreads	Percentage change in market value
+50	(1.9)%
+25	(1.0)%
-25	1.0%
-50	1.9%

Prepayment and Reinvestment Risk

Prepayment risk is the risk of an early, unscheduled return of principal on an investment. We are subject to prepayment risk from premiums paid on investments which we acquire. Purchase premiums on our investments are amortized as a reduction in interest income using the effective yield method under GAAP, adjusted for the actual and anticipated prepayment activity of the investment. An increase in the actual or expected rate of prepayment will typically accelerate the amortization of purchase premiums, thereby reducing the yield/interest income earned on such assets. Principal prepayments on our investments are influenced by changes in market interest rates and a variety of economic, geographic, government policy and other factors beyond our control.

Prepayment risk results from both our RMBS and CMBS investments. The majority of the loans underlying our RMBS are ARMs or hybrid ARMs. Prepayments on these loans accelerate in a declining interest rate environment, as the loans age, and as the loans near their respective interest rate reset dates, particularly the initial reset date. Our prepayment models anticipate acceleration of prepayments in these events. To the extent the actual prepayments exceed our modeled prepayments, or if we change our future prepayment expectations, we will record adjustments to our premium amortization which may negatively impact our net interest income and could impact the fair value of our RMBS.

As an indication of our prepayment risk on our RMBS portfolio, the following table summarizes information for our Agency RMBS portfolio regarding the net premium and weighted average coupon by months until interest rate reset ("MTR") or until maturity in the case of fixed-rate securities as of the end of the past four quarters:     

	September 30, 2014				June 30, 2014				March 31, 2014				December 31, 2013
($ in thousands)	Net Premium			WAC	Net Premium			WAC	Net Premium			WAC	Net Premium			WAC
0-12 MTR	$	33,582		2.93%	$	39,627		3.00%	$	37,353		3.02%	$	42,082		2.97%
13-24 MTR	5,229			4.05%	5,237			4.05%	9,210			3.64%	11,234			3.73%
25-60 MTR	38,807			3.42%	42,460			3.44%	46,756			3.50%	46,419			3.66%
> 60 MTR	43,059			2.99%	45,028			3.00%	46,591			3.00%	54,496			2.99%
Fixed rate	(10		)	2.50%	(10		)	2.51%	(11		)	2.51%	(11		)	2.51%
Total premium, net	$	120,667		3.14%	$	132,342		3.16%	$	139,899		3.20%	$	154,220		3.22%
Par/notional balance	$	2,200,149			$	2,360,799			$	2,438,133			$	2,591,568
Premium, net as a % of par value	5.5%				5.6%				5.7%				6.0%

Loans underlying our RMBS do not have any specific prepayment protection whereas loans underlying our CMBS and CMBS IO securities generally have some form of prepayment protection provisions (such as prepayment lock-outs) or prepayment

52

compensation provisions (such as yield maintenance or prepayment penalties). Yield maintenance and prepayment penalty requirements are intended to create an economic disincentive for the loans to prepay; however, the amount of the prepayment penalty required to be paid may decline over time, and as loans age, interest rates decline, or market values of collateral supporting the loans increase, prepayment penalties may lessen as an economic disincentive to the borrower over time. Generally, our experience has been that prepayment lock-out and yield maintenance provisions result in stable prepayment performance from period to period. There are no prepayment protections, however, if the loan defaults and is partially or wholly repaid earlier as a result of loss mitigation actions taken by the underlying loan servicer. Historically, our default experience on loans in CMBS and CMBS IO has been relatively low.

Without these prepayment protection provisions, prepayment risk on CMBS IO would be particularly acute as these investments have no principal balance (interest payments are based on the notional amount of the underlying commercial loans) and therefore are all premium. Prepayment protection and compensation provisions generally, but not always, differ by the type of GSE issuing the MBS. The majority of our Agency CMBS IO are issued by Freddie Mac which generally have initial prepayment lock-outs followed by a defeasance period which generally extends to within six months of the stated maturities of the underlying loans. We sold the majority of our Agency CMBS IO issued by Ginnie Mae during the third quarter of 2014 to reduce exposure to prepayment risk and in part to rotate capital into non-Agency CMBS IO. The following table details the fair value of our Agency CMBS IO portfolio by GSE as of the end of the past four quarters:

(amounts in thousands)	September 30, 2014		June 30, 2014		March 31, 2014		December 31, 2013
Fannie Mae	$	29,995	$	47,340	$	68,587	$	70,288
Freddie Mac	380,367		323,970		325,447		312,089
Ginnie Mae	1,355		76,190		77,211		77,950
	$	411,717	$	447,500	$	471,245	$	460,327

We seek to manage our prepayment risk on our MBS by diversifying our investments, seeking investments which we believe will have superior prepayment performance, and investing in securities which have some sort of prepayment prohibition or yield maintenance (as is the case with CMBS and CMBS IO). With respect to RMBS, we will seek to invest in RMBS where we believe the underlying loans have favorable prepayment characteristics such as lower loan balances or favorable origination, borrower or geographic characteristics.

We are also subject to reinvestment risk as a result of the prepayment, repayment and sales of our investments. Yields on assets in which we invest now are generally lower than yields on existing assets that we may sell or which may be repaid, due to lower overall interest rates and more competition for these as investment assets. As a result, our interest income may decline in the future, thereby reducing earnings per share. In order to maintain our investment portfolio size and our earnings, we need to reinvest our capital into new interest-earning assets. If we are unable to find suitable reinvestment opportunities, interest income on our investment portfolio and investment cash flows could be negatively impacted.

Credit Risk

Credit risk is the risk that we will not receive all contractual amounts due on investments that we own due to default by the borrower or due to a deficiency in proceeds from the liquidation of the collateral securing the obligation. We are also exposed to credit risk on investments that we own at a premium. For investments owned at premiums, defaults on the underlying loan typically result in the complete loss of any remaining unamortized premium we paid.

We attempt to mitigate our credit risk by purchasing Agency MBS and higher quality non-Agency MBS. Agency MBS have credit risk to the extent that Fannie Mae or Freddie Mac fails to remit payments on the MBS for which they have issued a guaranty of payment. Given the improved financial performance and conservatorship of these entities and the continued support of the U.S. government, we believe this risk is low. For our non-Agency MBS, we will generally only purchase investment grade securities (rated 'BBB' or better by a least one of the nationally recognized statistical ratings organizations).

Almost all of our non-Agency securities are CMBS and CMBS IO. Non-Agency CMBS IOs have no principal balance but the income we earn on these investments is based on a referenced pool of commercial mortgage loans. The performance of

53

these IOs is dependent in large measure on the credit performance of the pool of loans. We invest in non-Agency CMBS IOs only where we are comfortable with the credit profile of the loans and can monitor their credit performance.

The following table presents information on our non-Agency MBS by credit rating as of September 30, 2014:

	September 30, 2014
(amounts in thousands)	CMBS		CMBS IOs		RMBS		Weighted average
AAA	$	36,814	$	284,126	$	—	56.5	%
AA	75,343		1,140		—		13.5	%
A (1)	121,254		—		—		21.3	%
Below A or not rated (1)	36,862		2,947		9,555		8.7	%
	$	270,273	$	288,213	$	9,555	100.0	%

(1) Please refer to the "Non-Agency" section within "Financial Condition" contained within Item 2 of this Quarterly Report on Form 10-Q for additional information regarding non-Agency MBS with credit ratings less than AA at the time of purchase.

Liquidity Risk

We have liquidity risk principally from the use of recourse repurchase agreements to finance our ownership of securities. In general, our repurchase agreements provide a source of uncommitted short-term financing that finances a longer-term asset, thereby creating a mismatch between the maturity of the asset and of the associated financing. Our repurchase agreements are renewable at the discretion of our lenders and do not contain guaranteed roll-over terms. If we fail to repay the lender at maturity, the lender has the right to immediately sell the collateral and pursue us for any shortfall if the sales proceeds are inadequate to cover the repurchase agreement financing. In addition, repurchase agreements are collateral based and declines in the market value of our investments subject us to liquidity risk.

For further information, including how we attempt to mitigate liquidity risk and our liquidity position, please refer to “Liquidity and Capital Resources” in Part I, Item 2 of this Quarterly Report on Form 10-Q.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures.

Our management evaluated, with the participation of our Principal Executive Officer and Principal Financial Officer, the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. Based on that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2014 to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in internal control over financial reporting.

Our management is also responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rule 13a-15(f). There were no changes in our internal control over financial reporting during the three months ended September 30, 2014 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

54

PART II.    OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company and its subsidiaries are parties to various legal proceedings. Although the ultimate outcome of those legal proceedings cannot be ascertained at this time, and the results of legal proceedings cannot be predicted with certainty, the Company believes, based on current knowledge, that the resolution of any of those proceedings will not have a material adverse effect on the Company’s consolidated financial condition or liquidity. However, the resolution of any of the proceedings could have a material impact on consolidated results of operations or cash flows in a given future reporting period as the proceedings are resolved.

With respect to the putative class action lawsuit that was filed in June 2012 in the Court of Common Pleas of Allegheny County, Pennsylvania (the “Court”), and to which GLS Capital, Inc. and the Company are named defendants (as such lawsuit is described in more detail in our Annual Report on Form 10-K for the year ended December 31, 2013), on June 30, 2014, the Court dismissed with prejudice the plaintiffs’ complaint in its entirety. Plaintiffs have appealed.

There have been no material changes during the three or nine months ended September 30, 2014 for the legal proceedings discussed in the Annual Report on Form 10-K for the year ended December 31, 2013 other than those disclosed above.

ITEM 1A.    RISK FACTORS

Risks and uncertainties identified in our Forward-Looking Statements contained in this Quarterly Report on Form 10-Q together with those previously disclosed in the Annual Report on Form 10-K for the year ended December 31, 2013 or those that are presently unforeseen could result in significant adverse effects on our financial condition, results of operations and cash flows.  See “Forward-Looking Statements” contained in Part 1, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” within this Quarterly Report on Form 10-Q as well as Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013.

ITEM 2.    UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The Company has been authorized by its Board of Directors to repurchase up to $50 million of its outstanding shares of common stock through December 31, 2014. Subject to applicable securities laws and the terms of the Series A Preferred Stock designation and the Series B Preferred Stock designation, both of which are contained in our Articles of Incorporation, future repurchases of common stock will be made at times and in amounts as the Company deems appropriate, provided that the repurchase price per share is less than the Company's estimate of the current net book value of a share of common stock. Repurchases may be suspended or discontinued at any time.

The following table summarizes repurchases of our common stock that occurred during the three months ended September 30, 2014:

55

	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
					($ in thousands)
July 1, 2014 - July 31, 2014	—	$	—	—	$	42,145
August 1, 2014 - August 31, 2014	186	8.75		—	42,145
September 1 - September 30, 2014	—	—		—	42,145
Total	186	$	8.75	—	$	42,145

(1) These shares were withheld from certain employees to satisfy tax withholding obligations arising upon the vesting of restricted shares. Accordingly, these shares are not included in the calculation of approximate dollar value of shares that may yet be purchased under the $50 million repurchase plan authorized by the Company's Board of Directors.

ITEM 3.    DEFAULTS UPON SENIOR SECURITES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

None.

ITEM 5.    OTHER INFORMATION

None.

56

ITEM 6.    EXHIBITS

Exhibit No.	Description
3.1	Restated Articles of Incorporation, effective June 2, 2014 (incorporated herein by reference to Exhibit 3.1 to Dynex's Registration Statement on Form S-8 filed September 17, 2014).
3.2	Amended and Restated Bylaws, amended as of December 12, 2013 (incorporated herein by reference to Exhibit 3.2 to Dynex's Annual Report on Form 10-K filed March 4, 2014).
31.1	Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2	Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1	Certification of principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101	The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended September 30, 2014, formatted in XBRL (Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets (unaudited), (ii) Consolidated Statements of Comprehensive Income (unaudited), (iii) Consolidated Statements of Shareholders' Equity (unaudited), (iv) Consolidated Statements of Cash Flows (unaudited), and (v) Notes to the Unaudited Consolidated Financial Statements.

57

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		DYNEX CAPITAL, INC.
Date:	November 10, 2014	/s/ Byron L. Boston
		Byron L. Boston
		Chief Executive Officer, President,
		Co-Chief Investment Officer, and Director
		(Principal Executive Officer)
Date:	November 10, 2014	/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Executive Vice President, Chief Operating Officer and Chief Financial Officer
		(Principal Financial Officer)

58

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Byron L. Boston, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Dynex Capital, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	November 10, 2014
		/s/ Byron L. Boston
		Byron L. Boston
		Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Stephen J. Benedetti, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Dynex Capital, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	November 10, 2014
		/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Principal Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 906

In connection with the Quarterly Report on Form 10-Q of Dynex Capital, Inc. (the “Company”) for the three months endedSeptember 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, as the Principal Executive Officer of the Company and the Principal Financial Officer of the Company, respectively, certify, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	November 10, 2014	/s/ Byron L. Boston
		Byron L. Boston
		Principal Executive Officer
Date:	November 10, 2014	/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Principal Financial Officer

XML

Shareholders' Equity Share-based Compensation (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based incentive plan, number of shares authorized for issuance	2,500,000		2,500,000
Share-based incentive plan, number of shares remaining for issuance	1,078,908		1,078,908
Total share-based compensation expense	$ 690	$ 612	$ 2,045	$ 1,726
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value			3,703	2,708
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Restricted stock outstanding as of beginning of the period	746,830	526,803	520,969	448,283
Restricted stock granted during the period	0	0	457,538	255,158
Restricted stock vested during the period	(2,917)	(2,917)	(234,594)	(179,555)
Restricted stock outstanding as of end of the period	743,913	523,886	743,913	523,886
Nonvested restricted stock, fair value remaining to be amortized	4,969		4,969
Restricted Stock [Member] | Within twelve months [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	2,411		2,411
Restricted Stock [Member] | One to two years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	1,663		1,663
Restricted Stock [Member] | Two to three years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	750		750
Restricted Stock [Member] | Three to four years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	$ 145		$ 145

XML

Offsetting Assets and Liabilities Offsettting Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Offsetting Liabilities [Line Items]
Derivative liabilities, fair value, gross liability	$ 18,058		$ 6,681
Derivative liabilities, fair value, gross amount offset in balance sheet	0		0
Derivative liabilities, fair value, amount not offset against collateral	18,058		6,681
Derivative, Collateral, Right to Reclaim Securities	(777)	[1]	(1,299)	[1]
Derivative, Collateral, Right to Reclaim Cash	(17,281)	[1]	(5,382)	[1]
Derivative liabilities, fair value, amount offset against collateral	0		0
Repurchase agreements, gross liability	3,150,254		3,580,754
Repurchase agreements, gross amount offset in balance sheet	0		0
Repurchase agreements, amount not offset against collateral	3,150,254		3,580,754
Repurchase agreements, Collateral, Right to Reclaim Securities	(3,150,254)	[1]	(3,580,754)	[1]
Repurchase agreements, Collateral, Right to Reclaim Cash	0	[1]	0	[1]
Repurchase agreements, amount offset against collateral	0		0
Total gross liabilities	3,168,312		3,587,435
Total gross liabilities, gross amount offset in balance sheet	0		0
Total liabilities, amount not offset against collateral	3,168,312		3,587,435
Total liabilities, Collateral, Right to Reclaim Securities	(3,151,031)	[1]	(3,582,053)	[1]
Total liabilities, Collateral, Right to Reclaim Cash	(17,281)	[1]	(5,382)	[1]
Total liabilities, amount offset against collateral	$ 0		$ 0

[1] 1) Amount disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.

XML

Mortgage Backed Securities Mortgage backed securities designated as AFS (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended		12 Months Ended
	Sep. 30, 2014		Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	$ 2,781,833		$ 3,254,946
Available-for-sale MBS, Unamortized Premium (Discount)	811,251		758,950
Available-for-sale MBS, Amortized Cost	3,593,084		4,013,896
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	54,491		45,114
Available-for-sale MBS, Gross Unrealized Loss	(32,182)		(69,566)
Available-for-sale MBS, Fair Value	3,615,393		3,989,444
Agency MBS [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	2,505,715		2,865,398
Available-for-sale MBS, Unamortized Premium (Discount)	540,739		627,047
Available-for-sale MBS, Amortized Cost	3,046,454		3,492,445
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	32,340		26,792
Available-for-sale MBS, Gross Unrealized Loss	(31,442)		(63,976)
Available-for-sale MBS, Fair Value	3,047,352		3,455,261
Agency MBS [Member] | Residential Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	2,200,149		2,591,568
Available-for-sale MBS, Unamortized Premium (Discount)	120,667		154,220
Available-for-sale MBS, Amortized Cost	2,320,816		2,745,788
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	7,593		6,104
Available-for-sale MBS, Gross Unrealized Loss	(31,105)		(59,742)
Available-for-sale MBS, Fair Value	2,297,304		2,692,150
Available-for-sale MBS, Weighted Average Coupon	3.14%		3.22%
Agency MBS [Member] | Commercial Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	305,566		273,830
Available-for-sale MBS, Unamortized Premium (Discount)	19,186		19,061
Available-for-sale MBS, Amortized Cost	324,752		292,891	[1]
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	13,803		10,793
Available-for-sale MBS, Gross Unrealized Loss	(224)		(900)
Available-for-sale MBS, Fair Value	338,331		302,784	[1]
Available-for-sale MBS, Weighted Average Coupon	5.22%		5.07%
Agency MBS [Member] | CMBS IO [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	0	[2]	0	[3]
Available-for-sale MBS, Unamortized Premium (Discount)	400,886		453,766
Available-for-sale MBS, Amortized Cost	400,886		453,766
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	10,944		9,895
Available-for-sale MBS, Gross Unrealized Loss	(113)		(3,334)
Available-for-sale MBS, Fair Value	411,717		460,327
Available-for-sale MBS, Weighted Average Coupon	0.83%		0.83%
Notional balance for interest only securities	9,461,823		10,160,502
Non-Agency MBS [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	276,118		389,548
Available-for-sale MBS, Unamortized Premium (Discount)	270,512		131,903
Available-for-sale MBS, Amortized Cost	546,630		521,451
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	22,151		18,322
Available-for-sale MBS, Gross Unrealized Loss	(740)		(5,590)
Available-for-sale MBS, Fair Value	568,041		534,183
Non-Agency MBS [Member] | Residential Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	9,522		13,845
Available-for-sale MBS, Unamortized Premium (Discount)	(4)		(338)
Available-for-sale MBS, Amortized Cost	9,518		13,507
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	118		338
Available-for-sale MBS, Gross Unrealized Loss	(81)		(80)
Available-for-sale MBS, Fair Value	9,555		13,765
Available-for-sale MBS, Weighted Average Coupon	4.20%		4.61%
Non-Agency MBS [Member] | Commercial Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	266,596		375,703
Available-for-sale MBS, Unamortized Premium (Discount)	(12,374)		(18,277)
Available-for-sale MBS, Amortized Cost	254,222		357,426
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	16,397		15,366
Available-for-sale MBS, Gross Unrealized Loss	(346)		(3,511)
Available-for-sale MBS, Fair Value	270,273		369,281
Available-for-sale MBS, Weighted Average Coupon	4.89%		5.10%
Non-Agency MBS [Member] | CMBS IO [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	0	[2]	0	[3]
Available-for-sale MBS, Unamortized Premium (Discount)	282,890		150,518
Available-for-sale MBS, Amortized Cost	282,890		150,518
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	5,636		2,618
Available-for-sale MBS, Gross Unrealized Loss	(313)		(1,999)
Available-for-sale MBS, Fair Value	288,213		151,137
Available-for-sale MBS, Weighted Average Coupon	0.69%		0.66%
Notional balance for interest only securities	7,246,832		4,274,957
Agency MBS [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value	155,501		1,912,937
Available-for-sale MBS, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	(1,142)		(43,543)
Available-for-sale MBS, Number of Securities in Continuous Unrealized Loss Position for Less than One Year	25		150
Available-for-sale MBS, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	1,701,638		670,402
Available-for-sale MBS, Continuous Unrealized Loss Position, 12 Months or Longer, Gross Unrealized Losses	(30,299)		(20,433)
Available-for-sale MBS, Number of Securities in Continuous Unrealized Loss Position for Greater than or Equal to One Year	129		67
Non-Agency MBS [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value	74,239		162,558
Available-for-sale MBS, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	(427)		(5,435)
Available-for-sale MBS, Number of Securities in Continuous Unrealized Loss Position for Less than One Year	17		39
Available-for-sale MBS, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	31,348		6,310
Available-for-sale MBS, Continuous Unrealized Loss Position, 12 Months or Longer, Gross Unrealized Losses	$ (313)		$ (155)
Available-for-sale MBS, Number of Securities in Continuous Unrealized Loss Position for Greater than or Equal to One Year	8		6

[1] (1) As of December 31, 2013, the Company had Agency CMBS with an amortized cost of $26,920 and fair value of $28,717 which were designated as trading securities and are not included in this table. The Company changed the designation of these Agency CMBS to AFS during the three months ended June 30, 2014. Changes in the fair value of these MBS while they were designated as trading were recognized in net income within "fair value adjustments, net". Changes in the fair value of these MBS, which are now designated as AFS, are recognized in "other comprehensive income". As of September 30, 2014, the Company does not have any MBS designated as trading.

[2] (1)The notional balance for Agency CMBS IO and non-Agency CMBS IO was $9,461,823 and $7,246,832, respectively, as of September 30, 2014. December 31, 2013 Par Net Premium (Discount) Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Fair Value WACAgency: RMBS$2,591,568 $154,220 $2,745,788 $6,104 $(59,742) $2,692,150 3.22%CMBS (1)273,830 19,061 292,891 10,793 (900) 302,784 5.07%CMBS IO (2)— 453,766 453,766 9,895 (3,334) 460,327 0.83%Total Agency AFS:2,865,398 627,047 3,492,445 26,792 (63,976) 3,455,261 Non-Agency: RMBS13,845 (338) 13,507 338 (80) 13,765 4.61%CMBS375,703 (18,277) 357,426 15,366 (3,511) 369,281 5.10%CMBS IO (2)— 150,518 150,518 2,618 (1,999) 151,137 0.66%Total non-Agency AFS:389,548 131,903 521,451 18,322 (5,590) 534,183 Total AFS securities$3,254,946 $758,950 $4,013,896 $45,114 $(69,566) $3,989,444

[3] (2) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $10,160,502 and $4,274,957, respectively, as of December 31, 2013.

XML

Fair Value of Financial Instruments Recorded basis and Fair Value (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	$ 7,297		$ 18,488
Derivative Liabilities, Fair Value Disclosure	18,058		6,681
Carrying (Reported) Amount, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities, Fair Value Disclosure	3,615,393		4,018,161
Mortgage loans held for investment, net, Fair Value Disclosure	41,454		55,423
Derivative assets	7,297		18,488
Repurchase Agreements, Fair Value Disclosure	3,150,254		3,580,754
Non-recourse collateralized financing, Fair Value Disclosure	11,194		12,914
Derivative Liabilities, Fair Value Disclosure	18,058		6,681	[1]
Estimate of Fair Value, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities, Fair Value Disclosure	3,615,393		4,018,161
Mortgage loans held for investment, net, Fair Value Disclosure	36,590	[2]	46,383	[2]
Derivative assets	7,297		18,488
Repurchase Agreements, Fair Value Disclosure	3,150,254		3,580,997	[1]
Non-recourse collateralized financing, Fair Value Disclosure	10,757	[2]	12,414	[2]
Derivative Liabilities, Fair Value Disclosure	$ 18,058		$ 6,681	[1]

[1] (2) The difference between the recorded basis of repurchase agreements and their fair value as of December 31, 2013 is the unamortized deferred costs remaining for the 2-year repurchase facility.

[2] (1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate fair value of the Company's Level 3 non-Agency MBS.

XML

Mortgage Backed Securities Mortgage backed securities (Notes)

9 Months Ended

Sep. 30, 2014

Investments, Debt and Equity Securities [Abstract]

Mortgage-backed securities

MORTGAGE-BACKED SECURITIES

The following tables present the components and weighted average coupon ("WAC") for the portion of the Company’s MBS designated as AFS as of September 30, 2014 and December 31, 2013:

	September 30, 2014
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,200,149	$	120,667		$	2,320,816	$	7,593	$	(31,105	)	$	2,297,304	3.14	%
CMBS	305,566		19,186			$	324,752	13,803		(224		)	338,331		5.22	%
CMBS IO (1)	—		400,886			$	400,886	10,944		(113		)	411,717		0.83	%
Total Agency AFS:	$	2,505,715	$	540,739		$	3,046,454	$	32,340	$	(31,442	)	$	3,047,352
Non-Agency:
RMBS	$	9,522	$	(4	)	$	9,518	$	118	$	(81	)	$	9,555	4.20	%
CMBS	266,596		(12,374		)	254,222		16,397		(346		)	270,273		4.89	%
CMBS IO (1)	—		282,890			282,890		5,636		(313		)	288,213		0.69	%
Total non-Agency AFS:	$	276,118	$	270,512		$	546,630	$	22,151	$	(740	)	$	568,041
Total AFS securities	$	2,781,833	$	811,251		$	3,593,084	$	54,491	$	(32,182	)	$	3,615,393

(1) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $9,461,823 and $7,246,832, respectively, as of September 30, 2014.

	December 31, 2013
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,591,568	$	154,220		$	2,745,788	$	6,104	$	(59,742	)	$	2,692,150	3.22	%
CMBS (1)	273,830		19,061			292,891		10,793		(900		)	302,784		5.07	%
CMBS IO (2)	—		453,766			453,766		9,895		(3,334		)	460,327		0.83	%
Total Agency AFS:	2,865,398		627,047			3,492,445		26,792		(63,976		)	3,455,261
Non-Agency:
RMBS	13,845		(338		)	13,507		338		(80		)	13,765		4.61	%
CMBS	375,703		(18,277		)	357,426		15,366		(3,511		)	369,281		5.10	%
CMBS IO (2)	—		150,518			150,518		2,618		(1,999		)	151,137		0.66	%
Total non-Agency AFS:	389,548		131,903			521,451		18,322		(5,590		)	534,183
Total AFS securities	$	3,254,946	$	758,950		$	4,013,896	$	45,114	$	(69,566	)	$	3,989,444

(1) As of December 31, 2013, the Company had Agency CMBS with an amortized cost of $26,920 and fair value of $28,717 which were designated as trading securities and are not included in this table. The Company changed the designation of these Agency CMBS to AFS during the three months ended June 30, 2014. Changes in the fair value of these MBS while they were designated as trading were recognized in net income within "fair value adjustments, net". Changes in the fair value of these MBS, which are now designated as AFS, are recognized in "other comprehensive income". As of September 30, 2014, the Company does not have any MBS designated as trading.

(2) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $10,160,502 and $4,274,957, respectively, as of December 31, 2013.

The following table presents certain information for those Agency MBS in an unrealized loss position as of September 30, 2014 and December 31, 2013:

	September 30, 2014						December 31, 2013
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	155,501	$	(1,142	)	25	$	1,912,937	$	(43,543	)	150
Non-Agency MBS	74,239		(427		)	17	162,558		(5,435		)	39
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	1,701,638	$	(30,299	)	129	$	670,402	$	(20,433	)	67
Non-Agency MBS	31,348		(313		)	8	6,310		(155		)	6

Because the principal and interest related to Agency MBS are guaranteed by the government-sponsored entities Fannie Mae and Freddie Mac which have the implicit guarantee of the U.S. government, the Company does not consider any of the unrealized losses on its Agency MBS to be credit related. Although the unrealized losses are not credit related, the Company assesses its ability and intent to hold any Agency MBS with an unrealized loss until the recovery in its value. This assessment is based on the amount of the unrealized loss and significance of the related investment as well as the Company’s current leverage and anticipated liquidity. Based on this analysis, the Company has determined that the unrealized losses on its Agency MBS as of September 30, 2014 and December 31, 2013 were temporary.

The Company also reviews any non-Agency MBS in an unrealized loss position to evaluate whether any decline in fair value represents an OTTI. The evaluation includes a review of the credit ratings of these non-Agency MBS and the seasoning of the mortgage loans collateralizing these securities as well as the estimated future cash flows which include projected losses. The Company performed this evaluation for the non-Agency MBS in an unrealized loss position and has determined that there have not been any adverse changes in the timing or amount of estimated future cash flows that necessitate a recognition of OTTI amounts as of September 30, 2014 or December 31, 2013.

XML

Repurchase Agreements Repurchase Agreements, Counterparty Information (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014 Agreements
Counterparty Information [Line Items]
Line of Credit Facility, Amount Outstanding	$ 131,275
Line of Credit Facility, Maximum Borrowing Capacity	$ 250,000
Line of Credit Facility, Interest Rate at Period End	1.06%
Number of Counterparties with Borrowings Outstanding	21
Available Repurchase Agreement Counterparties	33

XML

Repurchase Agreements Repurchase Agreements, Term to Original Maturity (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Transfers Accounted for as Secured Borrowings, Associated Liabilities, Carrying Amount	$ 3,150,254	$ 3,580,754
Deferred Costs	0	(243)
Maturity up to 30 days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Transfers Accounted for as Secured Borrowings, Associated Liabilities, Carrying Amount	574,164	4,736
Maturity 30 to 90 Days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Transfers Accounted for as Secured Borrowings, Associated Liabilities, Carrying Amount	566,959	1,176,631
Maturity 91 to 180 days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Transfers Accounted for as Secured Borrowings, Associated Liabilities, Carrying Amount	1,514,454	1,439,225
Maturity 181 days up to 1 year [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Transfers Accounted for as Secured Borrowings, Associated Liabilities, Carrying Amount	329,232	960,405
Maturity 1 year or longer [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Transfers Accounted for as Secured Borrowings, Associated Liabilities, Carrying Amount	$ 165,445	$ 0

XML

Derivatives (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended			9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013	Dec. 31, 2013
Derivative [Line Items]
Derivative assets, fair value	$ 7,297			$ 7,297			$ 18,488
Derivative liabilities, fair value	(18,058)			(18,058)			(6,681)
Notional amount of derivative instruments added				7,950,000
Notional amount of derivative instruments terminated				(190,000)
Derivatives, notional amount	17,550,000			17,550,000			9,790,000
Gain (loss) on derivative instruments, net	4,842		(24,019)	(31,654)		(12,683)
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative assets, aggregate notional amount	4,700,000			4,700,000			575,000
Derivative liabilities, aggregate notional amount	12,850,000			12,850,000			9,215,000
Interest Rate Swap [Member]
Derivative [Line Items]
Derivative assets, fair value	6,958			6,958			18,488
Derivative liabilities, fair value	(437)			(437)			(1,336)
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative assets, aggregate notional amount	800,000			800,000			575,000
Derivative liabilities, aggregate notional amount	150,000			150,000			215,000
Eurodollar Future [Member]
Derivative [Line Items]
Derivative assets, fair value	339			339
Derivative liabilities, fair value	(17,621)			(17,621)			(5,345)
Notional amount of derivative instruments added				7,600,000
Notional amount of derivative instruments terminated				0
Derivatives, notional amount	16,600,000			16,600,000			9,000,000
Gain (loss) on derivative instruments, net	3,857		(17,794)	(11,937)		(17,794)
Eurodollar Future [Member] | Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative assets, aggregate notional amount	3,900,000	[1]		3,900,000	[1]
Derivative liabilities, aggregate notional amount	12,700,000	[1]		12,700,000	[1]		9,000,000	[1]
Long [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Notional amount of derivative instruments added				275,000
Notional amount of derivative instruments terminated				0
Derivatives, notional amount	275,000			275,000			0
Gain (loss) on derivative instruments, net	339		0	339		0
Long [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 37-48 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	0			0
Weighted-average Fixed Pay Rate	0.00%			0.00%
Weighted-average Fixed Receive Rate	0.00%			0.00%
Long [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 49-60 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	250,000			250,000
Weighted-average Fixed Pay Rate	2.00%			2.00%
Weighted-average Fixed Receive Rate	2.00%			2.00%
Long [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 61-72 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	0			0
Weighted-average Fixed Pay Rate	0.00%			0.00%
Weighted-average Fixed Receive Rate	0.00%			0.00%
Long [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 73-84 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	0			0
Weighted-average Fixed Pay Rate	0.00%			0.00%
Weighted-average Fixed Receive Rate	0.00%			0.00%
Long [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 97-108 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	0			0
Weighted-average Fixed Pay Rate	0.00%			0.00%
Weighted-average Fixed Receive Rate	0.00%			0.00%
Long [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 109-120 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	25,000			25,000
Weighted-average Fixed Pay Rate	3.00%			3.00%
Weighted-average Fixed Receive Rate	3.00%			3.00%
Short [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Notional amount of derivative instruments added				75,000
Notional amount of derivative instruments terminated				(190,000)
Derivatives, notional amount	675,000			675,000			790,000
Gain (loss) on derivative instruments, net	646		(6,225)	(20,056)		5,111
Short [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 37-48 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	185,000			185,000
Weighted-average Fixed Pay Rate	0.92%			0.92%
Weighted-average Fixed Receive Rate	0.92%			0.92%
Short [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 49-60 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	235,000			235,000
Weighted-average Fixed Pay Rate	1.45%			1.45%
Weighted-average Fixed Receive Rate	1.45%			1.45%
Short [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 61-72 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	25,000			25,000
Weighted-average Fixed Pay Rate	1.61%			1.61%
Weighted-average Fixed Receive Rate	1.61%			1.61%
Short [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 73-84 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	50,000			50,000
Weighted-average Fixed Pay Rate	2.20%			2.20%
Weighted-average Fixed Receive Rate	2.20%			2.20%
Short [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 97-108 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	30,000			30,000
Weighted-average Fixed Pay Rate	1.93%			1.93%
Weighted-average Fixed Receive Rate	1.93%			1.93%
Short [Member] | Interest Rate Swap [Member] | Interest Rate Swap Agreements, Maturities in Next 109-120 Months [Member]
Derivative [Line Items]
Derivatives, notional amount	$ 150,000			$ 150,000
Weighted-average Fixed Pay Rate	2.17%			2.17%
Weighted-average Fixed Receive Rate	2.17%			2.17%

[1] The Eurodollar futures aggregate notional amount represents the total notional of the 3-month contracts with expiration dates from 2015 to 2020. The maximum notional outstanding for any future 3-month period did not exceed $1,300,000 as of September 30, 2014 and $1,175,000 as of December 31, 2013.

XML

Derivatives Derivative Effect on Accumulated Other Comprehensive Income (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Reclassification adjustment for cash flow hedges (including de-designated hedges)	$ 1,442	$ 2,583	$ 5,339	$ 11,379
Derivative [Line Items]
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	4,026		4,026
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months			4,156
Dedesignated cash flow hedge amortization	1,442	2,583	5,339	2,583
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 0	$ 0	$ 0	$ 8,796

XML

Net Income Per Common Share

9 Months Ended

Sep. 30, 2014

Earnings Per Share, Basic and Diluted [Abstract]

Net Income per Common Share

NET INCOME (LOSS) PER COMMON SHARE

Net income (loss) per common share is presented on both a basic and diluted basis. The Company does not currently have any potentially dilutive securities outstanding. Because the Company's Series A Cumulative Redeemable Preferred Stock and Series B Cumulative Redeemable Preferred Stock are redeemable at the Company's option for cash only, and may convert into shares of common stock only upon a change of control of the Company, the effect of those shares is excluded from the calculation of diluted net income (loss) per common share. Holders of unvested shares of the Company's issued and outstanding restricted common stock are eligible to receive non-forfeitable dividends. As such, these unvested shares are considered participating securities as per ASC 260-10 and therefore are included in the computation of basic net income (loss) per share using the two-class method. Upon vesting, restrictions on transfer expire on each share of restricted stock, and each such share of restricted stock is converted to one equal share of common stock.

The following table presents the calculation of the numerator and denominator for both basic and diluted net income (loss) per common share for the periods indicated:

	For the Three Months Ended
	September 30, 2014					September 30, 2013
	Net  Income			Weighted-Average Common Shares		Net Loss			Weighted- Average Common Shares
Net income (loss)	$	30,866				$	(4,627	)
Preferred stock dividends	(2,294		)			(2,294		)
Net income (loss) to common shareholders	28,572			54,731,414		(6,921		)	54,903,637
Effect of dilutive instruments	—			—		—			—
Diluted net income (loss) to common shareholders	$	28,572		54,731,414		$	(6,921	)	54,903,637
Net income (loss) per common share:
Basic and diluted				$	0.52				$	(0.13	)

	For the Nine Months Ended
	September 30, 2014					September 30, 2013
	Net  Income			Weighted-Average Common Shares		Net  Income			Weighted- Average Common Shares
Net income (loss)	$	24,133				$	46,510
Preferred stock dividends	(6,882		)			(5,608		)
Net income (loss) to common shareholders	17,251			54,689,762		40,902			54,727,950
Effect of dilutive instruments	—			—		—			—
Diluted net income (loss) to common shareholders	$	17,251		54,689,762		$	40,902		54,727,950
Net income (loss) per common share:
Basic and diluted				$	0.32				$	0.75

XML

Offsetting Assets and Liabilities Offsetting Assets (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Offsetting Assets [Line Items]
Derivative assets, fair value, gross asset	$ 7,297		$ 18,488
Derivative assets, fair value, gross liability	0		0
Derivative assets, fair value, amount not offset against collateral	7,297		18,488
Derivative assets, Collateral, Obligation to Return Securities	(478)	[1]	(193)	[1]
Derivative assets, Collateral, Obligation to Return Cash	(2,672)	[1]	(12,141)	[1]
Derivative assets, fair value, amount offset against collateral	$ 4,147		$ 6,154

[1] 1) Amount disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
ASSETS
Mortgage-backed securities	$ 3,615,393	$ 4,018,161
Mortgage loans held for investment, net	41,454	55,423
Cash and cash equivalents	56,639	69,330
Restricted cash	32,755	13,385
Derivative assets	7,297	18,488
Receivable for securities sold	16,321	0
Principal receivable on investments	11,124	12,999
Accrued interest receivable	20,986	21,703
Other assets, net	11,542	7,648
Total assets	3,813,511	4,217,137
Liabilities:
Repurchase agreements	3,150,254	3,580,754
Payable for unsettled mortgage-backed securities	0	10,358
Non recourse collateralized financing	11,194	12,914
Derivative Liabilities	18,058	6,681
Accrued interest payable	1,492	2,548
Accrued dividends payable	15,621	16,601
Other liabilities	2,845	1,405
Total liabilities	3,199,464	3,631,261
Shareholders’ equity:
Common stock, par value $.01 per share, 200,000,000 shares authorized; 54,734,817 and 54,310,484 shares issued and outstanding, respectively	547	543
Additional paid-in capital	763,228	761,550
Accumulated other comprehensive income (loss)	16,462	(33,816)
Accumulated deficit	(275,848)	(252,059)
Total shareholders' equity	614,047	585,876
Total liabilities and shareholders’ equity	3,813,511	4,217,137
Series A Preferred Stock [Member]
Shareholders’ equity:
Preferred Stock, par value $.01 per share, 8.5% Series A Cumulative Redeemable; 8,000,000 shares authorized; 2,300,000 shares issued and outstanding ($57,500 aggregate liquidation preference)	55,407	55,407
Preferred Stock, par value $.01 per share, 7.625% Series B Cumulative Redeemable; 7,000,000 shares authorized 2,250,000 shares issued and outstanding ($56,250 aggregate liquidation preference)	55,407	55,407
Series B Preferred Stock [Member]
Shareholders’ equity:
Preferred Stock, par value $.01 per share, 8.5% Series A Cumulative Redeemable; 8,000,000 shares authorized; 2,300,000 shares issued and outstanding ($57,500 aggregate liquidation preference)	54,251	54,251
Preferred Stock, par value $.01 per share, 7.625% Series B Cumulative Redeemable; 7,000,000 shares authorized 2,250,000 shares issued and outstanding ($56,250 aggregate liquidation preference)	$ 54,251	$ 54,251

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities:
Net income (loss)	$ 24,133	$ 46,510
Adjustments to reconcile net income to cash provided by operating activities:
Decrease (increase) in accrued interest receivable	(717)	(906)
(Decrease) increase in accrued interest payable	(1,056)	(462)
Provision for loan losses	0	261
Loss (gain) on derivative instruments, net	(31,654)	(12,683)
Loss (gain) on sale of investments, net	5,273	2,597
Fair value adjustments, net	162	(590)
Amortization of investment premiums, net	104,293	97,860
Other amortization and depreciation	7,007	4,398
Stock-based compensation expense	2,045	1,762
Other operating activities	3,708	3,907
Net cash and cash equivalents provided by operating activities	159,650	158,004
Investing activities:
Purchase of investments	457,008	1,325,082
Principal payments received on investments	404,464	742,551
Proceeds from sales of investments	376,278	327,962
Principal payments received on mortgage loans held for investment, net	14,150	10,775
Net payments on derivatives not designated as hedges	9,086	23,644
Other investing activities	8	(5,402)
Net cash and cash equivalents used in investing activities	328,790	(262,036)
Financing activities:
(Repayments of) borrowings under repurchase agreements, net	(430,743)	110,409
Principal payments on non-recourse collateralized financing	(1,753)	(9,502)
Increase in restricted cash	(19,370)	(15,849)
Proceeds from issuance of preferred stock	0	54,251
Proceeds from issuance of common stock	144	7,375
Cash paid for repurchases of common stock	0	5,965
Payments Related to tax withholding for share-based compensation	507	545
Dividends paid	48,902	52,343
Net cash and cash equivalents provided by (used in) financing activities	(501,131)	87,831
Net increase (decrease) in cash and cash equivalents	(12,691)	(16,201)
Cash and cash equivalents at beginning of period	69,330	55,809
Cash and cash equivalents at end of period	56,639	39,608
Supplemental Disclosure of Cash Activities:
Cash paid for interest	$ 15,703	$ 22,065

XML

Fair Value of Financial Instruments Significant Unobservable Inputs Level 3 (Details) (Fair Value, Measurements, Recurring [Member], Fair Value, Inputs, Level 3 [Member])	3 Months Ended
	Sep. 30, 2014
Commercial Mortgage Backed Securities [Member]
Fair Value Inputs, Quantitative Information [Abstract]
Fair Value Inputs, Prepayment Rate	20.00%	[1]
Fair Value Inputs, Probability of Default	2.00%	[1]
Fair Value Inputs, Loss Severity	35.00%	[1]
Fair Value Inputs, Discount Rate	9.40%	[1]
Residential Mortgage Backed Securities [Member]
Fair Value Inputs, Quantitative Information [Abstract]
Fair Value Inputs, Prepayment Rate	10.00%	[1]
Fair Value Inputs, Probability of Default	1.00%	[1]
Fair Value Inputs, Loss Severity	20.00%	[1]
Fair Value Inputs, Discount Rate	6.60%	[1]

[1] Data presented are weighted averages.

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table presents the fair value of the Company’s assets and liabilities presented on its consolidated balance sheets, segregated by the hierarchy level of the fair value estimate, that are measured at fair value on a recurring basis as of the dates indicated:

	September 30, 2014
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	3,615,393	$	—	$	3,563,819	$	51,574
Derivative assets	7,297		339		6,958		—
Total assets carried at fair value	$	3,622,690	$	339	$	3,570,777	$	51,574
Liabilities:
Derivative liabilities	$	18,058	$	17,621	$	437	$	—
Total liabilities carried at fair value	$	18,058	$	17,621	$	437	$	—

	December 31, 2013
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	4,018,161	$	—	$	3,944,681	$	73,480
Derivative assets	18,488		—		18,488		—
Total assets carried at fair value	$	4,036,649	$	—	$	3,963,169	$	73,480
Liabilities:
Derivative liabilities	$	6,681	$	5,345	$	1,336	$	—
Total liabilities carried at fair value	$	6,681	$	5,345	$	1,336	$	—

Fair Value Inputs, Assets, Quantitative Information [Table Text Block]

The table below presents information about the significant unobservable inputs used in the fair value measurement for the Company's Level 3 non-Agency CMBS and RMBS as of September 30, 2014:

	Quantitative Information about Level 3 Fair Value Measurements (1)
	Prepayment Speed	Default Rate		Severity		Discount Rate
Non-Agency CMBS	20 CPY	2.0	%	35.0	%	9.4	%
Non-Agency RMBS	10 CPR	1.0	%	20.0	%	6.6	%

(1) Data presented are weighted averages.

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table presents the activity of the instruments fair valued at Level 3 during the three and nine months ended September 30, 2014:

	Level 3 Fair Values
	Three Months Ended									Nine Months Ended
	September 30, 2014									September 30, 2014
	Non-Agency CMBS			Non-Agency RMBS			Total assets			Non-Agency CMBS			Non-Agency RMBS			Total assets
Balance as of beginning of period	$	62,744		$	2,498		$	65,242		$	70,733		$	2,747		$	73,480
Unrealized gain (loss) included in OCI	878			(15		)	863			1,078			(138		)	940
Principal payments	(14,290		)	(298		)	(14,588		)	(22,598		)	(753		)	(23,351		)
Accretion	57			—			57			176			329			505
Balance as of end of period	$	49,389		$	2,185		$	51,574		$	49,389		$	2,185		$	51,574

Recorded basis and fair value [Table Text Block]

The following table presents a summary of the recorded basis and estimated fair values of the Company’s financial instruments as of the dates indicated:

	September 30, 2014				December 31, 2013
	Recorded Basis		Fair Value		Recorded Basis		Fair Value
Assets:
Mortgage-backed securities	$	3,615,393	$	3,615,393	$	4,018,161	$	4,018,161
Mortgage loans held for investment, net (1)	41,454		36,590		55,423		46,383
Derivative assets	7,297		7,297		18,488		18,488
Liabilities:
Repurchase agreements (2)	$	3,150,254	$	3,150,254	$	3,580,754	$	3,580,997
Non-recourse collateralized financing (1)	11,194		10,757		12,914		12,414
Derivative liabilities	18,058		18,058		6,681		6,681

XML

Fair Value of Financial Instruments Level 3 (Details) (Fair Value, Measurements, Recurring [Member], Fair Value, Inputs, Level 3 [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of the period	$ 65,242	$ 73,480
Unrealized (loss) gain included in OCI	863	940
Principal payments	(14,588)	(23,351)
Accretion	57	505
Balance at the end of the period	51,574	51,574
Non-Agency CMBS [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of the period	62,744	70,733
Unrealized (loss) gain included in OCI	878	1,078
Principal payments	(14,290)	(22,598)
Accretion	57	176
Balance at the end of the period	49,389	49,389
Non-Agency RMBS [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of the period	2,498	2,747
Unrealized (loss) gain included in OCI	(15)	(138)
Principal payments	(298)	(753)
Accretion	0	329
Balance at the end of the period	$ 2,185	$ 2,185

XML

Net Income Per Common Share (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income (loss)	$ 30,866	$ (4,627)	$ 24,133	$ 46,510
Preferred Stock Dividends	(2,294)	(2,294)	(6,882)	(5,608)
Net income (loss) to common shareholders	28,572	(6,921)	17,251	40,902
Weighted average common shares - basic and diluted	54,731,414	54,903,637	54,689,762	54,727,950
Effect of dilutive stock options on net income (loss)	0	0	0	0
Diluted net income (loss) to common shareholders	$ 28,572	$ (6,921)	$ 17,251	$ 40,902
Effect of dilutive instruments on weighted average common shares	0	0	0	0
Diluted, Weighted Average Number Common Shares	54,731,414	54,903,637	54,689,762	54,727,950
Net income (loss) per common share - basic and diluted	$ 0.52	$ (0.13)	$ 0.32	$ 0.75

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Organization and Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Dynex Capital, Inc., ("Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").

Basis of Presentation

The accompanying unaudited consolidated financial statements of Dynex Capital, Inc. and its subsidiaries (together, “Dynex” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all significant adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the consolidated financial statements have been included. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2014. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC.

Reclassifications

Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current year’s presentation. The Company's consolidated balance sheet as of December 31, 2013 now presents its "securitized mortgage loans, net" and "other investments, net" together as "mortgage loans held for investment, net". In addition, the Company has combined the presentation of its consolidated statements of income and its consolidated statements of other comprehensive income together as one financial statement which is now titled "consolidated statements of comprehensive income". The Company's "interest income - securitized mortgage loans" and "interest income-other investments" on its consolidated statements of income for the three and nine months ended September 30, 2013 is now presented together as "interest income-mortgage loans held for investment" on its consolidated statements of comprehensive income for the three and nine months ended September 30, 2013. These presentation changes have no effect on reported total assets, total liabilities, results of operations, or cash flow activities.

Consolidation

The consolidated financial statements include the accounts of the Company and the accounts of its majority owned subsidiaries and variable interest entities for which it is the primary beneficiary. All significant intercompany accounts and transactions have been eliminated in consolidation.

In accordance with Accounting Standards Codification ("ASC") Topic 810, the Company consolidates certain trusts through which it has securitized mortgage loans as a result of not meeting the sale criteria under GAAP at the time the financial assets were transferred to the trust. Additional information regarding the accounting policy for its securitized mortgage loans is provided below under "Mortgage Loans Held for Investment, Net".

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, fair value measurements of its investments, other-than-temporary impairments, contingencies, and amortization of premiums and discounts. These items are discussed further below within this note to the consolidated financial statements.

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT") under the Internal Revenue Code of 1986 and the corresponding provisions of state law. To qualify as a REIT, the Company must meet certain tests including investing in primarily real estate-related assets and the required distribution of at least 90% of its annual REIT taxable income to stockholders after consideration of its net operating loss carryforward and not including taxable income retained in its taxable subsidiaries. As a REIT, the Company generally will not be subject to federal income tax on the amount of its income or gain that is distributed as dividends to shareholders.

The Company assesses its tax positions for all open tax years and determines whether the Company has any material unrecognized liabilities in accordance with ASC Topic 740. The Company records these liabilities, if any, to the extent they are deemed more likely than not to have been incurred.

Mortgage-Backed Securities

In accordance with ASC Topic 320, the Company has designated its investments in MBS as available-for-sale ("AFS"). All of the Company’s MBS are recorded at fair value on the consolidated balance sheet. Changes in fair value for the Company's AFS securities are reported in other comprehensive income ("OCI") until each security is collected, disposed of, or determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income ("AOCI") into net income as a realized "gain (loss) on sale of investments, net" using the specific identification method.

The Company’s MBS pledged as collateral against repurchase agreements and derivative instruments are included in MBS on the consolidated balance sheets with the fair value of the MBS pledged disclosed parenthetically.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on MBS is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or "IO", securities) and their contractual terms.  Premiums and discounts on Agency MBS as well as any non-Agency MBS rated 'AA' and higher at the time of purchase are amortized into interest income over the expected life of such securities using the effective yield method and adjustments to premium amortization are made for actual cash payments as well as changes in projected future cash payments in accordance with ASC Topic 310-20. The Company's projections of future cash payments are based on input and analysis received from external sources and internal models, and includes assumptions about the amount and timing of credit losses, loan prepayment rates, fluctuations in interest rates, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets.

The Company holds non-Agency MBS that were rated less than 'AA' at the time of purchase by at least one national rating agency. These non-Agency MBS were purchased at discounts to their par value, which management does not believe to be substantial. The Company accretes the discount into income over the security's expected life, which reflects management's estimate of the security's projected cash flows in accordance with ASC Topic 325-40. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

Determination of MBS Fair Value.The Company estimates the fair value of the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company's MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security's coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. Refer to Note 7 for further discussion of MBS fair value measurements.

Other-than-Temporary Impairment.MBS is considered impaired when its fair value is less than its amortized cost. The Company evaluates all of its impaired MBS for other-than-temporary impairments ("OTTI") on at least a quarterly basis. An impairment is considered other-than-temporary if: (1) the Company intends to sell the MBS; (2) it is more likely than not that the Company will be required to sell the MBS before its fair value recovers; or (3) the Company does not expect to recover the full amortized cost basis of the MBS. If either of the first two conditions is met, the entire amount of the impairment is recognized in earnings. If the impairment is solely due to the inability to fully recover the amortized cost basis, the security is further analyzed to quantify any credit loss, which is the difference between the present value of cash flows expected to be collected on the MBS and its amortized cost. The credit loss, if any, is then recognized in earnings, while the balance of impairment related to other factors is recognized in other comprehensive income.

Following the recognition of an OTTI through earnings, a new cost basis is established for the security. Any subsequent recoveries in fair value may be accreted back into the amortized cost basis of the MBS on a prospective basis through interest income. Please see Note 3 for additional information related to the Company's evaluation for OTTI.

Mortgage Loans Held for Investment, Net

Mortgage loans held for investment, net consist of mortgage loans originated or purchased by the Company from 1992-1998, and these mortgage loans are reported at amortized cost in accordance with ASC Topic 310-10. Substantially all of these loans have been pledged as collateral to support the repayment of securitization financing bonds issued by the Company. The associated securitization financing bonds are treated as debt of the Company and are presented as "non-recourse collateralized financing" on the consolidated balance sheet. Securitized mortgage loans can only be sold subject to the lien of the respective securitization financing indenture. An allowance has been established for currently existing and probable losses on the Company's mortgage loans held for investment.

Repurchase Agreements

Repurchase agreements are accounted for as secured borrowings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments

The Company's derivative instruments, which currently include interest rate swaps and Eurodollar futures, are accounted for in accordance with ASC Topic 815, which requires an entity to recognize all derivatives as either assets or liabilities in the balance sheet and to measure those instruments at fair value. All periodic interest costs and other changes in fair value, including gains and losses recognized upon termination, associated with derivative instruments are recorded in "gain (loss) on derivative instruments, net" on the Company's consolidated statement of comprehensive income.

Effective June 30, 2013, the Company discontinued cash flow hedge accounting for derivative instruments which had previously been accounted for as cash flow hedges under ASC Topic 815. Activity up to and including June 30, 2013 for those agreements previously designated as cash flow hedges was recorded in accordance with cash flow hedge accounting as prescribed by ASC Topic 815, which states that the effective portion of the hedge relationship on an instrument designated as a cash flow hedge is reported in the current period's other comprehensive income while the ineffective portion is immediately reported as a component of the current period’s net income. The balance remaining in AOCI related to the de-designated cash flow hedges is amortized into the Company's net income as a portion of "interest expense" over the remaining life of the interest rate swap agreements. Subsequent to June 30, 2013, changes in the fair value of the Company's derivative instruments, plus periodic settlements, are recorded in the Company's net income as a portion of "gain (loss) on derivative instruments, net".

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. The Company attempts to minimize this risk by limiting its counterparties to major financial institutions with acceptable credit ratings, monitoring positions with individual counterparties and adjusting posted collateral as required.

Although MBS have characteristics that meet the definition of a derivative instrument, ASC 815 specifically excludes these instruments from its scope because they are accounted for as debt securities under ASC 320.

Share-Based Compensation

Pursuant to the Company’s 2009 Stock and Incentive Plan ("SIP"), the Company may grant share-based compensation to eligible employees, directors or consultants or advisers to the Company, including stock awards, stock options, stock appreciation rights, dividend equivalent rights, performance shares, and restricted stock units. The Company's restricted stock currently issued and outstanding under this plan may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date and recognized as compensation cost over the requisite service period with a corresponding credit to shareholders' equity as required by ASC Topic 718. The requisite service period is the period during which an employee is required to provide service in exchange for an award, which is equivalent to the vesting period specified in the terms of the share-based based award. None of the Company's restricted stock awards have performance based conditions. The Company does not currently have any share-based compensation issued or outstanding other than restricted stock.

Contingencies

In the normal course of business, there are various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, the Company evaluates whether to establish provisions for estimated losses from those matters in accordance with ASC Topic 450, which states that a liability is recognized for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed.

The Company and its subsidiaries are parties to various legal proceedings of which the ultimate outcome cannot be ascertained at this time. Although the results of those legal proceedings cannot be predicted with certainty, the Company believes, based on current knowledge, that the resolution of any of these proceedings will not have a material effect on the Company’s consolidated financial condition or liquidity. However, the resolution of any of those proceedings could have a material impact on consolidated results of operations or cash flows in a given future reporting period as the proceedings are resolved.

The Company has not been named as a party to any additional legal proceedings during the three or nine months ended September 30, 2014.

Recent Accounting Pronouncements

In June 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, which changes the accounting for repurchase-to-maturity transactions and repurchase financing arrangements. The guidance eliminates sale accounting for repurchase-to-maturity transactions and supersedes the guidance under which a transfer of a financial asset and a contemporaneous repurchase financing could be accounted for on a combined basis as a forward agreement, which has resulted in outcomes referred to as off-balance-sheet accounting. All of the Company's repurchase agreement transactions are accounted for as secured borrowings; therefore the accounting changes required by ASU No. 2014-11 do not impact the Company's consolidated financial statements. ASU No. 2014-11 also requires two additional disclosures about repurchase agreements and other similar transactions. The first disclosure requires an entity to disclose information on transfers accounted for as sales in transactions that are economically similar to repurchase agreements. The Company does not account for any of its repurchase agreement transactions as sales; therefore this new disclosure does not impact the Company's current disclosures. The second disclosure requires the following disclosures for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings: a disaggregation of the gross obligation by the class of collateral pledged; the remaining contractual tenor of the agreements; and a discussion of the potential risks associated with the agreements and the related collateral pledged, including obligations arising from a decline in the fair value of the collateral pledged and how those risks are managed. The Company already provides these disclosures in its "Notes to the Unaudited Consolidated Financial Statements" and within "Liquidity and Capital Resources" in Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Quarterly Report on Form 10-Q. The amendments provided in ASU No. 2014-11 are effective for public business entities for the first interim or annual period beginning after December 15, 2014. ASU No. 2014-11 will not have a material impact on the Company's consolidated financial statements.

In addition, the FASB issued ASU No. 2014-12, Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company has not issued and does not anticipate issuing any share-based payments with terms that require a performance-based target; therefore this ASU will not have an impact on the Company's consolidated financial statements.

The FASB issued ASU No. 2014-13, Consolidation (Topic 810): Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity, which provides an alternative to Topic 820, Fair Value Measurement, for measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity to eliminate the difference in the fair value of the financial assets of a collateralized financing entity, as determined under GAAP, when they differ from the fair value of its financial liabilities even when the financial liabilities have recourse only to the financial assets. When the measurement alternative is elected, both the financial assets and the financial liabilities of the collateralized financing entity should be measured using the more observable of the fair value of the financial assets or the fair value of the financial liabilities. The amendments clarify that when the measurement alternative is elected, a reporting entity's consolidated net income (loss) should reflect the reporting entity's own economic interests in the collateralized financing entity, including; (1) changes in the fair value of the beneficial interests retained by the reporting entity, and (2) beneficial interests that represent compensation for services. The measurement alternative provided in ASU No. 2014-13 may be applied using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. The amendments may also be applied retrospectively to all relevant prior periods beginning with the annual period in which ASU No. 2009-17 was initially adopted. ASU No. 2014-13 is effective for public entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2015, and early adoption is permitted as of the beginning of an annual period. Management has evaluated ASU No. 2014-13 and has determined that if the Company elects to adopt this measurement alternative in the future for its currently existing consolidated collateralized financing entity, it will not have a material impact on the Company's consolidated financial statements.

The FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance about management's responsibility under GAAP to evaluate whether there is substantial doubt about an organization's ability to continue as a going concern and to provide related footnote disclosures. Specifically, the ASU (1) provides a definition of the term "substantial doubt", (2) requires an evaluation by management every reporting period including interim periods, (3) provides principles for considering the mitigating effect of management's plans, (4) requires certain disclosures when substantial doubt exists regardless of the success of any mitigating plans or actions, (5) requires an express statement and other disclosures when substantial doubt is not alleviated, and (6) requires an assessment for a period of one year after the date that the financial statements are issued. The amendments in this ASU are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management intends to comply with the requirements set forth in ASU No. 2014-15.

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
ASSETS
Pledged MBS	$ 3,420,668	$ 3,873,584
Common stock, par value	$ 0.01	$ 0.01
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Shares, Issued	54,734,817	54,310,484
Common stock, shares outstanding	54,734,817	54,310,484
Series A Preferred Stock [Member]
ASSETS
Preferred Stock, Par Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	8,000,000	8,000,000
Preferred Stock, Shares Issued	2,300,000	2,300,000
Preferred Stock, Shares Outstanding	2,300,000	2,300,000
Preferred Stock, aggregate liquidation preference	57,500	57,500
Series B Preferred Stock [Member]
ASSETS
Preferred Stock, Par Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	7,000,000	7,000,000
Preferred Stock, Shares Issued	2,250,000	2,250,000
Preferred Stock, Shares Outstanding	2,250,000	2,250,000
Preferred Stock, aggregate liquidation preference	$ 56,250	$ 56,250

XML

Mortgage Backed Securities Mortgage backed securities (Tables)

9 Months Ended

Sep. 30, 2014

Investments, Debt and Equity Securities [Abstract]

Available-for-sale Securities [Table Text Block]

The following tables present the components and weighted average coupon ("WAC") for the portion of the Company’s MBS designated as AFS as of September 30, 2014 and December 31, 2013:

	September 30, 2014
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,200,149	$	120,667		$	2,320,816	$	7,593	$	(31,105	)	$	2,297,304	3.14	%
CMBS	305,566		19,186			$	324,752	13,803		(224		)	338,331		5.22	%
CMBS IO (1)	—		400,886			$	400,886	10,944		(113		)	411,717		0.83	%
Total Agency AFS:	$	2,505,715	$	540,739		$	3,046,454	$	32,340	$	(31,442	)	$	3,047,352
Non-Agency:
RMBS	$	9,522	$	(4	)	$	9,518	$	118	$	(81	)	$	9,555	4.20	%
CMBS	266,596		(12,374		)	254,222		16,397		(346		)	270,273		4.89	%
CMBS IO (1)	—		282,890			282,890		5,636		(313		)	288,213		0.69	%
Total non-Agency AFS:	$	276,118	$	270,512		$	546,630	$	22,151	$	(740	)	$	568,041
Total AFS securities	$	2,781,833	$	811,251		$	3,593,084	$	54,491	$	(32,182	)	$	3,615,393

(1) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $9,461,823 and $7,246,832, respectively, as of September 30, 2014.

	December 31, 2013
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,591,568	$	154,220		$	2,745,788	$	6,104	$	(59,742	)	$	2,692,150	3.22	%
CMBS (1)	273,830		19,061			292,891		10,793		(900		)	302,784		5.07	%
CMBS IO (2)	—		453,766			453,766		9,895		(3,334		)	460,327		0.83	%
Total Agency AFS:	2,865,398		627,047			3,492,445		26,792		(63,976		)	3,455,261
Non-Agency:
RMBS	13,845		(338		)	13,507		338		(80		)	13,765		4.61	%
CMBS	375,703		(18,277		)	357,426		15,366		(3,511		)	369,281		5.10	%
CMBS IO (2)	—		150,518			150,518		2,618		(1,999		)	151,137		0.66	%
Total non-Agency AFS:	389,548		131,903			521,451		18,322		(5,590		)	534,183
Total AFS securities	$	3,254,946	$	758,950		$	4,013,896	$	45,114	$	(69,566	)	$	3,989,444

(1) As of December 31, 2013, the Company had Agency CMBS with an amortized cost of $26,920 and fair value of $28,717 which were designated as trading securities and are not included in this table. The Company changed the designation of these Agency CMBS to AFS during the three months ended June 30, 2014. Changes in the fair value of these MBS while they were designated as trading were recognized in net income within "fair value adjustments, net". Changes in the fair value of these MBS, which are now designated as AFS, are recognized in "other comprehensive income". As of September 30, 2014, the Company does not have any MBS designated as trading.

(2) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $10,160,502 and $4,274,957, respectively, as of December 31, 2013.

Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block]

The following table presents certain information for those Agency MBS in an unrealized loss position as of September 30, 2014 and December 31, 2013:

	September 30, 2014						December 31, 2013
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	155,501	$	(1,142	)	25	$	1,912,937	$	(43,543	)	150
Non-Agency MBS	74,239		(427		)	17	162,558		(5,435		)	39
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	1,701,638	$	(30,299	)	129	$	670,402	$	(20,433	)	67
Non-Agency MBS	31,348		(313		)	8	6,310		(155		)	6

XML

Document and Entity Information (USD $)	9 Months Ended
	Sep. 30, 2014	Nov. 03, 2014	Jun. 30, 2013
Entity Information [Line Items]
Entity Registrant Name	DYNEX CAPITAL INC
Entity Central Index Key	0000826675
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		54,736,663
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 518,414,092

XML

Repurchase Agreements Repurchase Agreements (Tables)

9 Months Ended

Sep. 30, 2014

Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]

Schedule of Assets and Associated Liabilities Accounted for as Secured Borrowings [Table Text Block]

The following tables present the components of the Company’s repurchase agreements as of September 30, 2014 and December 31, 2013 by the fair value and type of securities pledged as collateral:

	September 30, 2014
Collateral Type	Balance		Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,081,924	0.36	%	2,168,095
Agency CMBS	258,024		0.33	%	302,352
Agency CMBS IOs	351,518		0.94	%	411,686
Non-Agency RMBS	7,724		1.67	%	8,803
Non-Agency CMBS	198,203		1.16	%	240,802
Non-Agency CMBS IO	242,458		1.03	%	288,202
Securitization financing bonds	10,403		1.50	%	11,885
	$	3,150,254	0.53	%	$	3,431,825

	December 31, 2013
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,522,503		0.42	%	2,598,158
Agency CMBS	246,849			0.39	%	306,318
Agency CMBS IOs	369,948			1.16	%	449,072
Non-Agency RMBS	10,569			1.80	%	12,746
Non-Agency CMBS	303,674			1.27	%	367,859
Non-Agency CMBS IOs	106,803			1.27	%	136,227
Securitization financing bonds	20,651			1.59	%	19,686
Deferred costs	(243		)	n/a		n/a
	$	3,580,754		0.61	%	$	3,890,066

The combined weighted average original term to maturity for the Company’s repurchase agreements was 106 days as of September 30, 2014 compared to 114 days as of December 31, 2013. The following table provides a summary of the original maturities as of September 30, 2014 and December 31, 2013:

Original Maturity	September 30, 2014		December 31, 2013
Less than 30 days	$	574,164	$	4,736
30 to 90 days	566,959		1,176,631
91 to 180 days	1,514,454		1,439,225
181 to 364 days	329,232		960,405
1 year or longer	165,445		—
Deferred costs	—		(243		)
	$	3,150,254	$	3,580,754

XML

Consolidated Statements of Comprehensive Income (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Interest income:
Mortgage-backed securities	$ 25,207	$ 30,820	$ 79,104	$ 95,827
Mortgage loans held for investment	793	846	2,255	2,711
Total interest income	26,000	31,666	81,359	98,538
Interest expense:
Repurchase agreements	6,028	8,477	20,187	29,860
Non recourse collateralized financing	30	241	76	760
Total interest expense	6,058	8,718	20,263	30,620
Net interest income	19,942	22,948	61,096	67,918
Provision for loan losses	0	0	0	(261)
Gain (loss) on derivative instruments, net	4,842	(24,019)	(31,654)	(12,683)
Gain (loss) on sale of investments, net	9,057	(825)	5,273	2,597
Fair value adjustments, net	42	150	162	(590)
Other income, net	897	748	1,108	761
General and administrative expenses:
Compensation and benefits	(2,351)	(2,282)	(7,232)	(6,948)
Other general and administrative	(1,563)	(1,347)	(4,620)	(4,284)
Net income (loss)	30,866	(4,627)	24,133	46,510
Preferred Stock Dividends	(2,294)	(2,294)	(6,882)	(5,608)
Net income (loss) to common shareholders	28,572	(6,921)	17,251	40,902
Change in fair value of available-for-sale investments	(6,867)	(2,671)	50,212	(112,037)
Reclassification adjustment for (gain) loss on sale of investments, net	(9,057)	825	(5,273)	(2,597)
Change in fair value of cash flow hedges	0	0	0	16,381
Reclassification adjustment for cash flow hedges (including de-designated hedges)	1,442	2,583	5,339	11,379
Other comprehensive (loss) income	(14,482)	737	50,278	(86,874)
Comprehensive income (loss) to common shareholders	$ 14,090	$ (6,184)	$ 67,529	$ (45,972)
Weighted average common shares - basic and diluted	54,731,414	54,903,637	54,689,762	54,727,950
Net income (loss) per common share - basic and diluted	$ 0.52	$ (0.13)	$ 0.32	$ 0.75
Dividends declared per common share	$ 0.25	$ 0.27	$ 0.75	$ 0.85

XML

Fair Value of Financial Instruments (Notes)

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 clarifies that fair value should be based on the assumptions market participants would use when pricing an asset or liability and also requires an entity to consider all aspects of nonperformance risk, including the entity's own credit standing, when measuring fair value of a liability. ASC Topic 820 established a valuation hierarchy of three levels as follows:

• Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

• Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.  

• Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date.  Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.  

The following table presents the fair value of the Company’s assets and liabilities presented on its consolidated balance sheets, segregated by the hierarchy level of the fair value estimate, that are measured at fair value on a recurring basis as of the dates indicated:

	September 30, 2014
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	3,615,393	$	—	$	3,563,819	$	51,574
Derivative assets	7,297		339		6,958		—
Total assets carried at fair value	$	3,622,690	$	339	$	3,570,777	$	51,574
Liabilities:
Derivative liabilities	$	18,058	$	17,621	$	437	$	—
Total liabilities carried at fair value	$	18,058	$	17,621	$	437	$	—

	December 31, 2013
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	4,018,161	$	—	$	3,944,681	$	73,480
Derivative assets	18,488		—		18,488		—
Total assets carried at fair value	$	4,036,649	$	—	$	3,963,169	$	73,480
Liabilities:
Derivative liabilities	$	6,681	$	5,345	$	1,336	$	—
Total liabilities carried at fair value	$	6,681	$	5,345	$	1,336	$	—

The Company did not have assets or liabilities measured at fair value on a non-recurring basis as of September 30, 2014 or December 31, 2013.

The Company's derivative assets and liabilities include interest rate swaps and Eurodollar futures. Interest rate swaps are valued using the income approach with the primary input being the forward interest rate swap curve, which is considered an observable input and thus their fair values are considered Level 2 measurements. Eurodollar futures are valued based on closing exchange prices on these contracts. Accordingly, these financial futures are classified as Level 1.

Agency MBS, as well a majority of non-Agency MBS, are substantially similar to securities that either are currently actively traded or have been recently traded in their respective market. Their fair values are derived from an average of multiple dealer quotes and thus are considered Level 2 fair value measurements. The Company’s remaining non-Agency MBS are comprised of securities for which there are not substantially similar securities that trade frequently, and their fair values are therefore considered Level 3 measurements. The Company determines the fair value of its Level 3 securities by discounting the estimated future cash flows derived from cash flow models using assumptions that are confirmed to the extent possible by third party dealers or other pricing indicators. Significant inputs into those pricing models are Level 3 in nature due to the lack of readily available market quotes. Information utilized in those pricing models include the security’s credit rating, coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected credit losses, and credit enhancement as well as certain other relevant information. Significant changes in any of these inputs in isolation would result in a significantly different fair value measurement. Generally Level 3 assets are most sensitive to the default rate and severity assumptions.

The table below presents information about the significant unobservable inputs used in the fair value measurement for the Company's Level 3 non-Agency CMBS and RMBS as of September 30, 2014:

	Quantitative Information about Level 3 Fair Value Measurements (1)
	Prepayment Speed	Default Rate		Severity		Discount Rate
Non-Agency CMBS	20 CPY	2.0	%	35.0	%	9.4	%
Non-Agency RMBS	10 CPR	1.0	%	20.0	%	6.6	%

(1) Data presented are weighted averages.

The following table presents the activity of the instruments fair valued at Level 3 during the three and nine months ended September 30, 2014:

	Level 3 Fair Values
	Three Months Ended									Nine Months Ended
	September 30, 2014									September 30, 2014
	Non-Agency CMBS			Non-Agency RMBS			Total assets			Non-Agency CMBS			Non-Agency RMBS			Total assets
Balance as of beginning of period	$	62,744		$	2,498		$	65,242		$	70,733		$	2,747		$	73,480
Unrealized gain (loss) included in OCI	878			(15		)	863			1,078			(138		)	940
Principal payments	(14,290		)	(298		)	(14,588		)	(22,598		)	(753		)	(23,351		)
Accretion	57			—			57			176			329			505
Balance as of end of period	$	49,389		$	2,185		$	51,574		$	49,389		$	2,185		$	51,574

The following table presents a summary of the recorded basis and estimated fair values of the Company’s financial instruments as of the dates indicated:

	September 30, 2014				December 31, 2013
	Recorded Basis		Fair Value		Recorded Basis		Fair Value
Assets:
Mortgage-backed securities	$	3,615,393	$	3,615,393	$	4,018,161	$	4,018,161
Mortgage loans held for investment, net (1)	41,454		36,590		55,423		46,383
Derivative assets	7,297		7,297		18,488		18,488
Liabilities:
Repurchase agreements (2)	$	3,150,254	$	3,150,254	$	3,580,754	$	3,580,997
Non-recourse collateralized financing (1)	11,194		10,757		12,914		12,414
Derivative liabilities	18,058		18,058		6,681		6,681

(1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate fair value of the Company's Level 3 non-Agency MBS.

(2) The difference between the recorded basis of repurchase agreements and their fair value as of December 31, 2013 is the unamortized deferred costs remaining for the 2-year repurchase facility.

XML

Derivatives

9 Months Ended

Sep. 30, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

DERIVATIVES

     The Company utilizes derivative instruments to economically hedge a portion of its exposure to market risks, primarily interest rate risk. The Company primarily uses pay-fixed interest rate swaps and Eurodollar contracts to hedge its exposure to changes in interest rates and uses receive-fixed interest rate swaps to offset a portion of its pay-fixed interest rate swaps in order to manage its overall hedge position. The objective of the Company's risk management strategy is to mitigate declines in book value resulting from fluctuations in the fair value of the Company's assets from changing interest rates and to protect the Company's earnings from rising interest rates. Please refer to Note 1 for information related to the Company's accounting policy for its derivative instruments.

The table below summarizes information about the Company’s derivative instruments treated as trading instruments on its consolidated balance sheet as of the dates indicated:  

	September 30, 2014
	Derivative Assets				Derivative Liabilities
Trading Instruments	Fair Value		Notional		Fair Value			Notional
Interest rate swaps	$	6,958	$	800,000	$	(437	)	$	150,000
Eurodollar futures (1)	339		3,900,000		(17,621		)	12,700,000
Total	$	7,297	$	4,700,000	$	(18,058	)	$	12,850,000

	December 31, 2013
	Derivative Assets				Derivative Liabilities
Trading Instruments	Fair Value		Notional		Fair Value			Notional
Interest rate swaps	$	18,488	$	575,000	$	(1,336	)	$	215,000
Eurodollar futures (1)	—		—		(5,345		)	9,000,000
Total	$	18,488	$	575,000	$	(6,681	)	$	9,215,000

(1) The Eurodollar futures aggregate notional amount represents the total notional of the 3-month contracts with expiration dates from 2015 to 2020. The maximum notional outstanding for any future 3-month period did not exceed $1,300,000 as of September 30, 2014 and $1,175,000 as of December 31, 2013.

The following table summarizes the contractual maturities remaining for the Company’s outstanding interest rate swap agreements as of September 30, 2014:

Remaining Maturity	Pay-Fixed Interest Rate Swaps		Pay-Fixed Weighted-Average Rate(1)		Receive Fixed Interest Rate Swaps		Receive-Fixed Weighted-Average Rate
37-48 months	$	185,000	0.92	%	$	—	—	%
49-60 months	235,000		1.45	%	250,000		1.91	%
61-72 months	25,000		1.61	%	—		—	%
73-84 months	50,000		2.20	%	—		—	%
85-96 months	—		—	%	—		—	%
97-108 months	30,000		1.93	%	—		—	%
109-120 months	150,000		2.17	%	25,000		2.71	%

The following table summarizes the volume of activity related to derivative instruments for the periods indicated:

For the nine months ended September 30, 2014:	Beginning of Period Notional Amount		Additions		Settlement, Termination, Expiration or Exercise			End of Period Notional Amount
Receive-fixed interest rate swaps	$	—	$	275,000	$	—		$	275,000
Pay-fixed interest rate swaps	790,000		75,000		(190,000		)	675,000
Eurodollar futures	9,000,000		7,600,000		—			16,600,000
	$	9,790,000	$	7,950,000	$	(190,000	)	$	17,550,000

The table below provides detail of the Company's "gain (loss) on derivative instruments, net" by type of interest rate derivative for the periods indicated:

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
Type of Derivative Instrument	2014		2013			2014			2013
Receive-fixed interest rate swaps	$	339	$	—		$	339		$	—
Pay-fixed interest rate swaps	646		(6,225		)	(20,056		)	5,111
Eurodollar futures	3,857		(17,794		)	(11,937		)	(17,794		)
Gain (loss) on derivative instruments, net	$	4,842	$	(24,019	)	$	(31,654	)	$	(12,683	)

Effective June 30, 2013, the Company de-designated certain interest rate swap agreements as cash flow hedges under ASC Topic 815. There is a net unrealized loss of $4,026 remaining in AOCI on the Company's consolidated balance sheet as of September 30, 2014 which represents the activity related to these interest rate swap agreements while they were previously designated as cash flow hedges, and this amount will be recognized in the Company's net income as a portion of "interest expense" over the remaining contractual life of the agreements. All forecasted transactions associated with interest rate swap agreements previously designated as cash flow hedges are expected to occur. No amounts have been reclassified to net income in any period in connection with forecasted transactions that are no longer considered probable of occurring. The Company estimates the portion of existing net unrealized loss on discontinued cash flow hedges expected to be reclassified to net income within the next 12 months is $4,156.

The table below describes the components of the reclassification adjustments out of AOCI related to certain interest rate swaps that were formerly designated as cash flow hedges and recognized as a portion of "interest expense" on the Company statements of comprehensive income for the periods indicated:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Reclassification adjustment due to amortization of de-designated cash flow hedges	$	1,442	$	2,583	$	5,339	$	2,583
Reclassification adjustment due to recognition of interest expense from cash flow hedges	—		—		—		8,796
Total reclassification adjustment related to cash flow hedges	$	1,442	$	2,583	$	5,339	$	11,379

Many of the Company's interest rate swaps were entered into under bilateral agreements which contain various covenants related to the Company’s credit risk. Specifically, if the Company defaults on any of its indebtedness, including those circumstances whereby repayment of the indebtedness has not yet been accelerated by the lender, or is declared in default of any of its covenants with any counterparty, then the Company could also be declared in default under the bilateral agreement. Additionally, these agreements allow those counterparties to require settlement of its outstanding derivative transactions if the Company fails to earn GAAP net income excluding derivative gains and losses greater than one dollar as measured on a rolling two quarter basis. These interest rate agreements also contain provisions whereby, if the Company fails to maintain a minimum net amount of shareholders’ equity, then the Company may be declared in default on its derivative obligations. The Company was in compliance with all covenants under bilateral agreements on September 30, 2014.

Please see Note 6 for the Company's disclosures related to offsetting assets and liabilities.

XML

Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

Preferred Stock [Text Block]

The Company has 2,300,000 shares of its 8.50% Series A Cumulative Redeemable Preferred Stock and 2,250,000 shares of its 7.625% Series B Cumulative Redeemable Preferred Stock issued and outstanding as of September 30, 2014 (collectively, the "Preferred Stock"). The Preferred Stock has no maturity and will remain outstanding indefinitely unless redeemed or otherwise repurchased or converted into common stock pursuant to the terms of the Preferred Stock. Except under certain limited circumstances intended to preserve the Company's REIT status, upon the occurrence of a change in control as defined in Article IIIA, Section 7(d) of the Company’s Articles of Incorporation, or to avoid the direct or indirect imposition of a penalty tax in respect of, or to protect the tax status of, any of the Company’s real estate mortgage investment conduits (“REMIC”) interests or a REMIC in which the Company may acquire an interest (as permitted by the Company’s Articles of Incorporation), the Company may not redeem the Series A Preferred Stock prior to July 31, 2017 or the Series B Preferred Stock prior to April 30, 2018. On or after these dates, at any time and from time to time, the Preferred Stock may be redeemed in whole, or in part, at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year. Because the Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company's consolidated balance sheet.

Schedule of Common Stock Outstanding Roll Forward [Table Text Block]

The following table presents a summary of the changes in the number of common shares outstanding for the periods presented:

	Nine Months Ended
	September 30,
	2014		2013
Balance as of beginning of period	54,310,484		54,268,915
Common stock issued under DRIP	12,459		509,831
Common stock issued under ATM program	—		180,986
Common stock issued or redeemed under stock and incentive plans	471,210		270,158
Common stock forfeited for tax withholding on share-based compensation	(59,336	)	(52,385	)
Common stock repurchased during the period	—		(751,456	)
Balance as of end of period	54,734,817		54,426,049

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Restricted stock outstanding as of beginning of period	746,830		526,803		520,969		448,283
Restricted stock granted	—		—		457,538		255,158
Restricted stock vested	(2,917	)	(2,917	)	(234,594	)	(179,555	)
Restricted stock outstanding as of end of period	743,913		523,886		743,913		523,886

Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]

The following table presents the amortization schedule for the Company's non-vested restricted stock remaining to be amortized into compensation expense as of September 30, 2014:

	Restricted Stock Amortization To Be Recognized
Within 12 months	$	2,411
13-24 months	1,663
25-36 months	750
37-48 months	145
Total restricted stock amortization remaining	$	4,969

XML

Derivatives (Tables)

9 Months Ended

Sep. 30, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

The table below summarizes information about the Company’s derivative instruments treated as trading instruments on its consolidated balance sheet as of the dates indicated:  

	September 30, 2014
	Derivative Assets				Derivative Liabilities
Trading Instruments	Fair Value		Notional		Fair Value			Notional
Interest rate swaps	$	6,958	$	800,000	$	(437	)	$	150,000
Eurodollar futures (1)	339		3,900,000		(17,621		)	12,700,000
Total	$	7,297	$	4,700,000	$	(18,058	)	$	12,850,000

	December 31, 2013
	Derivative Assets				Derivative Liabilities
Trading Instruments	Fair Value		Notional		Fair Value			Notional
Interest rate swaps	$	18,488	$	575,000	$	(1,336	)	$	215,000
Eurodollar futures (1)	—		—		(5,345		)	9,000,000
Total	$	18,488	$	575,000	$	(6,681	)	$	9,215,000

(1) The Eurodollar futures aggregate notional amount represents the total notional of the 3-month contracts with expiration dates from 2015 to 2020. The maximum notional outstanding for any future 3-month period did not exceed $1,300,000 as of September 30, 2014 and $1,175,000 as of December 31, 2013.

Schedule of Derivative Instruments [Table Text Block]

The following table summarizes the contractual maturities remaining for the Company’s outstanding interest rate swap agreements as of September 30, 2014:

Remaining Maturity	Pay-Fixed Interest Rate Swaps		Pay-Fixed Weighted-Average Rate(1)		Receive Fixed Interest Rate Swaps		Receive-Fixed Weighted-Average Rate
37-48 months	$	185,000	0.92	%	$	—	—	%
49-60 months	235,000		1.45	%	250,000		1.91	%
61-72 months	25,000		1.61	%	—		—	%
73-84 months	50,000		2.20	%	—		—	%
85-96 months	—		—	%	—		—	%
97-108 months	30,000		1.93	%	—		—	%
109-120 months	150,000		2.17	%	25,000		2.71	%

Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]

The following table summarizes the volume of activity related to derivative instruments for the periods indicated:

For the nine months ended September 30, 2014:	Beginning of Period Notional Amount		Additions		Settlement, Termination, Expiration or Exercise			End of Period Notional Amount
Receive-fixed interest rate swaps	$	—	$	275,000	$	—		$	275,000
Pay-fixed interest rate swaps	790,000		75,000		(190,000		)	675,000
Eurodollar futures	9,000,000		7,600,000		—			16,600,000
	$	9,790,000	$	7,950,000	$	(190,000	)	$	17,550,000

Schedule of Derivative Instruments Included in Trading Activities [Table Text Block]

The table below provides detail of the Company's "gain (loss) on derivative instruments, net" by type of interest rate derivative for the periods indicated:

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
Type of Derivative Instrument	2014		2013			2014			2013
Receive-fixed interest rate swaps	$	339	$	—		$	339		$	—
Pay-fixed interest rate swaps	646		(6,225		)	(20,056		)	5,111
Eurodollar futures	3,857		(17,794		)	(11,937		)	(17,794		)
Gain (loss) on derivative instruments, net	$	4,842	$	(24,019	)	$	(31,654	)	$	(12,683	)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

The table below describes the components of the reclassification adjustments out of AOCI related to certain interest rate swaps that were formerly designated as cash flow hedges and recognized as a portion of "interest expense" on the Company statements of comprehensive income for the periods indicated:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Reclassification adjustment due to amortization of de-designated cash flow hedges	$	1,442	$	2,583	$	5,339	$	2,583
Reclassification adjustment due to recognition of interest expense from cash flow hedges	—		—		—		8,796
Total reclassification adjustment related to cash flow hedges	$	1,442	$	2,583	$	5,339	$	11,379

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Organization [Text Block]

Organization

Dynex Capital, Inc., ("Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").

Basis of Presentation [Policy Text Block]

Basis of Presentation

The accompanying unaudited consolidated financial statements of Dynex Capital, Inc. and its subsidiaries (together, “Dynex” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all significant adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the consolidated financial statements have been included. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2014. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC.

Reclassifications [Policy Text Block]

Reclassifications

Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current year’s presentation. The Company's consolidated balance sheet as of December 31, 2013 now presents its "securitized mortgage loans, net" and "other investments, net" together as "mortgage loans held for investment, net". In addition, the Company has combined the presentation of its consolidated statements of income and its consolidated statements of other comprehensive income together as one financial statement which is now titled "consolidated statements of comprehensive income". The Company's "interest income - securitized mortgage loans" and "interest income-other investments" on its consolidated statements of income for the three and nine months ended September 30, 2013 is now presented together as "interest income-mortgage loans held for investment" on its consolidated statements of comprehensive income for the three and nine months ended September 30, 2013. These presentation changes have no effect on reported total assets, total liabilities, results of operations, or cash flow activities.

Consolidation [Policy Text Block]

Consolidation

The consolidated financial statements include the accounts of the Company and the accounts of its majority owned subsidiaries and variable interest entities for which it is the primary beneficiary. All significant intercompany accounts and transactions have been eliminated in consolidation.

In accordance with Accounting Standards Codification ("ASC") Topic 810, the Company consolidates certain trusts through which it has securitized mortgage loans as a result of not meeting the sale criteria under GAAP at the time the financial assets were transferred to the trust. Additional information regarding the accounting policy for its securitized mortgage loans is provided below under "Mortgage Loans Held for Investment, Net".

Use of Estimates [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, fair value measurements of its investments, other-than-temporary impairments, contingencies, and amortization of premiums and discounts. These items are discussed further below within this note to the consolidated financial statements.

Federal Income Taxes [Policy Text Block]

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT") under the Internal Revenue Code of 1986 and the corresponding provisions of state law. To qualify as a REIT, the Company must meet certain tests including investing in primarily real estate-related assets and the required distribution of at least 90% of its annual REIT taxable income to stockholders after consideration of its net operating loss carryforward and not including taxable income retained in its taxable subsidiaries. As a REIT, the Company generally will not be subject to federal income tax on the amount of its income or gain that is distributed as dividends to shareholders.

The Company assesses its tax positions for all open tax years and determines whether the Company has any material unrecognized liabilities in accordance with ASC Topic 740. The Company records these liabilities, if any, to the extent they are deemed more likely than not to have been incurred.

Mortgage Backed Securities [Policy Text Block]

Mortgage-Backed Securities

In accordance with ASC Topic 320, the Company has designated its investments in MBS as available-for-sale ("AFS"). All of the Company’s MBS are recorded at fair value on the consolidated balance sheet. Changes in fair value for the Company's AFS securities are reported in other comprehensive income ("OCI") until each security is collected, disposed of, or determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income ("AOCI") into net income as a realized "gain (loss) on sale of investments, net" using the specific identification method.

The Company’s MBS pledged as collateral against repurchase agreements and derivative instruments are included in MBS on the consolidated balance sheets with the fair value of the MBS pledged disclosed parenthetically.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on MBS is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or "IO", securities) and their contractual terms.  Premiums and discounts on Agency MBS as well as any non-Agency MBS rated 'AA' and higher at the time of purchase are amortized into interest income over the expected life of such securities using the effective yield method and adjustments to premium amortization are made for actual cash payments as well as changes in projected future cash payments in accordance with ASC Topic 310-20. The Company's projections of future cash payments are based on input and analysis received from external sources and internal models, and includes assumptions about the amount and timing of credit losses, loan prepayment rates, fluctuations in interest rates, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets.

The Company holds non-Agency MBS that were rated less than 'AA' at the time of purchase by at least one national rating agency. These non-Agency MBS were purchased at discounts to their par value, which management does not believe to be substantial. The Company accretes the discount into income over the security's expected life, which reflects management's estimate of the security's projected cash flows in accordance with ASC Topic 325-40. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

Determination of MBS Fair Value.The Company estimates the fair value of the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company's MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security's coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. Refer to Note 7 for further discussion of MBS fair value measurements.

Other-than-Temporary Impairment.MBS is considered impaired when its fair value is less than its amortized cost. The Company evaluates all of its impaired MBS for other-than-temporary impairments ("OTTI") on at least a quarterly basis. An impairment is considered other-than-temporary if: (1) the Company intends to sell the MBS; (2) it is more likely than not that the Company will be required to sell the MBS before its fair value recovers; or (3) the Company does not expect to recover the full amortized cost basis of the MBS. If either of the first two conditions is met, the entire amount of the impairment is recognized in earnings. If the impairment is solely due to the inability to fully recover the amortized cost basis, the security is further analyzed to quantify any credit loss, which is the difference between the present value of cash flows expected to be collected on the MBS and its amortized cost. The credit loss, if any, is then recognized in earnings, while the balance of impairment related to other factors is recognized in other comprehensive income.

Following the recognition of an OTTI through earnings, a new cost basis is established for the security. Any subsequent recoveries in fair value may be accreted back into the amortized cost basis of the MBS on a prospective basis through interest income. Please see Note 3 for additional information related to the Company's evaluation for OTTI.

Mortgage Loans Held for Investment, Net [Policy Text Block]

Mortgage Loans Held for Investment, Net

Mortgage loans held for investment, net consist of mortgage loans originated or purchased by the Company from 1992-1998, and these mortgage loans are reported at amortized cost in accordance with ASC Topic 310-10. Substantially all of these loans have been pledged as collateral to support the repayment of securitization financing bonds issued by the Company. The associated securitization financing bonds are treated as debt of the Company and are presented as "non-recourse collateralized financing" on the consolidated balance sheet. Securitized mortgage loans can only be sold subject to the lien of the respective securitization financing indenture. An allowance has been established for currently existing and probable losses on the Company's mortgage loans held for investment.

Repurchase Agreements [Policy Text Block]

Repurchase Agreements

Repurchase agreements are accounted for as secured borrowings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments [Policy Text Block]

Derivative Instruments

The Company's derivative instruments, which currently include interest rate swaps and Eurodollar futures, are accounted for in accordance with ASC Topic 815, which requires an entity to recognize all derivatives as either assets or liabilities in the balance sheet and to measure those instruments at fair value. All periodic interest costs and other changes in fair value, including gains and losses recognized upon termination, associated with derivative instruments are recorded in "gain (loss) on derivative instruments, net" on the Company's consolidated statement of comprehensive income.

Effective June 30, 2013, the Company discontinued cash flow hedge accounting for derivative instruments which had previously been accounted for as cash flow hedges under ASC Topic 815. Activity up to and including June 30, 2013 for those agreements previously designated as cash flow hedges was recorded in accordance with cash flow hedge accounting as prescribed by ASC Topic 815, which states that the effective portion of the hedge relationship on an instrument designated as a cash flow hedge is reported in the current period's other comprehensive income while the ineffective portion is immediately reported as a component of the current period’s net income. The balance remaining in AOCI related to the de-designated cash flow hedges is amortized into the Company's net income as a portion of "interest expense" over the remaining life of the interest rate swap agreements. Subsequent to June 30, 2013, changes in the fair value of the Company's derivative instruments, plus periodic settlements, are recorded in the Company's net income as a portion of "gain (loss) on derivative instruments, net".

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. The Company attempts to minimize this risk by limiting its counterparties to major financial institutions with acceptable credit ratings, monitoring positions with individual counterparties and adjusting posted collateral as required.

Although MBS have characteristics that meet the definition of a derivative instrument, ASC 815 specifically excludes these instruments from its scope because they are accounted for as debt securities under ASC 320.

Stock-based Compensation [Policy Text Block]

Share-Based Compensation

Pursuant to the Company’s 2009 Stock and Incentive Plan ("SIP"), the Company may grant share-based compensation to eligible employees, directors or consultants or advisers to the Company, including stock awards, stock options, stock appreciation rights, dividend equivalent rights, performance shares, and restricted stock units. The Company's restricted stock currently issued and outstanding under this plan may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date and recognized as compensation cost over the requisite service period with a corresponding credit to shareholders' equity as required by ASC Topic 718. The requisite service period is the period during which an employee is required to provide service in exchange for an award, which is equivalent to the vesting period specified in the terms of the share-based based award. None of the Company's restricted stock awards have performance based conditions. The Company does not currently have any share-based compensation issued or outstanding other than restricted stock.

Contingencies [Policy Text Block]

Contingencies

In the normal course of business, there are various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, the Company evaluates whether to establish provisions for estimated losses from those matters in accordance with ASC Topic 450, which states that a liability is recognized for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed.

The Company and its subsidiaries are parties to various legal proceedings of which the ultimate outcome cannot be ascertained at this time. Although the results of those legal proceedings cannot be predicted with certainty, the Company believes, based on current knowledge, that the resolution of any of these proceedings will not have a material effect on the Company’s consolidated financial condition or liquidity. However, the resolution of any of those proceedings could have a material impact on consolidated results of operations or cash flows in a given future reporting period as the proceedings are resolved.

The Company has not been named as a party to any additional legal proceedings during the three or nine months ended September 30, 2014.

Recent Accounting Pronouncements [Text Block]

Recent Accounting Pronouncements

In June 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, which changes the accounting for repurchase-to-maturity transactions and repurchase financing arrangements. The guidance eliminates sale accounting for repurchase-to-maturity transactions and supersedes the guidance under which a transfer of a financial asset and a contemporaneous repurchase financing could be accounted for on a combined basis as a forward agreement, which has resulted in outcomes referred to as off-balance-sheet accounting. All of the Company's repurchase agreement transactions are accounted for as secured borrowings; therefore the accounting changes required by ASU No. 2014-11 do not impact the Company's consolidated financial statements. ASU No. 2014-11 also requires two additional disclosures about repurchase agreements and other similar transactions. The first disclosure requires an entity to disclose information on transfers accounted for as sales in transactions that are economically similar to repurchase agreements. The Company does not account for any of its repurchase agreement transactions as sales; therefore this new disclosure does not impact the Company's current disclosures. The second disclosure requires the following disclosures for repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions that are accounted for as secured borrowings: a disaggregation of the gross obligation by the class of collateral pledged; the remaining contractual tenor of the agreements; and a discussion of the potential risks associated with the agreements and the related collateral pledged, including obligations arising from a decline in the fair value of the collateral pledged and how those risks are managed. The Company already provides these disclosures in its "Notes to the Unaudited Consolidated Financial Statements" and within "Liquidity and Capital Resources" in Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Quarterly Report on Form 10-Q. The amendments provided in ASU No. 2014-11 are effective for public business entities for the first interim or annual period beginning after December 15, 2014. ASU No. 2014-11 will not have a material impact on the Company's consolidated financial statements.

In addition, the FASB issued ASU No. 2014-12, Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company has not issued and does not anticipate issuing any share-based payments with terms that require a performance-based target; therefore this ASU will not have an impact on the Company's consolidated financial statements.

The FASB issued ASU No. 2014-13, Consolidation (Topic 810): Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity, which provides an alternative to Topic 820, Fair Value Measurement, for measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity to eliminate the difference in the fair value of the financial assets of a collateralized financing entity, as determined under GAAP, when they differ from the fair value of its financial liabilities even when the financial liabilities have recourse only to the financial assets. When the measurement alternative is elected, both the financial assets and the financial liabilities of the collateralized financing entity should be measured using the more observable of the fair value of the financial assets or the fair value of the financial liabilities. The amendments clarify that when the measurement alternative is elected, a reporting entity's consolidated net income (loss) should reflect the reporting entity's own economic interests in the collateralized financing entity, including; (1) changes in the fair value of the beneficial interests retained by the reporting entity, and (2) beneficial interests that represent compensation for services. The measurement alternative provided in ASU No. 2014-13 may be applied using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. The amendments may also be applied retrospectively to all relevant prior periods beginning with the annual period in which ASU No. 2009-17 was initially adopted. ASU No. 2014-13 is effective for public entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2015, and early adoption is permitted as of the beginning of an annual period. Management has evaluated ASU No. 2014-13 and has determined that if the Company elects to adopt this measurement alternative in the future for its currently existing consolidated collateralized financing entity, it will not have a material impact on the Company's consolidated financial statements.

The FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance about management's responsibility under GAAP to evaluate whether there is substantial doubt about an organization's ability to continue as a going concern and to provide related footnote disclosures. Specifically, the ASU (1) provides a definition of the term "substantial doubt", (2) requires an evaluation by management every reporting period including interim periods, (3) provides principles for considering the mitigating effect of management's plans, (4) requires certain disclosures when substantial doubt exists regardless of the success of any mitigating plans or actions, (5) requires an express statement and other disclosures when substantial doubt is not alleviated, and (6) requires an assessment for a period of one year after the date that the financial statements are issued. The amendments in this ASU are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Management intends to comply with the requirements set forth in ASU No. 2014-15.

XML

Shareholders' Equity

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

Shareholders' Equity

SHAREHOLDERS' EQUITY

Preferred Stock

The Company has 2,300,000 shares of its 8.50% Series A Cumulative Redeemable Preferred Stock and 2,250,000 shares of its 7.625% Series B Cumulative Redeemable Preferred Stock issued and outstanding as of September 30, 2014 (collectively, the "Preferred Stock"). The Preferred Stock has no maturity and will remain outstanding indefinitely unless redeemed or otherwise repurchased or converted into common stock pursuant to the terms of the Preferred Stock. Except under certain limited circumstances intended to preserve the Company's REIT status, upon the occurrence of a change in control as defined in Article IIIA, Section 7(d) of the Company’s Articles of Incorporation, or to avoid the direct or indirect imposition of a penalty tax in respect of, or to protect the tax status of, any of the Company’s real estate mortgage investment conduits (“REMIC”) interests or a REMIC in which the Company may acquire an interest (as permitted by the Company’s Articles of Incorporation), the Company may not redeem the Series A Preferred Stock prior to July 31, 2017 or the Series B Preferred Stock prior to April 30, 2018. On or after these dates, at any time and from time to time, the Preferred Stock may be redeemed in whole, or in part, at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year. Because the Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company's consolidated balance sheet. The Company announced that it will pay its regular quarterly dividends on its Preferred Stock for the third quarter on October 15, 2014 to shareholders of record as of October 1, 2014.

Common Stock

The following table presents a summary of the changes in the number of common shares outstanding for the periods presented:

	Nine Months Ended
	September 30,
	2014		2013
Balance as of beginning of period	54,310,484		54,268,915
Common stock issued under DRIP	12,459		509,831
Common stock issued under ATM program	—		180,986
Common stock issued or redeemed under stock and incentive plans	471,210		270,158
Common stock forfeited for tax withholding on share-based compensation	(59,336	)	(52,385	)
Common stock repurchased during the period	—		(751,456	)
Balance as of end of period	54,734,817		54,426,049

The Company's Dividend Reinvestment and Share Purchase Plan ("DRIP") allows registered shareholders to automatically reinvest some or all of their quarterly common stock dividends in shares of the Company’s common stock and provides an opportunity for investors to purchase shares of the Company’s common stock, potentially at a discount to the prevailing market price. Of the 3,000,000 shares reserved for issuance under the Company's DRIP, there were 2,454,439 shares remaining for issuance as of September 30, 2014. The Company declared a third quarter common stock dividend of $0.25 per share payable on October 31, 2014 to shareholders of record as of October 3, 2014. There was no discount for shares purchased through the DRIP during the third quarter of 2014.

The Company had approximately 7,416,520 shares of common stock that remain available to offer and sell through its sales agent, JMP Securities LLC, under its "at the market", or "ATM" program, as of September 30, 2014.

Of the $50,000 authorized by the Company's Board of Directors for the repurchase of its common stock through December 31, 2014, approximately $42,145 remains available for repurchase at the Company's option as of September 30, 2014.

2009 Stock and Incentive Plan. Of the 2,500,000 shares of common stock authorized for issuance under its 2009 Stock and Incentive Plan, the Company had 1,078,908 available for issuance as of September 30, 2014. Total stock-based compensation expense recognized by the Company for the three and nine months ended September 30, 2014 was $690 and $2,045 compared to $612 and $1,726 for the three and nine months ended September 30, 2013.

The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Restricted stock outstanding as of beginning of period	746,830		526,803		520,969		448,283
Restricted stock granted	—		—		457,538		255,158
Restricted stock vested	(2,917	)	(2,917	)	(234,594	)	(179,555	)
Restricted stock outstanding as of end of period	743,913		523,886		743,913		523,886

The combined grant date fair value of the restricted stock issued by the Company for the nine months ended September 30, 2014 was $3,703 compared to $2,708 for the nine months ended September 30, 2013. The following table presents the amortization schedule for the Company's non-vested restricted stock remaining to be amortized into compensation expense as of September 30, 2014:

	Restricted Stock Amortization To Be Recognized
Within 12 months	$	2,411
13-24 months	1,663
25-36 months	750
37-48 months	145
Total restricted stock amortization remaining	$	4,969

XML

Subsequent Events

9 Months Ended

Sep. 30, 2014

Subsequent Events [Abstract]

Subsequent Events

SUBSEQUENT EVENTS

Management has evaluated events and circumstances occurring as of and through the date this Quarterly Report on Form 10-Q was filed with the SEC and has determined that there have been no significant events or circumstances that qualify as a "recognized" or "nonrecognized" subsequent event as defined by ASC Topic 855.

XML

Net Income Per Common Share (Tables)

9 Months Ended

Sep. 30, 2014

Earnings Per Share, Basic and Diluted [Abstract]

Schedule of Calculation of Numerator and Denominator in Net Income Per Common Share [Table Text Block]

The following table presents the calculation of the numerator and denominator for both basic and diluted net income (loss) per common share for the periods indicated:

	For the Three Months Ended
	September 30, 2014					September 30, 2013
	Net  Income			Weighted-Average Common Shares		Net Loss			Weighted- Average Common Shares
Net income (loss)	$	30,866				$	(4,627	)
Preferred stock dividends	(2,294		)			(2,294		)
Net income (loss) to common shareholders	28,572			54,731,414		(6,921		)	54,903,637
Effect of dilutive instruments	—			—		—			—
Diluted net income (loss) to common shareholders	$	28,572		54,731,414		$	(6,921	)	54,903,637
Net income (loss) per common share:
Basic and diluted				$	0.52				$	(0.13	)

	For the Nine Months Ended
	September 30, 2014					September 30, 2013
	Net  Income			Weighted-Average Common Shares		Net  Income			Weighted- Average Common Shares
Net income (loss)	$	24,133				$	46,510
Preferred stock dividends	(6,882		)			(5,608		)
Net income (loss) to common shareholders	17,251			54,689,762		40,902			54,727,950
Effect of dilutive instruments	—			—		—			—
Diluted net income (loss) to common shareholders	$	17,251		54,689,762		$	40,902		54,727,950
Net income (loss) per common share:
Basic and diluted				$	0.32				$	0.75

XML

Fair Value of Financial Instruments Fair Value on a Recurring Basis (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	$ 3,615,393	$ 4,018,161
Derivative assets	7,297	18,488
Derivative Liabilities	18,058	6,681
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	3,615,393	4,018,161
Derivative assets	7,297	18,488
Total assets carried at fair value	3,622,690	4,036,649
Derivative Liabilities	18,058	6,681
Total liabilities carried at fair value	18,058	6,681
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	0	0
Derivative assets	339	0
Total assets carried at fair value	339	0
Derivative Liabilities	17,621	5,345
Total liabilities carried at fair value	17,621	5,345
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	3,563,819	3,944,681
Derivative assets	6,958	18,488
Total assets carried at fair value	3,570,777	3,963,169
Derivative Liabilities	437	1,336
Total liabilities carried at fair value	437	1,336
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	51,574	73,480
Derivative assets	0	0
Total assets carried at fair value	51,574	73,480
Derivative Liabilities	0	0
Total liabilities carried at fair value	$ 0	$ 0

XML

Offsetting Assets and Liabilities Offsetting Liabilities (Tables)

9 Months Ended

Sep. 30, 2014

Offsetting Liabilities [Line Items]

Offsetting Liabilities [Table Text Block]

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Posted as Collateral			Cash Posted as Collateral
September 30, 2014:
Derivative liabilities	$	18,058	$	—	$	18,058	$	(777	)	$	(17,281	)	$	—
Repurchase agreements	3,150,254		—		3,150,254		(3,150,254		)	—			—
	$	3,168,312	$	—	$	3,168,312	$	(3,151,031	)	$	(17,281	)	$	—
December 31, 2013:
Derivative liabilities	$	6,681	$	—	$	6,681	$	(1,299	)	$	(5,382	)	$	—
Repurchase agreements	3,580,754		—		3,580,754		(3,580,754		)	—			—
	$	3,587,435	$	—	$	3,587,435	$	(3,582,053	)	$	(5,382	)	$	—

XML

Mortgage Backed Securities Mortgage backed securities designated as Trading (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013
Schedule of Trading Securities and Other Trading Assets [Line Items]
MBS designated as trading, amortized cost	$ 27
MBS designated as trading, fair value	$ 29

XML

Consolidated Statements of Shareholders' Equity Statement (USD $) In Thousands	Total	Preferred Stock Including Additional Paid in Capital [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Retained Earnings [Member]	Shareholders' Equity [Member]
Total shareholders' equity, beginning balance at Dec. 31, 2013	$ 585,876	$ 109,658	$ 543	$ 761,550	$ (33,816)	$ (252,059)	$ 585,876
Stock issuance		0	1	215			216
Granting and vesting of restricted stock			4	2,041			2,045
Amortization of stock issuance costs				(72)			(72)
Adjustments for tax withholding on share-based compensation			(1)	(506)			(507)
Net income (loss)	24,133					24,133	24,133
Dividends on preferred stock						(6,882)	(6,882)
Dividends on common stock						(41,040)	(41,040)
Other comprehensive (loss) income	50,278						50,278
Total shareholders' equity, ending balance at Sep. 30, 2014	614,047	109,658	547	763,228		(275,848)	614,047
Total shareholders' equity, beginning balance at Jun. 30, 2014
Other comprehensive (loss) income	(14,482)				50,278
Total shareholders' equity, ending balance at Sep. 30, 2014	$ 614,047				$ 16,462

XML

Repurchase Agreements (Notes)

9 Months Ended

Sep. 30, 2014

Disclosure of Repurchase Agreements [Abstract]

Repurchase Agreements

REPURCHASE AGREEMENTS

The following tables present the components of the Company’s repurchase agreements as of September 30, 2014 and December 31, 2013 by the fair value and type of securities pledged as collateral:

	September 30, 2014
Collateral Type	Balance		Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,081,924	0.36	%	2,168,095
Agency CMBS	258,024		0.33	%	302,352
Agency CMBS IOs	351,518		0.94	%	411,686
Non-Agency RMBS	7,724		1.67	%	8,803
Non-Agency CMBS	198,203		1.16	%	240,802
Non-Agency CMBS IO	242,458		1.03	%	288,202
Securitization financing bonds	10,403		1.50	%	11,885
	$	3,150,254	0.53	%	$	3,431,825

	December 31, 2013
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,522,503		0.42	%	2,598,158
Agency CMBS	246,849			0.39	%	306,318
Agency CMBS IOs	369,948			1.16	%	449,072
Non-Agency RMBS	10,569			1.80	%	12,746
Non-Agency CMBS	303,674			1.27	%	367,859
Non-Agency CMBS IOs	106,803			1.27	%	136,227
Securitization financing bonds	20,651			1.59	%	19,686
Deferred costs	(243		)	n/a		n/a
	$	3,580,754		0.61	%	$	3,890,066

The combined weighted average original term to maturity for the Company’s repurchase agreements was 106 days as of September 30, 2014 compared to 114 days as of December 31, 2013. The following table provides a summary of the original maturities as of September 30, 2014 and December 31, 2013:

Original Maturity	September 30, 2014		December 31, 2013
Less than 30 days	$	574,164	$	4,736
30 to 90 days	566,959		1,176,631
91 to 180 days	1,514,454		1,439,225
181 to 364 days	329,232		960,405
1 year or longer	165,445		—
Deferred costs	—		(243		)
	$	3,150,254	$	3,580,754

As of September 30, 2014, shareholders' equity at risk did not exceed 10% for any of the Company's counterparties. The Company had $131,275 of its repurchase agreement balance as of September 30, 2014 outstanding under a two-year repurchase facility with Wells Fargo Bank National Association. This facility provides an aggregate maximum borrowing capacity of $250,000 and matures on August 6, 2015, subject to early termination provisions contained in the master repurchase agreement. The facility is collateralized primarily by CMBS IO, and its weighted average borrowing rate as of September 30, 2014 was 1.06%.

As of September 30, 2014, the Company had repurchase agreement amounts outstanding with 21 of its 33 available counterparties. The Company's counterparties, as set forth in the master repurchase agreement with the counterparty, require the Company to comply with various customary operating and financial covenants, including, but not limited to, minimum net worth, maximum declines in net worth in a given period, and maximum leverage requirements as well as maintaining the Company's REIT status. In addition, some of the agreements contain cross default features, whereby default under an agreement with one lender simultaneously causes default under agreements with other lenders. To the extent that the Company fails to comply with the covenants contained in these financing agreements or is otherwise found to be in default under the terms of such agreements, the counterparty has the right to accelerate amounts due under the master repurchase agreement. The Company was in compliance with all covenants as of September 30, 2014.

Please see Note 6 for the Company's disclosures related to offsetting assets and liabilities.

XML

Repurchase Agreements (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings	$ 3,150,254	$ 3,580,754
Repurchage agreement, Weighted Average Interest Rate	0.53%	0.61%
Fair Value of Collateral Pledged		3,890,066
Deferred Costs	0	(243)
Repurchase Agreement Counterparty, Weighted Average Maturity of Agreements	106 days	114 days
Collateralized Mortgage Obligations [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings		20,651
Repurchage agreement, Weighted Average Interest Rate	1.50%	1.59%
Fair Value of Collateral Pledged		19,686
Residential Mortgage Backed Securities [Member] | Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings	2,081,924	2,522,503
Repurchage agreement, Weighted Average Interest Rate	0.36%	0.42%
Fair Value of Collateral Pledged	2,168,095	2,598,158
Residential Mortgage Backed Securities [Member] | Non-Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings	7,724	10,569
Repurchage agreement, Weighted Average Interest Rate	1.67%	1.80%
Fair Value of Collateral Pledged	8,803	12,746
Commercial Mortgage Backed Securities [Member] | Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings	258,024	246,849
Repurchage agreement, Weighted Average Interest Rate	0.33%	0.39%
Fair Value of Collateral Pledged	302,352	306,318
Commercial Mortgage Backed Securities [Member] | Non-Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings	198,203	303,674
Repurchage agreement, Weighted Average Interest Rate	1.16%	1.27%
Fair Value of Collateral Pledged	240,802	367,859
CMBS IO [Member] | Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings	351,518	369,948
Repurchage agreement, Weighted Average Interest Rate	0.94%	1.16%
Fair Value of Collateral Pledged	411,686	449,072
CMBS IO [Member] | Non-Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements Accounted for as Secured Borrowings	242,458	106,803
Repurchage agreement, Weighted Average Interest Rate	1.03%	1.27%
Fair Value of Collateral Pledged	$ 288,202	$ 136,227

XML

Shareholders' Equity (Details) (USD $)	3 Months Ended		9 Months Ended						9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014 At the market progam [Member]	Sep. 30, 2013 At the market progam [Member]	Sep. 30, 2014 Series A Preferred Stock [Member]	Dec. 31, 2013 Series A Preferred Stock [Member]	Sep. 30, 2014 Series B Preferred Stock [Member]	Dec. 31, 2013 Series B Preferred Stock [Member]	Sep. 30, 2014 Common Stock [Member] At the market progam [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage							8.50%		7.625%
Preferred Stock, Liquidation Preference Per Share	$ 25.00		$ 25.00
Preferred Stock, Shares Issued							2,300,000	2,300,000	2,250,000	2,250,000
Shareholders' Equity, Common Stock [Roll Forward]
Balance as of beginning of period			54,310,484	54,268,915
Common stock issued under DRIP			12,459	509,831
Common stock issued under ATM program					0	180,986
Common stock issued or redeemed under stock and incentive Plans			471,210.00	270,158
Common stock forfeited for tax withholding on share-based compensation			(59,336)	(52,385)
Balance as of end of period	54,734,817	54,426,049	54,734,817	54,426,049
Dividend reinvestment plan, shares authorized	3,000,000		3,000,000
Stock issued during period, remaining shares available, dividend reinvestment plan	2,454,439		2,454,439
Dividends declared per common share	$ 0.25	$ 0.27	$ 0.75	$ 0.85
ATM program, authorized shares remaining											7,416,520
Stock Repurchase Program, Authorized Amount	$ 50,000,000		$ 50,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 42,145,000		$ 42,145,000
Stock Repurchased During Period, Shares			0	(751,456)

XML

Offsetting Assets and Liabilities Offsetting Assets (Tables)

9 Months Ended

Sep. 30, 2014

Offsetting Assets [Line Items]

Offsetting Assets [Table Text Block]

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Received as Collateral			Cash Received as Collateral
September 30, 2014:
Derivative assets	$	7,297	$	—	$	7,297	$	(478	)	$	(2,672	)	$	4,147
December 31, 2013:
Derivative assets	$	18,488	$	—	$	18,488	$	(193	)	$	(12,141	)	$	6,154